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“Adieu, dit le renard. Voici mon secret. Il est très simple: on ne voit bien qu’avec le 
coeur. L’essentiel est invisible pour les yeux!” 
Antoine de Saint-Exupéry (1900-1944) 
 
 
 
 
 
In tiefer Liebe und Dankbarkeit meinen Eltern, dass 
sie Mich die Bedeutung dieser Zeilen lehrten und 
meinen Brüder für ihre stete Hilfe auch in 
schwierigen Zeiten diese Zeilen nicht zu vergessen. 
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Explanation of the cover image 
 
 
 
 
 
GABAB1 protein in cultured hippocampal neurons 
Low-density cultured hippocampal neurons from WT mouse embryos were fixed at DIV23, permeabilized and 
triple-stained with a C-terminal antibody against GABAB1 (red), the dendritic marker MAP2 (blue) and the 
postsynaptic density protein PSD95 (green). The upper panel shows merged pictures from a triple staining 
(scale bar 25 ?m). The lower panels on the left represent separately the inverted images from the picture 
above (scale bar 25 ?m). The panels on the right show a dendritic section (scale bar 5 ?m).  GABAB1 punctae 
are rarely co-localizing with PSD95, indicating that most dendritic GABAB1 protein is present at 
extrasynaptic sites. A weak punctuate GABAB1 labeling is further visible in the axon (MAP2 negative; for 
more details about materials and methods see chapter 3).
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Summary 
 
GABAB receptors are G protein-coupled receptors for ?-aminobutyric acid (GABA), 
the main inhibitory neurotransmitter in the CNS. As such they mediate the late phase of 
GABAergic inhibitory neurotransmission and are promising drug targets for neurological 
and mental health disorders. Molecular diversity in the GABAB system arises from the 
GABAB1a and GABAB1b subunit isoforms, both of which assemble with the GABAB2 
subunit to form functional heteromeric receptors. Structurally, GABAB1a differs from 
GABAB1b by a pair of evolutionary conserved protein interaction motifs, the sushi domains 
(SDs). It is now generally accepted that two GABAB receptor subtypes, GABAB(1a,2) and 
GABAB(1b,2), are co-expressed in most if not all neurons. Drug development in the GABAB 
field has been hampered by the fact that receptor subtypes have indistinguishable 
pharmacological properties. Thus, any progress in the understanding of a differential 
distribution or functional regulation of receptor subtypes harbors high potential for 
therapeutic interference.  
Using genetically modified mice we were the first to demonstrate that the two 
GABAB receptor subtypes engage in non-redundant functions owing to their differing pre- 
versus postsynaptic localization. Most strikingly, it was observed that selectively GABAB1a 
assembles heteroreceptors controlling glutamate release, while predominantly GABAB1b 
mediates postsynaptic inhibition. To further unravel the molecular mechanism underlying 
GABAB receptor compartmentalization I aimed at identifying sequence determinants 
accounting for the selective occurrence of GABAB(1a,2) receptors at glutamatergic 
terminals. I analyzed the axonal versus dendritic distribution of diverse epitope-tagged 
expression constructs of individual GABAB receptor subunits in cultured hippocampal 
neurons. Thereby, I demonstrate that the GABAB1a-specific SDs engage in axonal 
targeting. Disruption of disulfide bond formation in the SDs abolishes GABAB1a axonal 
localization indicating that proper folding of the SDs is important for specific interaction 
with axon targeting proteins. Furthermore, the SDs are able to redirect a typical 
somatodendritic receptor to axons, thus dominating over dendritic targeting information. In 
addition, I provide evidence that somatodendritic targeting of GABAB receptors is 
mediated by sequences in the cytoplasmic C-terminal domain of the GABAB2 subunit. 
Thus a combination of distinct signals compartmentalizes GABAB receptors to pre- and 
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postsynaptic sites. Last, I demonstrate that exogenous application of a soluble recombinant 
SD protein to cultured hippocampal neurons completely abolishes heteroreceptor function. 
A likely mechanism involves scavenging of auxiliary cell surface proteins that normally 
bind to the SDs. This indicates that the SDs in GABAB1a not only mediate axonal targeting 
but further engage in a specific protein interaction at the cell surface, which is subject to 
modulation thereby regulating heteroreceptor function.  
It thus appears that the SDs interact with (diverse) intracellular and extracellular 
proteins important for the localization and proper function of GABAB(1a,2) receptors at 
glutamatergic terminals. This finding further provides a first potential tool for a selective 
therapeutic interference within the GABAB field. 
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Outline of the thesis 
 
Chapter I: Introduction 
This chapter briefly introduces the field of GABAB receptors and provides a short 
overview about axonal versus dendritic protein segregation in polarized neurons. It 
further explains the topic of this doctoral thesis. 
 
Chapter II: Differential compartmentalization and distinct functions of GABAB 
receptor variants 
By morphological and electrophysiological analysis of genetically modified mice 
we initially demonstrated that GABAB1 subunit isoforms localize to distinct 
synaptic sites and convey non-redundant functions.  
 
Chapter III: The N-terminal sushi domains of GABAB receptors function as a 
dominant axonal targeting signal 
In this second experimental approach, we address the role of the GABAB1a-specific 
SDs in the axonal targeting of GABAB(1a,2) receptors in glutamatergic neurons. 
 
Chapter IV: The sushi domains of secreted GABAB1 isoforms selectively impair 
GABAB heteroreceptors 
This study identifies GABAB1j, a soluble GABAB1 subunit isoform encoding the 
two SDs. Soluble recombinant SD protein (RSDP) mimicking GABAB1j, impaired 
GABAB heteroreceptor function, while leaving auto- and postsynaptic receptors 
unaffected. This provides a first tool for a selective interference with the GABAB 
receptor system. 
 
Chapter V: Discussion and Perspectives 
This last chapter summarizes the main findings described in chapter 2, 3 and 4 and 
discusses them with respect to the current understanding of GABAB receptor 
signalling.  
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GABAB receptors 
 
GABA is the main inhibitory neurotransmitter in the mammalian brain and modulates 
neuronal excitability by activating ionotropic GABAA/C receptors as well as metabotropic 
GABAB receptors. GABAB receptors were first identified based on their distinct 
pharmacological profile compared to ionotropic GABAA/C receptors (Hill & Bowery, 1981) 
and only subsequently were shown to function as G protein-coupled receptors (Hill, 1985). 
As such GABAB receptors mediate the late phase of GABAergic inhibitory 
neurotransmission in the CNS and are promising drug targets for neurological and mental 
health disorders like epilepsy, pain, spasticity, addiction, schizophrenia, depression and 
anxiety (Enna & Bowery, 2004; Bettler et al., 2004; Cryan & Kaupmann, 2005; Bowery, 
2006).  
 
 
Pre- versus postsynaptic localization and physiological function 
GABAB receptors are expressed on pre- and, more abundantly, on postsynaptic elements of 
GABAergic and glutamatergic neurons (Kaupmann et al., 1998; Kulik et al., 2002; Lopez-
Bendito et al., 2002; Kulik et al., 2003; Koyrakh et al., 2005). Presynaptic GABAB 
receptors are mainly detected in the extrasynaptic membrane and occasionally over 
presynaptic membrane specializations, while postsynaptic GABAB receptors are 
predominantly distributed to dendritic shafts and the extrasynaptic plasma membrane of 
spines (Drake et al., 1997; Kulik et al., 2003).  Activation of presynaptic GABAB receptors 
located on GABAergic terminals (autoreceptors) or other nerve terminals (heteroreceptors) 
suppresses neurotransmitter release by inhibiting voltage-sensitive Ca
2+
 channels (Mintz & 
Bean, 1993; Thompson et al., 1993; Poncer et al., 1997) and modulating synaptic vesicle 
priming (Sakaba & Neher, 2003). Stimulation of postsynaptic GABAB receptors produces 
a prolonged neuronal hyperpolarization through activation of inwardly rectifying Kir3-type 
K
+
 channels, which induce a slow inhibitory postsynaptic current (sIPSC) (Lüscher et al., 
1997). Both pre- and postsynaptic effector channels are regulated by the ??-subunit of the 
activated G-protein (Bowery et al., 2002; Calver et al., 2002; Bettler et al., 2004), while the 
G?i/o-subunit inhibits adenylate cyclase (Hill, 1985) with putative effects on transcription 
factors (Steiger et al., 2004) and kinases (Diverse-Pierluissi et al., 1997; Couve et al., 2002; 
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Ren & Mody et al., 2003). GABAB receptors further modulate synaptic plasticity (Davies 
et al., 1991; Patenaude et al., 2003; Huang et al., 2005), heterosynaptic depression (Vogt & 
Nicoll, 1999), population burst firing and inhibit backpropagating action potentials 
(Zilberter et al., 1999; Leung & Peloquin, 2006).  
 
 
Heteromer formation 
Biochemical and pharmacological studies in various in vivo preparations initially suggested 
the existence of a multitude of GABAB receptor subtypes with specific subcellular 
distribution and effector systems, analogous to the metabotropic glutamate receptors (Kerr 
& Ong, 1995; Conn & Pin, 1997). Molecular cloning, however, has only identified two 
genes encoding for GABAB receptors, namely GABAB1 and GABAB2 (Kaupmann et al., 
1997, 1998; Bettler et al., 2004), disproving the predicted diversity of native GABAB 
receptors based on pharmacological studies. The present dogma stipulates that functional 
GABAB receptors are heteromers assembled from GABAB1 and GABAB2 subunits 
(Kaupmann et al., 1998; Marshall et al., 1999; Mohler & Fritschy, 1999; Bettler et al., 
2004). The two subunits are functionally unique in that GABAB1 binds GABA with high 
affinity, whereas GABAB2 mediates coupling to G proteins (Pin et al., 2004).  
 
 
Surface trafficking 
The C-terminal domain of the GABAB1 subunit harbours an arginine-based ER 
retention/retrieval signal, RSRR, which retains unassembled GABAB1 subunits in the ER 
and restricts surface expression only to correctly assembled heteromeric receptors (Couve 
et al., 1998; Margeta-Mitrovic et al., 2000; Pagano et al., 2001). Presumably, the GABAB2 
subunit triggers forward trafficking by masking the RSRR motif. Monomeric GABAB1 
subunits that escape from the ER to the cis-Golgi compartment bind to COPI via the RSRR 
signal and are probably transported back to the ER via COPI - coated vesicles (Brock et al., 
2005). Scaffolding proteins of the 14-3-3 family compete with COPI for RSRR binding, 
however, their function remains elusive (Couve et al., 2001; Brock et al., 2005). The 
coiled-coil domain of GABAB1 contains an LL-motif involved in the association with 
msec7-1, a guanine-nucleotide-exchange factor (GEF) for ADP-ribosylation factor (ARF) 
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family of GTPases (Restitutio et al., 2005). msec7-1 acts at the level of the trans-Golgi 
network (TGN) and probably controls GABAB receptor export from this organelle. 
Moreover, the ?2S subunit of GABAA receptors has been shown to associate with GABAB1 
subunits and promotes their cell surface expression in the absence of GABAB2. This 
interaction further enhances agonist-induced internalization of heteromeric GABAB 
receptors (Balasubramanian et al., 2004).  
 
 
Molecular diversity 
Molecular diversity in the GABAB system arises from the GABAB1a and GABAB1b 
isoforms (Kaupmann et al., 1997), which are both generated from the GABAB1 gene by 
alternative promoter usage (Bischoff et al., 1999; Steiger et al., 2004). Structurally, the two 
subunit isoforms differ in their extracellular N-terminal domain by a pair of tandemly 
arranged SDs that are unique to GABAB1a and replaced by a short 18 amino acid sequence 
in GABAB1b (Hawrot et al., 1998; Blein et al., 2004). It is now generally accepted that two 
GABAB receptor subtypes, GABAB(1a,2) and GABAB(1b,2) are co-expressed in most if not all 
neurons of the central nervous system, and are pharmacologically and biophysically 
indistinguishable in vitro (Brauner-Osborne and Krogsgaard-Larsen, 1999).  
                    
Indirect evidence had long anticipated a differential segregation of GABAB1a and 
GABAB1b to pre- and postsynaptic structures (Benke et al., 1999; Billinton et al., 1999; 
Bischoff et al., 1999), but until recently no solid evidence was available. Of note, a 
differential distribution together with separate transcriptional control would allow for a 
high degree of plasticity permiting dynamically adjustable GABAB signalling in 
subcellular compartments. Classical compounds interfering with the GABAB system, like 
the GABAB receptor agonist baclofen, activate both GABAB receptor subtypes and cause 
the rapid development of tolerance and adverse effects in humans following systematic 
administration. Thus, differences in signalling between GABAB1 isoforms would 
potentially open up new opportunities for therapeutic interference with the GABAB system 
(Bonanno & Raiteri, 1999; Gemignani et al., 1994; Cunningham & Enna, 1996; Deisz et 
al., 1997; Mohler & Fritschy, 1999; Yamada et al., 1999; Bowery et al., 2002). However, 
the lack of subunit specific antibodies and selective pharmacological tools has so far 
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hindered the visualization of individual GABAB1 subunit isoforms in distinct subcellular 
compartments and prevented to study the individual contributions of GABAB1a and 
GABAB1b to pre- and postsynaptic GABAB functions.  
 
 
Sushi domains 
SDs, also known as complement control protein (CCP) modules or short consensus repeats 
(SCR), are evolutionary conserved protein interaction motifs (Lehtinen et al., 2004) that 
were first identified in Factor B, a protein of the complement system (Morley and 
Campbell, 1984). The three-dimensional structure of a typical SD has a compact 
hydrophobic core containing conserved residues sandwiched between small antiparallel ?-
sheets (Blein et al., 2004). Often occurring in multiple copies, SDs are structural motifs of 
about 60 amino acids characterized by a consensus sequence that includes four invariant 
cysteines, an almost invariant tryptophan and highly conserved prolines, glycines and 
hydrophobic residues (Kirkitadze & Barlow, 2001; Blein et al., 2004). The four cysteines 
form two disulfide bridges in a 1-3 and 2-4 pattern, which are essential for the SDs to 
maintain their tertiary structure. Recently, a SD was identified as the structural fold in the 
N-terminal hormone-binding domain of corticotrophin-releasing factor receptors (Perrin et 
al., 2006) raising the possibility that SDs are more universally used for regulating GPCR 
function (Grace et al., 2004). The SDs in GABAB1a display strikingly different structural 
properties: the first, N-terminal SD exhibits conformational heterogeneity under a wide 
range of conditions and interacts with the extracellular matrix protein fibulin-2, whereas 
the second SD is more compactly folded and shows stronger structural similarity to SDs in 
regulators of complement activation (Blein et al., 2004). It is thus likely that the GABAB1a-
specific SDs interact with multiple partners, which could generate some of the 
heterogeneity in the GABAB system predicted by studies with native GABAB receptors.  
 
                                                 
Vectorial protein transport in polarized neurons 
 
Polarity is a pivotal requirement for neuronal communication. On a basic level neurons are 
divided into two functionally and biochemically distinct domains: the axonal and 
  Chapter I - Introduction 
 
  
18 
somatodendritic compartment (Craig & Banker, 1994; Winkler & Mellmann, 1999). 
However, there are important functional specializations within these two compartments, 
which exhibit plasma membrane regions with specific molecular compositions (Horton & 
Ehlers, 2003). Among such specializations are the axonal initial segment, the nodes of 
Ranvier in myelinated neurons, presynaptic active zones as well as postsynaptic densities. 
It is thus evident that lipids, organelles, mRNAs and proteins must be precisely distributed 
to these specific subcellular compartments. This is especially important for the pre- versus 
postsynaptic segregation of neurotransmitter receptors being directly responsible for 
information transmission. Lateral diffusion of plasma membrane components between the 
axonal and somatodendritic compartment is inhibited by a cytoskeleton-based fence at the 
axonal initial segment (Kobayashi et al., 1992; Winckler & Mellmann, 1999). 
Nevertheless, how membrane proteins are initially sorted to axons and dendrites is still 
poorly defined. 
 
 
Protein targeting in epithelial and neuronal cells – a comparison 
Polarized membrane traffic is best understood in epithelial cells, where the plasma 
membrane is separated into basolateral and apical surfaces (Mellman 1995; Mostov & 
Cardone, 1995; Folsch et al., 1999; Mostov et al., 2003). Epithelial Madin-Darby canine 
kidney (MDCK) cells use the trans-Golgi network (TGN) as the main sorting station for 
polarized cargo by selectively accumulating membrane proteins destined for different 
domains into distinct vesicle populations (Wandinger-Ness et al., 1990). In contrast, 
hepatocytes, another epithelial cell type, transport almost all membrane proteins first to the 
basolateral surface. Subsequently, proteins scheduled for the apical surface are internalized 
and resorted towards the apical domain via endosomes, a process referred to as 
“transcytosis” or “indirect route” (Tuma and Hubbard, 2003). Neurons develop from the 
primitive neuroepithelium and thus could share sorting mechanisms with epithelial cells. 
Based on experiments studying the vectorial trafficking of apical and basolateral proteins 
in cultured hippocampal neurons it was hypothesized that the somatodendritic 
compartment corresponds to the basolateral compartment, whereas the apical compartment 
is the equivalent of the axonal compartment (Dotti & Simons, 1990). Indeed, for some 
transmembrane proteins basolateral signals also determine somatodendritic targeting. 
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However, the signals that target proteins to the apical membrane do not always appear to 
work for axonal targeting (West et al., 1997a; Jareb and Banker, 1998).  
 
 
Polarized protein transport in neurons 
In neurons, the majority of functional membrane proteins is synthesized in the cell body 
and subsequently transported to their target destination in axons or dendrites. In addition, 
some specific mRNAs are delivered to dendrites, where so called Golgi outposts support 
local protein synthesis (Job & Eberwine 2001; Hirokawa, 2006; Gardiol A et al., 1999; 
Horton & Ehlers 2003a). The extent to which protein synthesis occurs at presynaptic sites 
remains elusive, but recent evidence suggests that mRNAs are also present and translated 
locally in axons (Alvarez et al., 2000; Guiditta et al., 2002; Piper & Holt, 2004). 
Like in MDCK cells, most axonal and dendritic membrane proteins are sorted into specific 
post-Golgi carriers and transported by microtubuli-dependent motors to the appropriate 
domain (Hirokawa & Takemura, 2005). Microtubuli are dynamic polymers with intrinsic 
polarity (Desai & Mitchison 1997). In axons and distal dendrites microtubuli are unipolar, 
whereas proximal dendrites contain microtubuli of mixed polarity (Burton & Paige 1981; 
Baas et al., 1988; Hirokawa & Takemura, 2005). Selectivity is further provided by the 
kinesin-superfamily of molecular motor proteins. Fourty-five family-members were 
identified in neurons, each holding binding affinities for different cargos. Moreover, 
individual kinesins possess differential preference for axonal or dendritic microtubuli 
(Hirokawa 1998; Baas et al., 1999; Hirokawa & Takemura, 2005).  
At the surface, the protein-laden vesicles fuse with the plasma membrane. Membrane 
proteins are thus inserted and subsequently linked to the submembranous cytoskeleton if 
they have reached the appropriate compartment. Otherwise, proteins are internalized and 
degraded or resorted towards the correct location.  The information required for such 
directional transport is usually harboured in the amino acid sequence or tertiary structure of 
the given protein or provided by posttranslational modifications. Such structural motifs 
typically associate with specific molecules like molecular motors or clathrin adaptors. The 
two following sections state some examples for axonal and somatodendritic targeting 
signals. 
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Somatodendritic determinants 
Somatodendritic targeting is mostly mediated by amino acid residues in the cytoplasmic 
domains of transmembrane proteins. The low-density lipoprotein receptor (Jareb and 
Banker, 1998) and the transferrin receptor (West et al., 1997; Jareb and Banker, 1998) are 
targeted to dendrites by a cytosolic tyrosine-based motif characterized by an essential 
tyrosine in the context of YXX? (where X represents any amino acid and ? is a bulky 
hydrophobic residue). Dendritic targeting of glycine transporter 1b (Poyatos et al, 2000) 
and potassium channel Kv4.2 (Rivera et al., 2003) is mediated by dileucine-based motifs. 
Both tyrosine-based and dileucine-containing signals have been shown to bind to subunits 
of adaptor protein complexes (Ohno et al., 1995; Rapoport et al., 1998). It is possible that 
the interaction of such adaptors with the targeting motifs may either initialize clathrin-
mediated endocytosis of the existing receptors or contribute to the loading of newly 
synthesized receptors into vesicles bound for specific localizations (Burack et al., 2000; 
Garrido et al., 2001; Bonifacino & Traub, 2003).  
 
 
Axonal determinants 
Much less is known about the signals that lead to the targeting of proteins towards the 
axonal compartment (Winckler & Mellman, 1999; Burack et al., 2000). The first identified 
discrete motif required for axonal targeting was a RRK-tripeptide in the membrane 
proximal region of mGluR1 receptors. It directs the shorter splice variant mGluR1b to 
axons of chick retinal cells. However, it is masked in mGluR1a by its longer C-terminal 
domain harbouring somatodendritic targeting information (Francesconi & Duvoisin, 2002). 
For mGluR5 the interaction with different splice variants of Homer1 protein regulates 
axonal versus dendritic targeting. In cerebellar granule cells, Homer1b/c translocates 
mGluR5 to dendrites, whereas Homer1a mediates distribution to both axons and dendrites 
(Ango et al., 2000). In contrast, a cytoplasmic 60 amino acid motif determines both 
dendritic targeting of mGluR2 and axonal targeting of mGluR7 (Stowell & Craig, 1999). 
Moreover, the voltage-gated Shaker K+ channel Kv1.2 is targeted to the axonal 
compartment by a cytosolic T1 domain, a region of ~130 amino acid residues that mediates 
tetramerization (Gu et al., 2003). Interaction between the T1 domain and the auxiliary 
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Kv?(2) subunit links Kv1.2 channels to EB1 (microtuble (MT) plus-end tracking protein 
(+TIP) end-binding-protein 1) and KIF3/kinesin II (Gu et al., 2006) and is thus mandatory 
for axonal trafficking. Furthermore, short peptide motifs that include palmitoylation signals 
specifically target intracellular proteins like GAP-43 and GAD-65 to the Golgi apparatus 
and subsequently to the axon (El-Husseini Ael et al., 2001; Kanaani et al., 2002).  
 
 
Topic of the thesis 
 
GABAB receptors mediate the late phase of GABAergic inhibitory neurotransmission and 
as such are promising drug targets for neurological and mental health disorders (Enna & 
Bowery, 2004; Bettler et al., 2004; Cryan & Kaupmann, 2005; Bowery, 2006). It is now 
generally accepted that two GABAB receptor subtypes, GABAB(1a,2) and GABAB(1b,2), are 
coexpressed in most if not all neurons. Nevertheless, drug development in the GABAB 
field has been hampered since receptor subtypes have indistinguishable pharmacological 
properties. A differential segregation of GABAB1a and GABAB1b isoforms to pre- and 
postsynaptic structures was expected based on earlier studies (Benke et al., 1999; Billinton 
et al., 1999; Bischoff et al., 1999), but solid evidence was lacking. To dissociate the native 
functions of GABAB receptor subtypes knock-in mice with point-mutations in the 
translation start codons of either the GABAB1a or GABAB1b transcript were generated. 
Morphological and electrophysiological analysis of these mice revealed that the two 
pharmacological indistinguishable GABAB1 isoforms localize to distinct synaptic sites and 
convey non-redundant functions. Most strikingly it was observed that at CA3-to-CA1 
synapses in the hippocampus GABAB1a assembles heteroreceptors controlling glutamate 
release, while postsynaptic inhibition is predominantly mediated by GABAB1b. Moreover, 
transfected CA3 pyramidal neurons exhibited a remarkable expression of GABAB1a, but 
not GABAB1b protein in axon, whereas both isoforms are present in dendrites. This was the 
first solid evidence for a differential compartmentalization of GABAB1 isoforms. Since the 
GABAB1a-specific SDs provide the only region of sequence divergence between the two 
GABAB1 isoforms, they are likely engaged in their segregation. The molecular mechanism 
underlying GABAB receptor compartmentalization is still poorly defined. Within this 
doctoral thesis I thus aimed at deciphering the role of the SDs in the pre- versus 
postsynaptic distribution and functional segregation of GABAB receptor subtypes. 
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My contribution to this paper 
This PhD thesis is based on a study published by Bischoff et al. in 1999. They analyzed the 
spatial distribution of GABAB1a and GABAB1b transcripts as well as GABAB receptor 
binding sites in rat cerebellum. They found that GABAB1a transcripts are mainly present in 
the granule cell layer, whereas GABAB1b mRNA was predominantly localized in the 
Purkinje cell layer. In addition, GABAB receptor binding sites were basically detected in 
the molecular cell layer, where parallel fibers make synapses onto Purkinje cells (Figure 
S2.1). They therefore suggested that the GABAB1a subunit isoform assembles presynaptic  
 
 
 
 
Figure S2.1: Model of the possible localization of the GABAB1a and GABAB1b receptor subunits on the 
cerebellar circuitry. This hypothetical model is based on the data on the localization of the mRNA 
transcripts, the autoradiographic distribution of [3H]CGP 54626-labeled binding sites, and the first 
immunohistochemical data with ultrastructural localization of antibodies in the molecular (Mol), Purkinje 
cell (Pl), and granular layers (Gr) of the cerebellum. The GABAB1b subunit, which is essentially expressed in 
Purkinje cells, might play a key role in the inhibitory output of the cerebellum. The GABAB1a subunit is 
expected to be located on presynaptic terminals of the glutamate-containing (Glu) parallel fibers (PF), the 
excitatory climbing fibers (CF) of glutamate and/or aspartate nature (Glu/Asp) and the 
serotonin/noradrenaline modulatory afferents from the raphe nucleus (RN) and locus coerulus (LC). In view 
of the low density of binding sites in the granular layer, few GABAB1a receptors might be localized in the 
granule or Golgi cells or on the terminals of the mossy fibers (MF) (adapted from Bischoff et al., 1999). 
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receptors, whereas GABAB1b forms postsynaptic receptors. Nevertheless, solid evidence 
revealing a differential pre- versus postsynaptic segregation of GABAB1a and GABAB1b on 
the protein level was lacking. Since the GABAB1a -specific SDs constitute the only 
molecular difference between GABAB1a and GABAB1b it was hypothesized that the SDs 
are responsible for the axonal targeting of GABAB receptors. 
 
To decipher the role of the SDs in the pre- versus postsynaptic distribution and functional 
segregation of GABAB receptor subtypes several different experimental approaches were 
undertaken in the Bettler lab and in collaboration. My task was to investigate the role of 
the SDs in axonal targeting at the molecular level in cell culture experiments. These 
experiments contributed to the different papers and paper drafts presented in this thesis 
(chapter II, III, IV and (VI)).  
The SDs in the ectodomain of GABAB1a are part of the extracellular N-terminal protein 
sequence of the receptor. Therefore, the SDs are unable to interact directly with cytosolic 
molecular motor or adaptor proteins often responsible for axonal targeting (see chapter I).  
It was thus hypothesized that the SDs interact with membrane bound or ECM protein(s) at 
the cell surface thereby leading to the predominant axonal localization of GABAB1a. Since 
organotypic slice cultures preserve the extracellular matrix I initially investigated the 
axonal versus dendritic distribution of eGFP-tagged GABAB1a and eCFP-tagged GABAB1b 
in organotypic slice cultures of mouse cerebellum. For this purpose, the corresponding 
cytomegalovirus-based expression plasmids were electroporated into organotypic 
cerebellar slices or transferred using Similiki-Forest-Virus. Unfortunately, the analysis of 
the axonal versus dendritic protein distribution was extremely difficult to perform in these 
slices. Distal neurites were often covered by neighboring cells on pictures obtained with a 
conventional epifluorescent microscope, whereas when using a confocal microscope to 
gain 3D stacks of the tissue the high laser intensity used at the time in such set ups 
bleached the eGFP, and especially the eCFP tags of the expression constructs. 
Unfortunately, a two-photon microscope circumventing these experimental problems was 
at that time yet not available at Basel.  
I thus continued this study using dissociated hippocampal primary cultures, a culture 
system that is widely used for axonal versus dendritic targeting studies. In such monolayer 
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cultures the analysis of the axonal versus dendritic protein distribution is generally easier 
to perform. Nevertheless, the preparation of cultured hippocampal neurons involves a 
dissociation step partially disrupting the native cellular environment. It is thus possible that 
a surface protein potentially important for the proper localization of GABAB1a is missing in 
such cultures. I made cultures from GABAB1a
-/-
, GABAB1b
-/-
 and WT mouse embryos and 
analyzed the axonal versus dendritic distribution of GABAB receptors using a pan 
antibody. Both, endogenous GABAB1a and GABAb1b protein was present in the soma and 
dendrites, whereas selectively GABAB1a was found in axons. Nevertheless, I could not 
detect a differential distribution of transfected GABAB1a-eGFP and GABAB1b-eGFP 
expressed under the cytomegalovirus-based expression plasmids (Figure S2.2). For this 
reason 
 
 
 
 
Figure S2.2: Both GABAB1a-eGFP (1a) and GABAB1b-eGFP (1b) are localized to axons when expressed by 
the CMV promoter in cultured hippocampal neurons. Neurons were fixed at DIV6, permeabilzed and 
immunostained with the dendritic marker MAP2 and an antibody against the eGFP tag (Anti-EGFP). Axons 
are marked by arrows, dendrites by arrow heads. Scale bar 50 ?m. 
 
the experiment was repeated by Yan-Ping Zhang and Thomas G. Oertner (FMI, Basel) in 
organotypic slice cultures of the hippocampus and analyzed with their newly established 
two-photon laser scanning microscope. Further, a neuron-specific synapsin-1 promoter was 
used. With this approach it was possible to show that transfected CA3 neurons selectively 
express GABAB1a in axons, whereas both isoforms are present in dendrites (Chapter II). I 
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subsequently investigated the distribution of these expression constructs in cultured 
hippocampal neurons and revealed a selective occurrence of GABAB1a in axons (Chapter 
III). This shows that the cytomegalovirus-based eukaryotic expression vector is not 
suitable for studying the axonal versus dendritic distribution of GABAB receptors. 
Nevertheless, it also appears that dissociated hippocampal neurons despite of their partially 
disrupted ECM preserve the native targeting of GABAB receptor subtypes and were thus 
used to further decipher the role of the SDs in axonal targeting (chapter III).  
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Summary 
GABAB receptors are the G protein-coupled receptors for the main inhibitory 
neurotransmitter in the brain, ?-aminobutyric acid (GABA). Molecular diversity in the 
GABAB system arises from the GABAB1a and GABAB1b subunit isoforms that solely differ 
in their ectodomains by a pair of sushi repeats that is unique to GABAB1a. Using a 
combined genetic, physiological, and morphological approach, we now demonstrate that 
GABAB1 isoforms localize to distinct synaptic sites and convey separate functions in vivo. 
At hippocampal CA3-to-CA1 synapses, GABAB1a assembles heteroreceptors inhibiting 
glutamate release, while predominantly GABAB1b mediates postsynaptic inhibition. 
Electron microscopy reveals a synaptic distribution of GABAB1 isoforms that agrees with 
the observed functional differences. Transfected CA3 neurons selectively express 
GABAB1a in distal axons, suggesting that the sushi repeats, a conserved protein interaction 
motif, specify heteroreceptor localization. The constitutive absence of GABAB1a but not 
GABAB1b results in impaired synaptic plasticity and hippocampus-dependent memory, 
emphasizing molecular differences in synaptic GABAB functions. 
 
Introduction 
GABAB receptors are considered promising drug targets for the treatment of neurological 
and mental health disorders (Bettler et al., 2004 and Cryan and Kaupmann, 2005). 
Presynaptic GABAB receptors are subdivided into auto- and heteroreceptors that control 
the release of GABA and other neurotransmitters, respectively. They restrict 
neurotransmitter release either by inhibiting voltage-sensitive Ca
2+
 channels or through a 
direct modulation of synaptic vesicle priming (Mintz and Bean, 1993, Poncer et al., 1997 
and Sakaba and Neher, 2003). Postsynaptic GABAB receptors induce slow inhibitory 
potentials by gating Kir3-type K
+
 channels (Lüscher et al., 1997). Considerable evidence 
has accumulated over the years, using a variety of preparations and techniques, to support 
the notion that multiple subtypes of GABAB receptors exist (Bonanno and Raiteri, 1993, 
Bowery et al., 2002, Cunningham and Enna, 1996, Deisz et al., 1997, Gemignani et al., 
1994, Lei and McBain, 2003, Mohler and Fritschy, 1999, Pozza et al., 1999 and Yamada et 
al., 1999). The predicted receptor heterogeneity is not readily supported by molecular 
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studies (Bettler et al., 2004). GABAB receptors are heterodimers composed of GABAB1 
and GABAB2 subunits, which are both required for normal receptor functioning (Marshall 
et al., 1999 and Mohler and Fritschy, 1999). Accordingly, mice lacking GABAB1 (referred 
to as 1
?/?
 mice) or GABAB2 subunits show a complete absence of typical GABAB 
responses (Gassmann et al., 2004, Prosser et al., 2001 and Schuler et al., 2001). The only 
firmly established molecular diversity in the GABAB system arises from the GABAB1a and 
GABAB1b subunit isoforms (Kaupmann et al., 1997). However, no unique pharmacological 
or functional properties could be assigned to GABAB1a or GABAB1b. Most, if not all 
neurons coexpress GABAB1a and GABAB1b, which are generated by differential promoter 
usage from the GABAB1 gene (Bischoff et al., 1999 and Steiger et al., 2004). GABAB1a and 
GABAB1b expression levels vary during development and across individual cells, suggestive 
of a functional specialization. Structurally, the isoforms differ in their N-terminal 
ectodomain by a pair of sushi repeats that is present in GABAB1a but not in GABAB1b 
(Blein et al., 2004). Sushi repeats, also known as complement control protein modules, or 
short consensus repeats, are found in other G protein-coupled receptors as well (Grace et 
al., 2004) and mediate protein interactions in a wide variety of adhesion proteins (Lehtinen 
et al., 2004). The presence of sushi repeats in GABAB1a, together with the absence of 
functional or pharmacological differences in vitro, suggested the existence of auxiliary 
proteins that modify receptor activity, pharmacology, and localization (Marshall et al., 
1999 and Mohler and Fritschy, 1999), precedence for which is found with other G protein-
coupled receptors (McLatchie et al., 1998). So far, the lack of selective reagents has not 
allowed addressing the individual contributions of GABAB1a and GABAB1b to native 
GABAB functions. In the light of the proposed heterogeneity of native GABAB receptors, it 
therefore remains a key question whether GABAB1 isoforms exhibit pharmacological 
and/or functional differences in vivo. Here, we have taken a genetic approach to dissociate 
the native functions of GABAB1a and GABAB1b.  
 
Results 
 
Generation of Mice Selectively Expressing GABAB1a or GABAB1b Subunits 
To selectively prevent translation of the GABAB1a and GABAB1b proteins, we converted 
their initiation codons in the GABAB1 gene into stop codons (Figure 1). Balb/c gene 
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targeting constructs with mutated initiation codons (Figure 1A) were electroporated into 
Balb/c embryonic stem cells (Dinkel et al., 1999) and homologous recombination events 
diagnosed with short-arm PCR and Southern blots (data not shown). Targeted embryonic 
stem cells were injected into C57BL/6 blastocysts. Founder mice were crossed with Balb/c 
mice expressing Cre-recombinase under control of the cytomegalus virus promoter to 
excise the neomycin cassette. Pups born from these matings were scored for Cre-mediated 
loss of the neomycin cassette and bred to homozygosity. Consequently, all mutant mice 
were on a pure inbred Balb/c genetic background, which was maintained throughout the 
experiments. Homozygous mice with mutations in the GABAB1a (referred to as 1a
?/?
 mice) 
or GABAB1b (1b
?/?
 mice) initiation codon were viable, reproduced normally, and exhibited 
no overt phenotypic abnormalities. Mutant mice showed normal levels of GABAB1a and 
GABAB1b mRNA, indicating that the genetic manipulations do not influence mRNA 
expression or stability (Figure 1B). Immunoblot analysis revealed the total absence of 
GABAB1a and GABAB1b protein in 1a
?/?
 and 1b
?/?
 mice, respectively, confirming that 
mutation of the initiation codons prevents translation of the individual subunits (Figure 
1C). GABAB1a and GABAB1b proteins appeared upregulated in total brain extracts of 
knockout mice (Figure 1C), possibly because of increased availability of complementary 
GABAB2 protein, which is required for cross-stabilization (Gassmann et al., 2004). We 
analyzed whether GABAB protein is also upregulated in the CA1 region of the 
hippocampus, where the electrophysiological and morphological studies described below 
were carried out. Similar to those seen in total brain extracts, GABAB1a and GABAB1b 
protein levels in CA1 extracts were increased in the 1b
?/?
 (129% of wild-type) and 1a
?/?
 
mice (115% of wild-type), respectively (Figure S1).  
 
 
Immunohistochemical, Pharmacological, and Biochemical Characterization of 1a
?/?
 
and 1b
?/?
 Mice 
Immunohistochemistry in the CA1 and CA3 region of the hippocampus revealed 
completely overlapping expression patterns for the GABAB1a and GABAB1b proteins 
(Figure 2), consistent with an ubiquitous expression of the two proteins in brain neurons 
(Bischoff et al., 1999). The regional immunostaining in 1a
?/?
 and wild-type mice was 
similar, while the staining in 1b
?/?
 mice was more diffuse and lacked distinct laminar  
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Figure.1. Generation of a 1a-/- and 1b-/- Mice  
(A) 5? region of wild-type (WT) (Martin et al., 2001) and mutated GABAB1 alleles. Exons encoding the N 
terminus of GABAB1a are represented by white boxes and specify the signal peptide (exon 2a), a pair of sushi 
repeats of 75 amino acids each (exons 3a, 4a), and a linker of six amino acids (exon 5a). The exon specifying 
the N terminus of GABAB1b is represented by a gray box. All exons downstream of exon 1b are shared 
between the two isoforms (only exon 6 is shown; hatched box). Start codons for GABAB1a (Ma) and GABAB1b 
(Mb) transcripts were converted into stop codons (S) using a knockin approach. A putative alternative start 
site (Ma
*
) in GABAB1a transcripts was mutated in addition. The floxed neomycin cassette (black bar) for 
selection of transfected embryonic stem cells was introduced in the introns between exons 2a/3a (1a
?/?
neo) 
or exons 5a/1b (1b
?/?
neo). A loxP site (arrow) is left behind after Cre-mediated excision of the neomycin 
cassette (1a
?/?
, 1b
?/?
).  
(B) Northern blot analysis of GABAB1a and GABAB1b mRNA expression in the brain of WT, heterozygous 
(
+/?
), and homozygous (
?/?
) knockout mice. The 1a hybridization probe (1a probe) corresponds to nucleotides 
1–405 of the GABAB1a cDNA (Kaupmann et al., 1997) and detects GABAB1a as well as a truncated GABAB1j 
transcript (M.G., unpublished data) of ~1.6 kb (upper panel). The 1b probe corresponds to nucleotides 16–
259 of the GABAB1b cDNA (Kaupmann et al., 1997) and detects 1b transcripts (lower panel).  
(C) Immunoblot analysis of total brain lysates using antibodies recognizing the common C terminus of 
GABAB1a and GABAB1b (AB1ab) (Gassmann et al., 2004). Anti-syntaxin (ABstx) antibodies control for sample 
loading. 
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boundaries. Immunohistochemistry therefore suggests differences in the relative 
abundance of the two isoform proteins at different subcellular sites. For example, intense 
immunoreactivity is evident in CA3 stratum lucidum of 1b
?/?
 mice, which may hint at a 
preferential expression of GABAB1a protein at presynaptic sites (arrowhead in Figure 2). 
The immunostainings obtained with antibodies directed at the GABAB1 and GABAB2 
proteins are similar in the different strains of mice, suggesting that most of the GABAB2 
and GABAB1 protein assembles into heterodimeric receptors. 
 
                  
 
Figure 2. Distribution of GABAB1a and GABAB1b Protein in the Hippocampus of 1a
?/?
 and 1b
?/?
 Mice  
Immunohistochemistry in the CA1/CA3 region using antibodies specific for GABAB1 (AB1ab, recognizing an 
epitope shared by GABAB1a and GABAB1b), GABAB1b (AB1b), and GABAB2 (AB2). No GABAB1a-specific 
antibody suitable for immunohistochemistry is available. The expression pattern of GABAB1a protein is 
revealed in 1b
?/?
 mice stained with AB1ab. No specific immunostaining is observed with AB1b in 1b
?/?
 mice, 
demonstrating the specificity of this antibody for GABAB1b protein. No specific immunostaining was obtained 
in control experiments with AB1ab/AB1b and AB2 antibodies in mice devoid of GABAB1 and GABAB2 
subunits, respectively (Fritschy et al., 2004). Abbreviations: so, stratum oriens; sl, stratum lucidum; sr, 
stratum radiatum; slm, stratum lacunosum-moleculare. Scale bar, 200 μm. The WT mouse was a littermate of 
the 1a
?/?
 mouse.  
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To compare the pharmacology of GABAB1a and GABAB1b in native tissue, we analyzed the 
inhibition of [
125
I]CGP64213 antagonist binding (Kaupmann et al., 1997) by GABA and L-
baclofen in cortical membranes (Figure 3A). In agreement with recombinant data 
(Kaupmann et al., 1998), the inhibition curves for wild-type, 1a
?/?
, and 1b
?/?
 mice were 
almost identical (IC50 values for wild-type, 1a
?/?
, and 1b
?/?
 mice in μM are as follows: 
GABA: 0.7 ± 0.2, 0.4 ± 0.2, 0.6 ± 0.2; baclofen: 1.2 ± 0.3, 0.8 ± 0.3, 0.9 ± 0.3; n = 3 per 
genotype). [
3
H]baclofen binding in 1a
?/?
 and 1b
?/?
 cortical membranes was similarly 
reduced compared to wild-type membranes (Figure 3B), in agreement with the relative 
abundance of the two isoform proteins in the cortex (Kaupmann et al., 1997). To determine 
functional GABAB receptor levels, we measured GTP?[35S] binding, which assesses the 
activation of G?i/o-type G proteins, the main effectors of GABAB receptors (Figure 3C). 
Cortical membranes of 1a
?/?
 and 1b
?/?
 mice showed 52% ± 4% and 28% ± 8% of the 
maximal GTP?[35S] binding seen with wild-type mice. The sum of the maximal GTP?[35S] 
responses in knockout membranes is therefore 20% lower than expected. This suggests the 
absence of a compensatory upregulation of functional receptor levels, despite the 
upregulation of GABAB1 isoforms seen at the protein level (Figure 1C and Figure S1 in the 
Supplemental Data available with this article online). Presumably, most of the extra 
GABAB1 isoform protein is retained intracellularly and does not participate in functional 
responses.  
 
 
Distinct Contributions of GABAB1a and GABAB1b to Pre- and Postsynaptic GABAB 
Functions 
Using whole-cell patch-clamp recording in slice preparations, we examined whether wild-
type and knockout mice differ in their hippocampal GABAB responses. We first checked 
for the presence of heteroreceptors on excitatory terminals. Stimulation of the Schaffer 
collateral-commissural fibers induces excitatory postsynaptic currents (EPSCs) in CA1 
pyramidal neurons, which are reduced by blocking glutamate release through activation of 
GABAB heteroreceptors (Schuler et al., 2001). Baclofen, a GABAB agonist, was effective 
in reducing the EPSC amplitude in wild-type and 1b
?/?
 mice but not in 1a
?/?
 mice (Figures 
4A and 4B). As a control, adenosine inhibited glutamate release in all three genotypes. 
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Figure 3. Pharmacological and Biochemical Analysis of Brain Membranes from Wild-Type, 1a
?/?
, and 
1b
?/?
 Mice  
(A) Inhibition of [
125
I]CGP64213 GABAB antagonist binding to cortical membranes by the agonists GABA 
and L-baclofen (L-Bac). The curves were fitted using nonlinear regression (Graph Pad PRISM program, 
Graph Pad software Inc., San Diego). Error bars (±SEM) are smaller than the symbols.  
(B) Binding of [
3
H]baclofen to cortical membranes of 1a
?/?
 and 1b
?/?
 mice was 57% ± 2% and 50% ± 7%, 
respectively, of the binding to WT membranes (±SEM of two independent experiments performed in 
triplicate).  
(C) GABA-stimulated GTP?[35S] binding in cortical membranes. Data points are mean (±SEM) values 
calculated from five (WT) and four (1a
?/?
, 1b
?/?
, 1
?/?
) mice.  
 
 
This indicates that 1a
?/?
 mice, in contrast to 1b
?/?
 mice, lack GABAB heteroreceptors on 
Schaffer collateral terminals. Small residual heteroreceptor activity in 1a
?/?
 mice suggests 
that minute amounts of GABAB receptors assembled with GABAB1b are localized at 
glutamatergic terminals. We next looked for the presence of autoreceptors on GABAergic 
terminals and recorded inhibitory postsynaptic currents (IPSCs) in the presence of the 
ionotropic glutamate receptor antagonist kynurenate. Baclofen reduced the amplitude of 
IPSCs in CA1 pyramidal neurons of all genotypes, suggesting that both GABAB1a and 
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GABAB1b can efficiently participate in autoreceptor function (Figures 4C and 4D). 
Postsynaptic GABAB receptors induce a late IPSC by activating Kir3-type K
+
 channels 
(Lüscher et al., 1997). At a holding potential of ?50 mV and in physiological extracellular 
[K
+
], baclofen elicited similar outward currents in CA1 pyramidal cells of 1a
?/?
 and wild-
type mice (Figures 4E and 4F). However, in CA1 pyramidal cells of 1b
?/?
 mice, the 
baclofen-induced outward current was reduced by ~60% compared to wild-type or 1a
?/?
 
mice. This indicates that predominantly GABAB1b mediates postsynaptic inhibition. As a 
control, adenosine receptors, which converge on the same Kir3 channels (Lüscher et al., 
1997), induced similar outward currents in all genotypes. It is formally possible that the 
upregulation of GABAB1a protein observed in the 1b
?/?
 mice (Figure 1C and Figure S1) 
compensates to some extent for the missing GABAB1b protein. We consider this unlikely 
because functional receptor levels in the 1b
?/?
 mice are lower than expected (Figure 3C). 
Moreover, GFP-tagged GABAB1a protein clearly distributes to the dendritic compartment 
of CA1 neurons when expressed in organotypic slice culture (Figure 6A). Likely, 
therefore, both GABAB1a- and GABAB1b-containing receptors address Kir3 channels under 
normal conditions.  
 
 
Distinct Subcellular Compartmentalization of the GABAB1a and GABAB1b Proteins 
The lack of suitable antibodies thus far prevented studying the distribution of GABAB1 
isoforms using electron microscopy. We now used the 1a
?/?
 and 1b
?/?
 mice to determine 
the subcellular localization of GABAB1b and GABAB1a protein, respectively. Preembedding 
immunogold labeling experiments in the CA1 stratum radiatum of wild-type mice 
confirmed that GABAB1 protein is present in pre- and postsynaptic elements (Figure 5A), 
as reported for rat brain (Kulik et al., 2003). In 1a
?/?
 mice, GABAB1b was mostly found in 
spines opposite glutamate release sites (Figures 5B and 5C). In 1b
?/?
 mice, GABAB1a 
predominantly localized to glutamatergic terminals (Figures 5D and 5E). Quantitative 
analysis of GABAB1 labeling showed that the ratio of pre- to postsynaptic immunoparticles 
in wild-type, 1a
?/?
, and 1b
?/?
 mice was 0.31, 0.17, and 1.61, respectively (Figure 5F). 
Thus, the electron microscopy data support the electrophysiological data (Figure 4) and 
confirm that GABAB1a preferentially localizes to glutamatergic terminals. Consistent with  
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Figure 4. GABAB Responses in Wild-Type, 1a
?/?
, and 1b
?/?
 CA1 Pyramidal Neurons  
(A and B) Peak amplitudes and representative traces (A) and summary histogram (B) of monosynaptic EPSC 
inhibition by baclofen and adenosine. Baclofen (50 μM) depresses the amplitude of EPSCs in WT (76.5% ± 
3.1% inhibition; n = 8) and 1b
?/?
 (83.4% ± 2.9% inhibition; n = 5) but not in 1a
?/?
 (15.9% ± 5.3% 
inhibition; n = 13; p < 0.001, ANOVA/Scheffe post hoc test) mice. Adenosine (100 μM) depresses EPSCs in 
all genotypes (WT: 89.1% ± 1.6% inhibition, n = 6; 1a
?/?
: 85.3% ± 1.8% inhibition, n = 13; 1b
?/?
: 85.6% ± 
6.6% inhibition, n = 4).  
(C and D) Peak amplitudes and representative traces (C) and summary histogram (D) of IPSC inhibition by 
baclofen. Baclofen significantly depresses the IPSC amplitude in all genotypes (WT: 82.7% ± 4.8% 
inhibition, n = 12; 1a
?/?
: 71.8% ± 2.3% inhibition, n = 9; 1b
?/?
 mice: 85.7% ± 2.4% inhibition, n = 7).  
(E and F) Representative changes in the holding current of CA1 neurons following application of baclofen 
and adenosine (E) and summary histogram of the amplitude of baclofen- and adenosine-induced K
+
 currents 
(F). The amplitude of the outward K
+
 current induced by baclofen application is similar in 1a
?/?
 (99.3 ± 8.8 
pA; n = 14) and WT (89.8 ± 7.7 pA; n = 16) neurons. In 1b
?/?
 cells, the amplitude of the baclofen-induced 
current is strongly reduced (37.4 ± 2.7 pA; n = 10; p < 0.001, ANOVA/Scheffe post hoc test). Control 
adenosine-induced K
+
 currents are similar in all genotypes. (Vclamp: ?50 mV, TTX 1 μM, ***p < 0.001, 
ANOVA/Scheffe post hoc test). All baclofen-induced responses (inhibition of PSCs and activation of K
+
 
currents) were fully blocked by the GABAB antagonist CGP54626 (1 μM). Values are expressed as mean ± 
SEM.  
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residual heteroreceptor activity (Figures 4A and 4B), some presynaptic immunogold 
labeling persisted at glutamatergic 1a
?/?
 synapses.  
 
 
                                  
 
 
Figure 5. Preembedding Electron Micrographs Showing GABAB1 Immunogold Labeling at Asymmetrical, 
i.e. Glutamatergic, Synapses in CA1 Stratum Radiatum  
(A) Pre- and postsynaptic immunogold labeling in WT mice.  
(B and C) Predominant postsynaptic (B) and rare presynaptic (C) labeling (arrowhead) in 1a
?/?
 mice.  
(D and E) Predominant presynaptic (D) and less frequent postsynaptic (E) labeling in 1b
?/?
 mice.  
(F) Percentage of pre- and postsynaptic immunogold particles in WT, 1a
?/?
, and 1b
?/?
 mice (presynaptic: 
WT, 24% ± 1%; 1a
?/?
, 14% ± 3%; 1b
?/?
, 62% ± 4%; n = 3 for each genotype; mean ± SEM). Immunogold 
labeling was less frequent in 1b
?/?
 compared to 1a
?/?
 mice, which is reflected in the number of immunogold 
particles that were analyzed. Arrow: examples of immunogold particles in spines and dendritic shafts; 
arrowhead: examples of immunogold particles in presynaptic terminals. t, terminal; s, spine; d, dendrite; 
scale bars, 200 nm.  
 
 
Selective Localization of GABAB1a to Axons and GABAB1b to Dendritic Spines in 
Transfected Hippocampal Neurons 
We analyzed whether GFP-tagged GABAB1a and GABAB1b proteins exhibit a distinct 
subcellular distribution when expressed in hippocampal neurons. For these experiments, 
we transfected organotypic hippocampal slice cultures, which preserve the basic CA3-CA1 
connectivity, with expression vectors coding for GABAB1a-GFP or GABAB1b-GFP. We 
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coexpressed a freely diffusible red fluorescent protein (RFP), tdimer2, to normalize the 
green fluorescence to the red fluorescence. Both GABAB1a-GFP and GABAB1b-GFP 
proteins were robustly expressed in the dendrites of transfected CA1 pyramidal neurons 
(Figures 6A, 6B, and 6D). GABAB1b-GFP was expressed in the majority of dendritic 
spines, while GABAB1a-GFP was largely excluded from this location. This agrees with the 
electron microscopy data showing a preferential association of the GABAB1b protein with 
spines opposite to glutamate release sites (Figures 5B and 5C), a location where Kir3 
channels are highly coclustered with GABAB receptors (Kulik et al., 2006). This may 
explain why predominantly GABAB1b mediates the activation of Kir3 currents (Figures 4E 
and 4F). The data further indicate an almost exclusive association of the GABAB1a-GFP 
protein with distal axons (Figure 6), again in agreement with the electrophysiological 
(Figures 4A and 4B) and morphological data (Figures 5D and 5E).  
 
 
Impaired Synaptic Plasticity in 1a
?/?
 Mice 
Activation of postsynaptic GABAB receptors was shown to restrict long-term potentiation 
(LTP), whereas activation of autoreceptors promotes LTP (Davies and Collingridge, 1996 
and Davies et al., 1991). A role for GABAB heteroreceptors in synaptic plasticity is not 
known. We therefore addressed whether the genetic loss of heteroreceptors in 1a
?/?
 mice 
affects LTP at CA3-to-CA1 synapses. In wild-type CA1 neurons, the pairing protocol 
induced a marked potentiation of the EPSC amplitude (268.9% ± 58.3%; n = 7) (Figures 
7A and 7B). No LTP developed when NMDA receptors were antagonized (CPP + 7-Cl-
kynurenic acid) or when the cell under recording was kept at ?70 mV (Figure 7B). 1?/? 
mice, which completely lack functional GABAB receptors (Schuler et al., 2001), did not 
exhibit notable LTP (9.4% ± 20.3%; n = 5), nor did 1a
?/?
 mice (?8.9% ± 9.3%; n = 9) 
(Figures 7A and 7B). In contrast, 1b
?/?
 mice exhibited normal LTP (228.7% ± 43.3%; n = 
5). Wild-type neurons developed LTP even after acute pharmacological blockade of 
GABAB receptors with the antagonist CGP54626 (182.8% ± 54%; n = 6), showing that 
acute blockade of GABAB receptors does not prevent the induction of LTP. Adaptive 
changes (see below) due to the constitutive absence of heteroreceptors are therefore 
expected to underlie the lack of LTP in 1a
?/?
 neurons (Figure 7B).  
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Synaptic Modifications in 1a
?/?
 Mice 
The amplitude ratio of evoked EPSCs in response to paired-pulse stimulation was similar 
in wild-type, 1a
?/?
, and 1b
?/?
 CA1 pyramidal neurons (Figure 7C). A change in the paired-
pulse ratio is generally believed to reflect an underlying change in the presynaptic 
probability of release. The absence of differences in the paired-pulse ratio between the 
three genotypes therefore provides no evidence for a change in the release probability in 
1a
?/?
 mice. Moreover, these results indicate that the paired-pulse protocol does not result in 
the activation of GABAB heteroreceptors in wild-type neurons, nor do heteroreceptors 
appear to be tonically activated by ambient GABA, in agreement with earlier studies 
(Morrisett et al., 1991 and Scanziani, 2000). CGP54626 had no effect on the miniature 
EPSC (mEPSC) frequency or amplitude in wild-type CA1 neurons, further supporting that 
ambient GABA does not tonically activate heteroreceptors under baseline conditions 
(Figure 7D). The frequency of spontaneous mEPSCs was significantly increased in 1a
?/?
 
mice, while the mEPSC amplitude remained similar as in wild-type or 1b
?/?
 mice (Figure 
7E). The observed increase in the baseline mEPSC frequency in 1a
?/?
 mice would normally 
argue for an increase in the probability of glutamate release. However, since CA3-to-CA1 
synapses in 1a
?/?
 mice exhibit no change in the paired-pulse ratio and heteroreceptors 
remain inactive under baseline conditions, we favor that the increase in mEPSC frequency 
is indicative of an increased number of functional synapses. An increase in mEPSC 
frequency, with a concomitant modest increase in mEPSC amplitude, has been observed in 
cultured hippocampal neurons as a consequence of the unmasking of “silent” synapses 
(Liao et al., 1999). The insertion of AMPA receptors into synapses that only contain 
NMDA receptors is expected to result in a decrease in the coefficient of variation (CV) of 
the AMPA receptor-mediated component of the EPSC (CVAMPA), with no change in the 
CV of the NMDA component (CVNMDA) (Kullmann, 1994). We measured the variability of  
the AMPA and NMDA receptor-mediated EPSC amplitudes recorded in the same cells at 
?70 mV and +30 mV, respectively (Figure 7F). We found that the CVAMPA was 
significantly higher for the wild-type (0.37 ± 0.04; n = 12) than for the 1a
?/?
 mice (0.24 ± 
0.03; n = 10; p < 0.02), while the CVNMDA for wild-type (0.23 ± 0.02; n = 12) and 1a
?/?
 
mice (0.22 ± 0.03; n = 10) was similar. Comparison of the CVAMPA and CVNMDA between 
1a
?/?
 and wild-type mice is therefore consistent with a decreased proportion of silent 
synapses in 1a
?/?
 mice (Figure 7G).  
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Figure 6. Expression of GFP-Tagged GABAB1a and GABAB1b Subunits in Organotypic Slice Culture 
(A, B) Maximum intensity projections of dendrites and axons in the CA1 region of the hippocampus 
expressing GABAB1a-GFP (A) or GABAB1b-GFP (B) in combination with the freely diffusible tdimer2 RFP 
are shown. The ratio of green-to-red fluorescence (G/R) is coded in rainbow colors. Scale bar, 5 μm.  
(C) Predominantly GABAB1a-GFP protein is expressed in axons. The axonal expression level of GABAB1a and 
GABAB1b was normalized to the dendritic expression level (GABAB1a: 133.84% ± 29.53%, n = 9; GABAB1b: 
18.01% ± 2.80%, n = 5; mean ± SEM).  
(D) GABAB1b-GFP was expressed in the majority of dendritic spines, while GABAB1a-GFP was excluded from 
most spines (spines positive for GABAB1a-GFP: 21 of 82; spines positive for GABAB1b-GFP: 42 of 62). 
Examples of positive spines are indicated by white arrowheads in the G/R ratio images in (A) and (B).  
(E) Example of an organotypic hippocampal slice culture 7 days after cotransfection of GABAB1b-GFP and 
tdimer2 expression vectors.  
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Figure 7. Lack of LTP and Reduction in the Proportion of Silent Synapses in 1a
?/?
 Mice  
(A) The pairing protocol fails to induce LTP in 1
?/?
 and 1a
?/?
 mice but induces a clear potentiation of the 
EPSC amplitude in WT and 1b
?/?
 mice. Averages of the maximal EPSC amplitudes (±SEM) are shown. 
Pairing induction is indicated with an arrow. (Insets) Mean of 10 to 15 successive EPSCs recorded before 
and after pairing. Scale, 20 ms, 50 pA.  
(B) Summary histogram of LTP experiments. The percent increase in EPSC amplitude after pairing is shown. 
Values for EPSC potentiation were assessed 25 min after induction. No LTP is induced in WT mice in the 
presence of NMDA antagonists (5 μM R-CPP + 10 μM 7-Cl-kynurenate; WT + NMDA antagonist; p < 0.001 
compared to WT, Student's t test) and in the absence of paradigm-associated depolarization (WT with 
pairing at ?70 mV; p < 0.05 compared to WT, Student's t test). LTP is not significantly impaired in the 
presence of 1 μM CGP54626 (WT +CGP). The ANOVA/Scheffe post hoc test was used for the comparison of 
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genotypes. For clarity, only the statistical significance between the genotypes linked by the brackets are 
shown (
*
p < 0.05; 
**
p < 0.01; 
***
p < 0.001). 
 (C) The paired-pulse ratio of EPSCs at CA3-to-CA1 synapses in WT (2.54 ± 0.11; n = 15), 1a
?/?
 (2.27 ± 
0.16; n = 15) and 1b
?/?
 (2.64 ± 0.28; n = 8) mice was similar.  
(D) The GABAB antagonist CGP54626 (1 μM) did not alter mEPSC frequency (increase of 13.6% ± 15.3% 
versus control; n = 11) or amplitude (increase of 4.3% ± 5.1%; n = 11) in WT mice.  
(E) The frequency of mEPSCs was increased in 1a
?/?
 mice (WT: 0.44 ± 0.05 Hz, n = 11; 1a
?/?
: 0.90 ± 0.14 
Hz, n = 15; 1b
?/?
: 0.49 ± 0.09 Hz, n = 8; p < 0.05, Student's t test). In contrast, the mEPSC amplitude did 
not differ between WT (16.39 ± 0.79 pA; n = 11), 1a
?/?
 (17.12 ± 0.78 pA; n = 18), and 1b
?/?
 (15.68 ± 0.88 
pA; n = 8) mice. 
(F) Raw traces of AMPA and NMDA receptor-mediated EPSCs components (top). The protocol used to 
determine the CVAMPA and CVNMDA is outlined. At ?70 mV, NMDA receptors are blocked by Mg2+ ions, and 
the EPSCs are primarily mediated by AMPA receptors. NMDA receptor-mediated EPSCs were recorded in 
the same cell at +30 mV in the presence of 10 μM DNQX, a non-NMDA receptor antagonist.  
(G) The variability of the AMPA compared to the NMDA EPSC component (calculated as [1 ? 
(CVNMDA/CVAMPA)] ? 100) is significantly smaller in 1a?/? than in WT mice (WT: 34.0 ± 5.0, n = 12; 1a?/?: 
5.6 ± 3.9, n = 10; p < 0.01, Student's t test), suggestive of a decreased proportion of silent synapses. WT 
mice were littermates of 1a
?/?
 mice. Data are represented as mean ± SEM.  
 
 
Impaired Object Recognition in 1a
?/?
 Mice 
Changes in hippocampal LTP accompany certain alterations in cognitive function (Barnes 
et al., 1994). We used an object recognition task that depends on hippocampal function 
(Broadbent et al., 2004) to analyze whether impaired presynaptic heteroreceptor inhibition 
and lack of LTP in 1a
?/?
 mice is paralleled by memory deficits. The task relies upon the 
tendency of rodents to attend to a novel object more than to a familiar one. For each 
mouse, we scored the number of stretch attend postures (SAP, defined as head and 
shoulders extended toward the object) in response to a PVC disc presented at times 10 min 
and 24 hr following initial presentation at time 0, as well as to a novel PVC cone at 24 hr + 
10 min. Wild-type and 1b
?/?
 mice, in contrast to 1a
?/?
 mice, showed a significantly reduced 
number of SAPs toward the familiar object (time 10 min) and subsequently an increased 
number of SAPs toward the novel versus familiar object (time 24 hr + 10 min) (Figure 
8A). Calculation of discrimination indices (DIs) showed that 1a
?/?
 mice did not 
discriminate between familiar or novel objects (Figure 8B). Therefore, in 1a
?/?
 mice, the 
lack of LTP is correlated with an impairment of nonspatial hippocampal  
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Figure.8. Impaired Object Recognition in 1a
?/?
 Mice  
(A) Data represent the number of SAPs (mean ± SEM) to a PVC disc presented at time 0 min (0), 10 min 
(0:10), and 24 hr (24:00), and to a novel PVC cone at 24 hr + 10 min (24:10). 
**
p < 0.01 versus 0 min; +p < 
0.05 versus 10 min; ++p < 0.01 versus 10 min. 1a
?/?
 mice do not discriminate between familiar and novel 
objects (?2 = 5.824, 3 df, p = 0.121), in contrast to WT (?2 = 13.80, 3 df, p = 0.003) and 1b?/? mice (?2 = 
23.016, 3 df, p < 0.001). This deficit of 1a
?/?
 mice was also evident in a separate cohort of mice (data not 
shown).  
(B) Discrimination indices (DIs; mean ± SEM) in the object recognition test for WT, 1a
?/?
, and 1b
?/?
 mice. 
Time points for calculating DIs were chosen to reflect the following: short-term memory of a familiar object 
(familiar 10 min delay), long-term memory of a familiar object (familiar 24 hr delay), and short-term 
discriminative memory between a novel and familiar object (novel versus familiar). The mean DI for 
discrimination of a familiar object after 10 min delay appeared to be lower in 1a
?/?
 mice but failed to meet 
statistical significance [DI: F(2, 26) = 2.006; p = 0.149]. However, the decrease in the mean DI for 
discrimination of a novel versus a familiar object is significantly lower in 1a
?/?
 mice than in 1b
?/?
 or WT 
mice [F(2, 26) = 4.404; p = 0.023]. After a delay of 24 hr, the three genotypes similarly demonstrated a lack 
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of familiarity with the previously presented disc [DI: F(2, 26) = 0.001; p = 0.999]. 
*
p = 0.05 versus WT; +p 
< 0.05 versus 1a
?/?
.  
 
 
memoryformation. The effects on synaptic plasticity and memory formation in 1a
?/?
 mice 
emphasize that the GABAB1b protein cannot compensate for the loss of GABAB1a protein. 
 
 
Discussion 
 
The objective of this study was to determine if GABAB1a and GABAB1b exhibit functional 
or pharmacological differences in vivo. Our experiments with genetically modified mice 
indicate that, at CA3-to-CA1 synapses, GABAB1a assembles heteroreceptors inhibiting 
glutamate release, while predominantly GABAB1b mediates postsynaptic inhibition (Figure 
4). This functional specialization relates, at least in part, to a distinct subcellular 
distribution of the GABAB1 isoforms (Figure 5). Autoreceptor function is unaltered in the 
1a
?/?
 and 1b
?/?
 mice (Figures 4C and 4D). Possibly, both GABAB1a and GABAB1b are 
present at GABAergic terminals impinging onto CA1 pyramidal neurons. However, since 
our recordings from the CA1 pyramidal soma cannot distinguish IPSCs from different 
types of GABAergic neurons, it is equally possible that some GABAergic terminals 
express GABAB1a and others express GABAB1b. In general, the extent of subcellular 
segregation of GABAB1a and GABAB1b may vary according to brain regions and cell types. 
For example, GABAergic neurons impinging onto cortical layer 5 pyramidal neurons 
express GABAB1a but not GABAB1b at their terminals (Pérez-Garci et al., 2006). The 
distribution of GABAB1a and GABAB1b may also vary within the dendritic compartment. 
This is suggested by the organotypic slice culture experiments showing that GABAB1a-GFP 
is mostly excluded from dendritic spines, while GABAB1b-GFP is expressed in most spines 
(Figure 6).  
No significant pharmacological differences were found in radioligand binding experiments 
with cortical membranes from 1b
?/?
 and 1a
?/?
 mice (Figure 3). This confirms that GABAB 
isoforms display a similar binding pharmacology in vivo, as already suggested by earlier 
experiments with the photoaffinity antagonist [
125
I]CGP71872 (Malitschek et al., 1998). Of 
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note, receptors assembled from GABAB1a or GABAB1b may still display pharmacological 
differences in functional assays, depending on the local effector system and/or the receptor 
reserve. This may also be the reason why the data obtained in a functional assay 
(GTP?[35S] binding) and in 3[H]baclofen binding show differences in the relative 
contribution to the total binding (Figures 3B and 3C). Depending on the subcellular 
localization, GABAB1a and GABAB1b may also be exposed to different concentrations of 
ambient GABA. Tonic activation of GABAB auto- but not heteroreceptors could, for 
example, account for different potencies of baclofen in inhibiting release at excitatory and 
inhibitory terminals (Lei and McBain, 2003 and Scanziani, 2000). Moreover, GABAB1a 
and GABAB1b may exhibit distinct desensitization properties depending on their 
localization and exposure to cyclic AMP-dependent protein kinase (Couve et al., 2002). 
These factors may have contributed to pharmacological differences between pre- and 
postsynaptic receptors reported in the past (Lei and McBain, 2003 and Pozza et al., 1999). 
However, they likely do not explain differences in the rank order of drug potencies at 
native GABAB receptors, which have been reported as well (Bonanno et al., 1997 and 
Cunningham and Enna, 1996).  
An interesting question is how the functional segregation between the GABAB1a and 
GABAB1b isoforms is achieved. In principle, receptor compartmentalization could involve 
mechanisms such as mRNA trafficking, protein targeting, or protein retention (Horton and 
Ehlers, 2003 and Sampo et al., 2003). We addressed the mechanism underlying the 
differential compartmentalization by expressing GFP-tagged GABAB1a or GABAB1b 
proteins in hippocampal neurons in organotypic slice cultures. The data show an almost 
exclusive association of the GABAB1a-GFP protein with the axons of transfected CA3 
neurons (Figure 6). We therefore favor protein targeting or retention as the reason for 
GABAB1a compartmentalization, in which case the information for segregation is probably 
carried by the extracellular pair of sushi repeats, the only region of sequence divergence 
between GABAB1a and GABAB1b. Interestingly, the two sushi repeats in GABAB1a have 
strikingly different structural properties (Blein et al., 2004). This led to the proposal that 
they participate in protein interactions with multiple partners, which could generate 
additional heterogeneity in the GABAB receptor system.  
An open question remains why LTP at CA3-to-CA1 synapses is impaired in 1a
?/?
 mice. 
Since autoreceptor and postsynaptic GABAB functions are preserved in 1a
?/?
 mice (Figure 
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4), the impairment of LTP must relate to the constitutive absence of heteroreceptors. 
Heteroreceptors do not appear to be activated by ambient or released GABA under 
baseline conditions (Figures 7C and 7D), as already suggested in earlier experiments 
(Morrisett et al., 1991 and Scanziani, 2000). Presumably, heteroreceptors are only 
activated during periods of intense neuronal activity, when GABA released from 
interneurons spills over to the glutamatergic terminals. Uncontrolled release of glutamate 
during such periods is likely to trigger adaptive changes (Burrone and Murthy, 2003). For 
example, excess released glutamate may spill over to synapses at which glutamate release 
has not occurred (Scimemi et al., 2004), which could convert silent synapses to a 
functional state (Isaac et al., 1995 and Liao et al., 1995). The observed increase in the 
mEPSC frequency in 1a
?/?
 mice (Figure 7E) could reflect such an increase in the rate of 
activation of previously silent synapses (Liao et al., 1999). We addressed this possibility 
and compared the CVs of AMPA and NMDA receptor-mediated EPSCs in wild-type and 
1a
?/?
 mice. The CVAMPA was significantly reduced in 1a
?/?
 mice, while the CVNMDA was 
unaffected by genotype, consistent with a decreased number of silent synapses in 1a
?/?
 
mice (Kullmann, 1994). Since silent synapses provide an ideal substrate for LTP (Durand 
et al., 1996, Isaac et al., 1995, Kullmann, 1994, Liao et al., 1995 and Malinow and 
Malenka, 2002), the observed impairment of LTP in 1a
?/?
 mice could be explained by the 
decrease in the proportion of silent synapses. A plausible physiological role for 
heteroreceptors could therefore be to limit the loss of silent synapses and to ensure that 
plasticity processes are maintained in the dynamic range. However, the constitutive 
absence of heteroreceptors in 1a
?/?
 mice may have allowed time for other compensatory 
adaptations. For example, disinhibition of adenylate cyclase activity (Pineda et al., 2004), 
transcriptional (West et al., 2002) and/or morphological changes (Luthi et al., 2001) may 
contribute to the impairment of LTP and hippocampus-dependent memory. Importantly, 
however, the LTP and behavioral data reinforce that GABAB1a and GABAB1b convey 
separate functions in vivo.  
In summary, our combined physiological, morphological, and behavioral analysis of 1a
?/?
 
and 1b
?/?
 mice clearly establishes that GABAB1a and GABAB1b are differentially 
compartmentalized and fulfill distinct functions. We hypothesize that interactions with the 
sushi repeats are responsible for retaining GABAB1a at its specific location. From a 
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pharmaceutical perspective, the existence of functionally distinct receptor subtypes opens 
up new opportunities for therapeutic interference.  
 
 
 
Experimental Procedures 
 
Generation and Pharmacological and Biochemical Characterization of 1a
?/?
 and 1b
?/?
  
Mice 
Knockin mice were generated as outlined in Figure 1. All animal experiments were 
subjected to institutional review and conducted in accordance with Swiss guidelines and 
approved by the veterinary Office of Basel-Stadt. [
125
I]CGP64213 was synthesized at 
Novartis and labeled to a specific radioactivity of >2000 Ci/mmol (ANAWA, Wangen, 
Switzerland). The probes used for Northern blot analysis, the [
125
I]CGP64213 
displacement experiments, immunoblot, and GTP?[35S] analysis were as described 
(Bischoff et al., 1999, Gassmann et al., 2004 and Kaupmann et al., 1997). Since we did not 
observe significant differences in any of our assays between wild-type littermates derived 
from 1a
+/?
 or 1b
+/?
 heterozygous breeding pairs, the data from wild-type mice were 
pooled.  
 
 
Electrophysiology 
Standard procedures were used to prepare 300 μm thick parasagittal hippocampal slices 
from P18–P28 mice. Slices were incubated for 45 min at 35°C in an interface chamber 
containing saline (124 mM NaCl, 2.7 mM KCl, 1.3 mM MgCl2, 2 mM CaCl2, 1.24 mM 
NaH2PO4, 26 mM NaHCO3, 18 mM glucose, 2.25 mM ascorbate) equilibrated with 95% 
O2/5% CO2. Slices were then kept at room temperature for at least 45 min before starting 
recordings at 30°C–32°C. Whole-cell patch-clamp recordings were performed from the 
somata of CA1 pyramidal neurons to measure holding currents and synaptic responses; 
neurons were visualized using infrared and differential interference contrast optics. Drugs, 
applied by superfusion into the recording chamber, were kept as aliquots, and solutions 
were freshly prepared on the day of the experiment. K
+
 currents induced by baclofen (50 
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μM) or adenosine (100 μM) were elicited at ?50 mV in the presence of TTX (1 μM). Patch 
electrodes ( 5 M?) were filled with a solution containing the following: 140 mM K-
gluconate, 5 mM HEPES, 2 mM MgCl2, 1.1 mM EGTA, 2 mM Na2ATP, 5 mM 
phosphocreatine, 0.6 mM Tris-GTP, at pH 7.25 with KOH and 285 mOsm). EPSCs and 
IPSCs were elicited by voltage pulses (100 μs, 2–5 V stimuli) or by current pulses (100 μs, 
0.1–0.3 mA stimuli) delivered through a bipolar Pt-Ir electrode (25 μm in diameter) placed 
in the stratum radiatum at a distance of 150–200 μm from the soma of the recorded cell. 
The recording electrode was filled with a solution containing the following: 140 mM Cs-
gluconate, 10 mM HEPES, 10 mM phosphocreatine, 5 mM QX-314, 4 mM Mg-ATP, 0.3 
mM Na-GTP, at pH 7.25 with CsOH and 285 mOsm. EPSCs were measured at ?70 mV in 
the presence of 100 μM picrotoxin. In some cells, stimuli were delivered in pairs 
(interpulse interval 70 ms) (Palmer et al., 2004), and the paired-pulse ratio (PPR) was 
calculated as the ratio of the 2nd EPSC amplitude/1st EPSC amplitude. IPSCs were 
measured at 0 mV in the presence of 2 mM kynurenic acid. For the LTP experiments, the 
baseline stimulus frequency was set to 0.05 Hz to minimize “rundown” of the EPSC 
amplitudes (Gasparini et al., 2000 and Xiao et al., 2004). Cells were voltage clamped at 
?70 mV during baseline and recovery periods. LTP was induced by depolarizing the cell to 
0 mV while delivering 40 stimuli at 0.5 Hz at baseline stimulus intensity (pairing 
paradigm) (Palmer et al., 2004). When the potentiation of EPSC amplitudes lasted for >30 
min, we considered this as LTP. mEPSCs were recorded at ?70 mV in the presence of 0.5 
μM TTX and 10 μM bicuculline. Detection and analysis of mEPSCs were done using the 
MiniAnalysis software (Synaptosoft, Decatur, GA). For analysis of the CVAMPA 
(Kullmann, 1994), AMPA receptor-mediated EPSCs were recorded in the presence of 100 
μM picrotoxin and 5 μM bicuculline while neurons were clamped at ?70 mV (0.05 Hz 
stimulation). Following 15–20 min recording, non-NMDA glutamate receptors were 
blocked with 10 μM DNQX, and the holding voltage was changed to +30 mV. For analysis 
of the CVNMDA, NMDA receptor-mediated EPSCs were recorded for >10 min and, as a 
control, eventually blocked by adding CPP (5 μM) and 7-chlorokynurenate (10 μM) to the 
superfusion. CVAMPA and CVNMDA were calculated as SD/mean of AMPA and NMDA 
receptor-mediated EPSC peak amplitudes, respectively. Data were obtained with an 
Axopatch 200B (Axon Instruments, Union City, CA), filtered at 2 kHz and digitized at 10 
kHz, and acquired and analyzed with pClamp9 (Axon Instruments, Union City, CA). 
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Values are expressed as mean ± SEM. The experimenter was blind to the genotype of the 
mice.  
 
 
Immunohistochemistry and Preembedding Electron Microscopy 
Hippocampal sections were treated for light and electron microscopy immunolabeling as 
described (Gassmann et al., 2004 and Kulik et al., 2002). For ultrastructural analysis, only 
immunogold particles inside the plasma membrane (closer than 30 nm) of morphologically 
identifiable terminals (with presynaptic active zone or clear vesicles) and dendrites/spines 
were counted. Unassigned particles represent background labeling and labeling in axonal 
fibers (Kulik et al., 2002). The immunogold particle density in 1
?/?
 mice, which 
completely lack GABAB1 protein (Schuler et al., 2001), was 7% of that seen in wild-type 
mice. The presynaptic percentage of particles allocated to the plasma membrane in 1
?/?
 
mice was 52%, thus showing that background labeling equally distributes over pre- and 
postsynaptic membranes. Only asymmetrical (glutamatergic) synapses were analyzed. An 
ultrastructural analysis of GABAergic (symmetrical) synapses in 1a
?/?
 and 1b
?/?
 mice was 
impossible due to infrequent GABAB1 immunogold labeling (Kulik et al., 2002 and Kulik 
et al., 2003). The experimenter was aware of the genotype of the mice.  
 
 
Transfection of Organotypic Slice Cultures and Two-Photon Laser Scanning 
Microscopy 
Organotypic hippocampal slices were prepared from Wistar rats at postnatal day 5 as 
described (Stoppini et al., 1991). After 7 days in vitro, cultures were biolistically 
transfected with a Helios Gene Gun (Bio-Rad, CA) with GABAB1a-GFP or GABAB1b-GFP 
expression vectors in combination with a tdimer2 expression vector (gift from R. Tsien). 
Expression of GABAB1a-GFP and GABAB1b-GFP was under control of the neuron-specific 
synapsin-1 promoter (gift from K. Svoboda) for 7–8 days. For imaging, we used a custom-
built two-photon laser scanning microscope based on a BX51WI microscope (Olympus, 
Japan) and a pulsed Ti:Sapphire laser (Chameleon XR, Coherent, Scotland) tuned to ? = 
870 nm, controlled by an open source software package (ScanImage) written in Matlab 
(Pologruto et al., 2003). Fluorescence was detected in epifluorescence (LUMPlan W-IR2 
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60 ? 0.9 NA, Olympus) and transfluorescence mode (achromatic aplanatic condenser, 1.4 
NA, Olympus) using four photomultiplier tubes (R2896, Hamamatsu, Japan). We used 
725DCXR dichroic mirrors and E700SP blocking filters to reflect emitted photons into a 
secondary beamsplitter, containing a 560DCXR dichroic, 525/50 (green) and 610/75 (red) 
band-pass filters (AHF Analysentechnik AG, Tübingen, Germany). The slice was placed 
into a perfusion chamber and superfused continuously (2 ml/min) with ACSF (119 mM 
NaCl, 2.5 mM KCl, 4 mM CaCl2, 4 mM MgCl2, 26.2 mM NaHCO3, 1 mM NaH2PO4, 11 
mM glucose, gassed with 95% O2 and 5% CO2 at room temperature). Stacks of images 
(256 ? 256 pixels) from secondary dendritic branches and thin axons were obtained from 
transfected CA3 and CA1 pyramidal neurons (Z step: 0.5 μm). Maximum intensity 
projections of green and red stacks were constructed. For the ratio images, we used a 
hue/saturation/brightness model, where hue was determined by the green/red ratio (using a 
rainbow color table), and the intensity in the red channel was used to set the brightness. For 
quantitative analysis, we calculated the green-to-red ratio in a region of interest (dendrite 
or axon) after subtracting the background fluorescence. To compensate for differences in 
laser power and expression level, we normalized the ratio in the axon by the average 
dendritic ratio. Spines were identified by anatomy from tdimer2 images. GABAB1a-GFP- 
and GABAB1b-GFP-positive spines were defined as having intensity in the green channel at 
least three standard deviations above background.  
 
 
Object Recognition Test 
The test was designed according to the principles of Ennaceur and Delacour (1988), which 
rely upon the natural tendency of rodents to attend to a novel object more than a familiar 
one. Male wild-type (n = 7), 1a
?/?
 (n = 8), and 1b
?/?
 (n = 13) single-housed mice, aged 21 
(± 0.7) weeks, were used. Mice were habituated overnight (17–21 hr) to a novel enclosure 
[22 ? 37 ? 15 (h)cm], with 2 cm sawdust and standard food and water provided ad 
libitum until testing began. All sessions were recorded on video while the experimenter 
was out of the testing room. The number of SAPs for each mouse in each 3 min period was 
scored by a trained observer blinded to the animals' genotypes. All videos were scored 
twice by the same observer, and duplicate SAP scores were averaged within animal and 
time point. The intrascorer correlation (Pearson Product Moment correlation) was 0.91. A 
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DI, the difference in SAP numbers at a pair of time points divided by the total number of 
SAPs at those time points, was calculated for each animal (Figure 8B). DIs reflect (1) 
short-term memory of a familiar object ([Number of SAPs at Time 0 min ? Number of 
SAPs at Time 10 min]/[Total number of SAPs at both time points]); (2) long-term memory 
of a familiar object ([Number of SAPs at Time 0 min ? Number of SAPs at Time 24 
hr]/[Total number of SAPs at both time points]); and (3) short-term discriminative memory 
between a novel and a familiar object ([Number of SAPs at Time 24 hr + 10 min ? 
Number of SAPs at Time 10 min]/[Total number of SAPs at both time points]). A DI of 1 
reflects perfect discrimination, while a DI of 0 indicates complete loss of discrimination. 
SAP data were analyzed within a given genotype for the factor “Time” using the 
nonparametric Friedman repeated measures ANOVA on ranks test followed by Dunn's 
method for post hoc analysis. DIs were analyzed within a given time for the factor 
“Genotype” using one-way ANOVA followed by Fisher's LSD post hoc analysis.  
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Abstract 
 
GABAB receptor subtypes are differentially localized and exhibit non-redundant synaptic 
functions in glutamatergic neurons. Here we demonstrate that the sushi domains (SDs), 
conserved protein interaction motifs present in the ectodomain of the GABAB1a subunit 
isoform direct axonal localization. In the absence of this isoform endogenous GABAB 
receptors are confined to the somatodendritic compartment and fail to form presynaptic 
receptors controlling glutamate release. When exogenously expressed in cultured 
hippocampal neurons, GABAB1a is targeted to axons, but not GABAB1b, an isoform lacking 
the SDs. Moreover, mutations preventing disulfide bond formation within the SDs abolish 
axonal targeting of GABAB1a, suggesting that appropriate folding of the SDs is essential. 
The SDs of GABAB1a are sufficient to redirect a somatodendritic metabotropic glutamate 
receptor to the axonal compartment, indicating dominance of the axonal determinant. 
Moreover, we provide evidence that somatodendritic targeting of GABAB receptors 
involves the cytoplasmic C-terminal domain of the GABAB2 subunit. Thus a combination 
of extracellular/luminal and cytoplasmic targeting signals mediates axonal and dendritic 
localization of GABAB receptors. 
 
 
Introduction 
 
GABAB receptors are the G protein-coupled receptors for ?-aminobutyric acid (GABA), 
the main inhibitory neurotransmitter in the brain. Depending on their subcellular 
localization GABAB receptors exert distinct regulatory effects on synaptic transmission. 
Activation of presynaptic GABAB receptors suppresses neurotransmitter release at 
inhibitory as well as excitatory terminals, whereas postsynaptic GABAB receptors induce 
membrane hyperpolarization thereby inhibiting neuronal excitability. Molecular diversity 
in the GABAB system arises from the GABAB1 subunit isoforms, GABAB1a and GABAB1b 
(Kaupmann et al., 1997). These isoforms differ in their N-terminal ectodomain by a pair of 
tandemly arranged sushi domains (SDs) that are unique to GABAB1a (Hawrot et al., 1998). 
Most if not all neurons in the central nervous system co-express both GABAB1 isoforms, 
which combine with GABAB2 subunits to form functional heteromeric receptors. Thus, it is 
generally accepted that two GABAB receptor subtypes, GABAB(1a,2) and GABAB(1b,2), are 
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assembled in individual neurons. We have recently shown that these two 
pharmacologically indistinguishable GABAB receptor subtypes exhibit non-redundant 
synaptic functions, most likely resulting from their differential compartmentalization. The 
most distinctive feature is the selective localization of the GABAB1a isoform at 
glutamatergic terminals at various synapses (Perez-Garci et al., 2006; Shaban et al., 2006; 
Ulrich et al., 2007; Vigot et al., 2006). It is likely that the SDs, the only region of sequence 
divergence between GABAB1a and GABAB1b, play an important role in the axonal 
localization of GABAB receptors. SDs are conserved protein interaction motifs also known 
as complement control proteins (CCP) modules or short consensus repeats. They mediate 
protein interactions in proteins of the complement system as well as in a wide variety of 
adhesion molecules (Lehtinen et al., 2004; Morley and Campbell, 1984). Binding of the 
extracellular matrix (ECM) protein fibulin-2 to the SDs of GABAB1a has been reported 
(Blein et al., 2004), however, the physiological relevance of this interaction is unclear. SDs 
were recently identified as a structural module in the extracellular domains of other G 
protein-coupled receptors (GPCRs) (Grace et al., 2004), where they engage in ligand-
binding or are thought to facilitate extracellular protein interactions (Perrin et al., 2006).  
 
The accurate sorting and transport of proteins to distinct plasma membrane domains, such 
as axons and dendrites, is fundamental for neuronal signaling. Sorting generally occurs in 
the trans-Golgi network (TGN). There proteins are selectively packaged into axonal and/or 
somatodendritic carriers that are transported along microtubuli into the appropriate 
compartment where they fuse with the plasma membrane. Asymmetric distribution of 
neuronal membrane proteins can also be achieved following non-selective delivery into 
axons and dendrites via selective retention at the appropriate cell-surface domain and/or 
preferential endocytosis from the plasma membrane in inappropriate compartments (Craig 
and Banker, 1994; Horton and Ehlers, 2003; Winckler and Mellman, 1999). Usually 
sorting of membrane proteins in neurons relies on targeting signals, some of which are 
related to known determinants identified in polarized epithelial proteins. In particular, 
transport of membrane proteins to the somatodendritic compartment is often mediated by 
cytoplasmic signals involved in basolateral targeting in epithelial cells (Jareb and Banker, 
1998; West et al., 1997). In contrast, axonal targeting usually involves diverse cytosolic or 
luminal sequence motifs, which are distinct from the known apical sorting determinants 
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(Winckler and Mellman, 1999). Thus, axonal targeting of NgCAM, a neural cell adhesion 
molecule, depends on sequences in its ectodomain, which mediate sorting into carriers that 
directly deliver their cargo to the axonal membrane (Sampo et al., 2003). However, an 
indirect axonal targeting pathway involving endocytosis of NgCAM from the 
somatodendritic domain was also proposed (Wisco et al., 2003). Similarly VAMP2, a 
synaptic vesicle v-SNARE protein is removed from the dendritic membrane and polarized 
to the axonal surface due to an endocytosis motif in its cytoplasmic domain (Sampo et al., 
2003). A number of studies addressed the subcellular targeting of GPCRs and identified an 
important role of the cytosolic C-terminal domains (Das and Banker, 2006; Francesconi 
and Duvoisin, 2002; Jolimay et al., 2000; Stowell and Craig, 1999). A discrete tripeptide 
motif RRK was identified in the membrane proximal region of mGluR1, which directs 
axonal targeting of the shorter splice variant mGluR1b in retinal ganglion cells. In 
mGluR1a this motif is masked by its longer C-terminal tail also harboring somatodendritic 
targeting information (Francesconi and Duvoisin, 2002). For mGluR5 the interaction with 
different Homer1 proteins regulates axonal versus dendritic targeting in cerebellar granule 
cells (Ango et al., 2000). Moreover, a 60 amino acid sequence in the C-terminal tail of 
mGluR7 was shown to direct axonal targeting, whereas the homologous domain in 
mGluR2 mediates axonal exclusion (Stowell and Craig, 1999).  
 
The present study aimed at identifying the sequence determinants and mechanisms 
underlying axonal localization of GABAB receptors. We designed epitope-tagged 
expression constructs of individual GABAB receptor subunits and investigated their axonal 
and dendritic targeting in cultured hippocampal neurons. Our data identify the SDs of 
GABAB1a as a novel axonal targeting signal that is able to function in the context of a 
heterologous protein. Additionally, we found that the cytosolic C-terminal domain of the 
GABAB2 subunit harbours somatodendritic targeting information. Therefore, our data 
suggest a model in which differential targeting of heteromeric GABAB receptors is 
mediated by a co-operation of the SDs with dendritic targeting signals. 
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Results  
 
Differential subcellular distribution of GABAB1 isoforms in cultured hippocampal 
neurons. 
Imaging studies in hippocampal slice cultures have shown that GABAB1a, but not 
GABAB1b protein is present in the axons of transfected pyramidal neurons (Vigot et al., 
2006). It is likely that the extracellular pair of SDs, the only region of sequence divergence 
between GABAB1a and GABAB1b, dictates axonal localization. Because the SDs are 
evolutionary conserved protein interaction motifs we speculated that they mediate axonal 
localization through interaction with specific protein(s). However, the specific sequence 
determinant(s) for axonal localization of GABAB1a as well as the cellular mechanisms 
involved are unknown. We first investigated whether axonal localization of GABAB1a is 
retained when the characteristic cytoarchitecture of the hippocampus is disrupted. To this 
aim we assessed the distribution of specific GABAB1 isoforms in dissociated hippocampal 
neurons, which provide a suitable experimental system to study axonal versus dendritic 
targeting of transmembrane proteins (Stowell and Craig, 1999). 
 
Due to the lack of isoform-specific antibodies we determined the subcellular localization of 
endogenous GABAB1 isoform in cultured hippocampal neurons established from mice 
lacking one or the other isoform (referred to as 1a
-/-
 and 1b
-/-
 mice, respectively) (Vigot et 
al., 2006). Pyramidal neurons, which typically make up 85-90% of neurons in cultured 
hippocampal neurons (Goslin K., 1998) were identified by their extensively branched 
spiny dendrites (Benson et al., 1994; Obermair et al., 2003). The discrimination between 
axons and dendrites was based on MAP2 staining, a somatodendritic marker protein 
(Caceres et al., 1984). In 1b
-/-
 pyramidal neurons, punctuate endogenous GABAB1a staining 
was observed in the somatodendritic domain as well as along the axon (Fig. 1 A). In 
contrast, in 1a
-/-
 pyramidal neurons GABAB1b labelling is restricted to the somatodendritic 
compartment (Fig. 1 A). This demonstrates that in dissociated hippocampal neurons 
GABAB1a, but not GABAB1b localizes to axons, indicating that the axonal targeting of 
GABAB1a is achieved by a cell intrinsic mechanism. 
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Figure 1. Differential subcellular distribution and functional segregation of GABAB1 isoforms in cultured 
hippocampal neurons. 
(A) Cultured hippocampal neurons from wild-type (WT), GABAB1a
-/- 
(1a-/-) and GABAB1b
-/-
 (1b-/-) mouse 
embryos were fixed at DIV23, permeabilized and stained with a polyclonal antibody against the common C-
terminal domain of GABAB1 (Gb1) and an antibody against the dendritic marker MAP2. The upper panels 
show merged pictures of the antibody labelling against GABAB1 (red) and MAP2 (green) on neurons from the 
genotypes indicated. The boxed areas marked by arrows (axons) and arrowheads (dendrites) are shown in 
the lower panels at higher magnification. Whereas in WT and 1b-/- neurons GABAB1 staining is present in 
soma, axons and dendrites, in 1a-/- neurons it is only observed in soma and dendrites. This indicates that in 
cultured hippocampal neurons endogenous GABAB1b protein is excluded from axons. Scale bar upper panels 
25 μm, lower panels 5 μm. Black arrows indicate distinct GABAB1 labelled puncta along axons and dendrites. 
(B) The percentage of mEPSC frequency inhibition by the selective GABAB receptor agonist baclofen was 
analyzed in 2-3 weeks old cultured hippocampal neurons obtained from WT, 1a-/- and 1b-/- mouse embryos 
(mean ± SEM, n = 10-16 per genotype). Baclofen (50 ?M) inhibits the frequency of mEPSCs in WT (78.1 ± 
3.1%), in 1b-/- (70.8 ± 5.1%) but not in 1a-/- (7.7 ± 2.8%) neurons. This demonstrates that 1a-/- neurons lack 
functional heteroreceptors controlling the release of glutamate from presynaptic terminals. Statistics: One-
way ANOVA, Scheffe post-hoc test, p*** ? 0.001.  
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GABAB1a, but not GABAB1b, assembles presynaptic receptors inhibiting glutamate 
release from cultured hippocampal neurons.  
In hippocampal slices axonal localization of GABAB1a is associated with a functional 
specialization. Exclusively GABAB1a assembles heteroreceptors inhibiting glutamate 
release at CA3-to-CA1 synapse (Vigot et al., 2006). We therefore investigated whether this 
functional specialization is retained in cultured hippocampal neurons. Activation of 
heteroreceptors by baclofen, a specific GABAB agonist, inhibits the spontaneous release of 
glutamate resulting in a reduction of the frequency of miniature excitatory postsynaptic 
currents (mEPSCs) (Yamada et al., 1999). Accordingly, baclofen-induced inhibition of 
mEPSC frequency is a measure for functional GABAB heteroreceptors. As shown in Fig. 1 
B, baclofen significantly reduced the frequency of mEPSCs recorded in WT neurons. 
While similar results were obtained in 1b
-/-
 neurons, the baclofen-induced effect on 
mEPSC frequency was not observed in 1a
-/-
 neurons. This demonstrates that functional 
heteroreceptors are lacking in 1a
-/-
 neurons. Thus, the electrophysiological data confirm 
that exclusively GABAB1a localizes to glutamatergic terminals. This shows that the distinct 
subcellular distribution and functional specialization of GABAB1 isoforms observed in 
slice cultures is retained in cultured hippocampal neurons. 
 
 
GABAB1 isoforms expressed by the synapsin-1 promoter are differentially distributed 
in cultured hippocampal neurons. 
We next assessed whether tagged GABAB1 isoforms expressed in transfected cultured 
hippocampal neurons recapitulate the subcellular distribution of the endogenous isoforms. 
For these experiments, GABAB1 isoforms with an N-terminal c-myc-epitope were 
transfected together with a freely diffusible red fluorescent protein (RFP/tdimer2) into 
cultured hippocampal neurons at 5 days-in-vitro (DIV5). Soluble RFP outlines the 
morphology of transfected neurons and was used as a reference to quantify the axonal 
versus dendritic distribution. The GABAB1 isoforms were expressed under control of the 
synapsin-1 promoter, which mediates neuron-specific expression (Boulos et al., 2006; 
Kugler et al., 2001). Following transfection, neurons were fixed at DIV14, permeabilized 
and stained with antibodies against the c-myc-tag and the dendritic marker protein MAP2. 
As shown in Fig. 2 A, Myc-1a was present in axons, soma and dendrites, whereas Myc-1b 
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was restricted to the somatodendritic compartment. To quantify the axonal versus dendritic 
receptor distribution the c-myc-specific fluorescence intensity was normalized to the RFP 
signal and the axon-to-dendrite (A:D) ratio was determined (Gu et al., 2003; Sampo et al., 
2003). In agreement with an increased association of Myc-1a with axonal processes, the 
A:D ratio for Myc-1b was significantly reduced compared to Myc-1a (Myc-1a: 0.38 ± 
0.06, n = 8; Myc-1b: 0.14 ± 0.05, n = 10, **p < 0.01) (Fig. 2 B). However, for both 
constructs the (A:D) ratio was smaller than 1.0 indicating that Myc-1a as well as Myc-1b  
were robustly expressed in the somatodendritic compartment. From these results we can 
conclude that the SDs, the only region of sequence divergence between GABAB1a and 
GABAB1b, contain axonal targeting information. In addition, we visualized GABAB1 
isoforms at the cell surface of transfected neurons by live-cell immunostaining against the 
N-terminal c-myc-epitope. We failed to detect robust cell surface expression for any of the 
GABAB1 constructs analyzed (unpublished data). This suggests that when exogenously 
expressed in neurons, the majority of GABAB1 protein is present in intracellular 
membranes (Couve et al., 1998; Filippov et al., 2000). 
 
 
Mutation of the SDs in GABAB1a abolishes axonal targeting 
SDs are protein interaction motifs originally discovered in proteins of the complement 
cascade and in cell-adhesion molecules. Whenever they occur towards the N-terminus of a 
cell-surface protein, as it is the case in GABAB1a, they were shown to directly engage in 
protein interactions (Hawrot et al., 1998). For binding and function it is essential that SDs 
are correctly folded into a compact globular structure, which is maintained by disulfide 
bonds between highly conserved cysteine residues (Ichinose et al., 1990; Wei et al., 2001). 
To confirm the functional importance of the tertiary structure of the SDs for axonal 
localization of GABAB1a, we replaced two cysteines in each SD with serines to generate 
Myc-1aCS (Fig. 3 A). The four single-residue mutations in Myc-1aCS prevent disulfide 
bond formation in both SDs. Following transfection into hippocampal neurons, Myc-1aCS 
was robustly expressed in distal dendrites, but absent from axons (Fig. 3 B). Accordingly, 
the A:D ratio in Myc-1aCS was significantly reduced compared to Myc-1a (Myc-1a: 0.37± 
0.06, n = 7; Myc-1aCS: 0.14 ± 0.03, n = 10; **p < 0.01; Fig. 3 C). Of note, the Myc-1aCS 
distribution was similar to the one observed for Myc-1b (Fig. 2). Altogether, these results  
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Figure 2. GABAB1 isoforms expressed by the neuron-specific synapsin-1 promoter are differentially 
distributed in cultured hippocampal neurons. 
(A) Myc-tagged GABAB1 isoforms were co-transfected with soluble RFP into cultured hippocampal neurons. 
At DIV14, neurons were fixed, permeabilized and stained with an antibody against the c-myc-epitope. Myc-
GABAB1a (Myc-1a) is found in soma, axons and dendrites, whereas Myc-GABAB1b (Myc-1b) is restricted to 
the somatodendritic compartment. To distinguish between axons and dendrites the neurons were additionally 
stained with the dendritic marker MAP2. Pictures of the RFP signal (red) and the immunolabelling against 
the c-myc epitope (green) and MAP2 (blue) were merged. Scale bar upper panels 50 μm, lower panels 10 
μm. Axons are marked with white arrows, dendrites with white arrowheads. MAP2-positive dendrites are 
indicated with black arrows. 
(B) Axon-to-dendrite (A:D) ratio of Myc-1a and Myc-1b expression normalized to RFP (mean ± SEM, n = 8-
10). The A:D ratio is significantly higher in Myc-1a than in Myc-1b transfected neurons. Statistics: Student’s 
t-Test, p** ? 0.01. 
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Figure 3. Mutation of the sushi domains (SDs) in GABAB1a abolishes axonal targeting.  
(A) Schematic representation of SD mutations on GABAB1a. The tertiary structure of the SDs is maintained by 
disulfide bonds. Each SD (grey bar) possesses four cysteines (C) forming two disulfide bonds (-S-S-) in a 1-3 
and 2-4 pattern (Kirkitadze & Barlow, 2001). To interfere with disulfide bond formation the first and fourth 
cysteine in each SD of Myc-1a were mutated to serine (S), thereby generating Myc-1aCS. The green bar 
represents the c-myc-epitope, black bars the transmembrane domains. 
(B) Myc-1a and Myc-1aCS were co-transfected with soluble RFP into cultured hippocampal neurons. 
Neurons were fixed at DIV14, permeabilized and stained with an antibody against the c-myc-epitope. To 
distinguish between axons and dendrites the neurons were additionally stained with the dendritic marker 
MAP2 (not shown). Pictures of the RFP signal (red) and the immunolabelling against the c-myc epitope 
(green) were merged. In contrast to Myc-1a, Myc-1aCS is excluded from axons. Scale bar 10 μm.  
(C) A:D ratio of Myc-1a and Myc-1aCS expression normalized to RFP (mean ± SEM, n = 7-10). The A:D 
ratio is significantly higher in Myc-1a than in Myc-1aCS transfected neurons. Statistics: Student’s t-Test, p** 
? 0.01. 
 
demonstrate that correct folding of the SDs is critical for axonal targeting of GABAB1a. 
Therefore, it is likely that the SDs engage in specific protein interactions that are necessary 
for axonal localization of GABAB1a. 
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The two GABAB1a-specific SDs differ from each other. The first SD shows conformational 
heterogeneity under a wide range of conditions and interacts with the extracellular matrix 
protein fibulin-2, whereas the second SD is more compactly folded and shows stronger 
structural similarity to SDs in regulators of complement activation (Blein et al., 2004). It is 
therefore conceivable that the two SDs in GABAB1a exert different functions and interact 
with different proteins. Possibly, only one of the two SDs plays a role in axonal targeting. 
We therefore deleted either the first SD (Myc-1a?SD1) or the second SD (Myc-1a?SD2) 
from Myc-1a and analyzed their subcellular distribution in cultured hippocampal neurons. 
As shown in Fig. 4, both GABAB1a deletion mutants were observed in axons and exert no 
different A:D ratio compared to full-length Myc-1a (Myc-1a?SD1: 0.49 ± 0.05, n = 8; 
Myc-1a?SD2: 0.47 ± 0.04, n = 8; Myc-1a: 0.39 ± 0.06, n = 7). This suggests that each of 
the two SDs in GABAB1a is sufficient to mediate axonal localization. 
 
 
  
 
 
 
Figure 4. The individual SDs both mediate axonal targeting.  
(A) GABAB1a constructs missing either the first (Myc-1a?SD1) or the second sushi domain (Myc-1a?SD2) 
were co-transfected with soluble RFP into cultured hippocampal neurons. Myc-1a?SD1 and Myc-1a?SD2 
are both found in axons and dendrites. In the upper panels, the pictures of the RFP signal (red) and the 
immunolabelling against the c-myc epitope (green) were merged. Scale bar 10 μm.  
(B) A:D ratio of Myc-1a, Myc-1a?SD1 and Myc-1a?SD2 expression normalized to RFP (mean ± SEM, n = 
7-8). No significant differences were observed between the A:D ratios of the three constructs. Statistics: One-
way ANOVA, Scheffe post-hoc test, p ? 0.05. 
 
 Chapter III – The sushi domains of GABAB receptors function as a dominant axonal targeting signal 
 
  
64 
    
 
Figure 5. The SDs redirect a typical dendritic transmembrane receptor to the axon.  
(A) The SDs were fused to the extracellular N-terminal domain of metabotropic glutamate receptor 1a 
(mGluR1a), thereby generating Myc-SD-mGluR1a. Myc-mGluR1a and Myc-SD-mGluR1a were co-
transfected with RFP into cultured hippocampal neurons. At DIV14, neurons were fixed, permeabilized and 
stained with an antibody against the c-myc-epitope. Myc-mGluR1a is restricted to the somatodendritic 
compartment, whereas Myc-SD-mGluR1a is found in the soma, axons and dendrites. Black arrows indicate 
the axon, black arrowheads the dendrites. Scale bar 25 μm. 
(B) Axonal and dendritic sections of Myc-mGluR1a and Myc-SD-mGluR1a transfected neurons. In the upper 
panels the pictures of the RFP signal (red) and the immunolabelling against the c-myc epitope (green) were 
merged. Scale bar 10 μm.  
(C) A:D ratio of Myc-mGluR1a and Myc-SD-mGluR1a expression normalized to RFP (mean ± SEM, n = 9-
11). The A:D ratio is significantly higher in Myc-SD-mGluR1a compared to Myc-mGluR1a transfected 
neurons. Statistics: Student’s t-Test, p*** ? 0.001.  
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The SDs of GABAB1a redirects a typical dendritic transmembrane receptor to the 
axonal compartment. 
We next investigated whether the SDs of GABAB1a are sufficient to redirect a 
transmembrane protein with a somatodendritic distribution to the axonal compartment. For 
these experiments we chose the metabotropic glutamate receptor 1a (mGluR1a), which is 
polarized to dendrites and clusters at postsynaptic sites (Das and Banker, 2006; 
Francesconi and Duvoisin, 2002). We constructed a myc-tagged SD-mGluR1a chimera, in 
which both SDs of GABAB1a were fused N-terminally to the ectodomain of mGluR1a. As 
expected, when expressed in cultured hippocampal neurons, “wild-type” Myc-mGluR1a 
was polarized to the somatodendritic compartment (Fig. 5, A and B). In contrast, Myc-SD-
mGluR1a was additionally observed in axonal processes and its A:D ratio was significantly 
increased (Myc-mGluR1a: 0.03 ± 0.06, n = 9; Myc-SD-mGluR1a: 1.26 ± 0.15, n = 11; 
p*** < 0.001; Fig. 5 C). This demonstrates that the SDs of GABAB1a are sufficient to 
redirect a somatodendritic receptor to the axonal compartment. Moreover it shows that 
they are able to function in the context of a heterologous protein, which identifies them as 
a general axonal targeting signal. 
 
 
The C-terminal domain of GABAB1b is dispensable for somatodendritic targeting.  
GABAB1b is highly polarized to the somatodendritic compartment (Figs. 1 A and 2 A). It is 
therefore likely that GABAB1b is specifically targeted to dendrites, a process generally 
mediated through signals within cytoplasmic domains. Interestingly, the C-terminal tail of 
GABAB1b contains two dileucine- as well as one tyrosine-based motif reminiscent of 
dendritic targeting motifs identified in other membrane proteins (Jareb and Banker, 1998; 
Poyatos et al., 2000; Rivera et al., 2003; West et al., 1997). To evaluate the role of the C-
terminal domain of GABAB1b in dendritic localization we generated constructs with C-
terminal truncations (Fig. 6 A). Myc-1bP812 has a C-terminal truncation of 32 residues but 
retains the coiled-coil domain, which is important for C-terminal interaction with GABAB2 
(Pagano et al., 2001). In contrast, Myc-1bI744 lacks the entire C-terminus. When 
expressed in cultured hippocampal neurons both truncated GABAB1b subunits were 
observed in dendrites but not in axons, similar to full-length Myc-1b (Fig. 6 B). 
Accordingly, there were no significant differences between the A:D ratios of the three 
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constructs (Myc-1b: 0.15 ± 0.03, n = 10; Myc-1bI744: 0.17 ± 0.05, n = 10; Myc-1bP812: 
0.16 ± 0.03, n = 11; Fig. 6 C). This indicates that none of the potential C-terminal dendritic 
targeting motifs is essential for dendritic localization and polarization of GABAB1b. 
 
 
The distal C-terminal domain of GABAB2 is required for dendritic polarization. 
A structural feature of GABAB receptors is that they assemble into heteromeric complexes 
composed of GABAB1 and GABAB2, which are both required for normal receptor 
functioning (Marshall et al., 1999a; Marshall et al., 1999b). Therefore, somatodendritic 
targeting information for GABAB receptors could also be associated with the GABAB2 
subunit. To test this hypothesis we generated a truncated GABAB2 subunit, Myc-R2P820, 
which lacks the C-terminal 120 amino acid sequence downstream of the coiled-coil domain 
(Fig. 7 A). Wild-type GABAB2 as well as Myc-R2P820 were both shown to dimerize with 
GABAB1 in heterologous cells (Pagano et al., 2001) and it is expected that exogenously 
expressed GABAB2 subunits dimerize to some extend with endogenous GABAB1 subunits 
in neurons. Endogenous GABAB1a could therefore target exogenously expressed GABAB2 
subunits to the axon, which would compromise the identification of sequence determinants 
critical for dendritic polarization. To circumvent this problem we used for the following 
experiments cultured hippocampal neurons established from 1a
-/-
 mice. As shown in Fig. 7 
B, full-length GABAB2 (Myc-R2) was polarized to the somatodendritic compartment, 
while the C-terminally truncated GABAB2 protein (Myc-R2P820) was relocated to the 
axon to some extent. Accordingly, the A:D ratio of Myc-R2P820 is significantly increased 
compared to Myc-R2 (Myc-R2: 0.3 ± 0.03, n = 9; Myc-R2P820: 0.45 ± 0.06, n = 5; Fig. 7 
C). These results demonstrate that the C-terminal 120 amino acids of GABAB2 are 
involved in dendritic targeting. 
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Figure 6. The C-term of GABAB1 is not involved in somatodendritic targeting.  
(A) Schematic representation of GABAB1b expression constructs used in this experiment. The GABAB1b C-
terminal domain possesses a number of putative somatodendritic targeting signals: two dileucine-based 
motifs (LL) and one tyrosine-based motif (Y). Myc-1b was used to generate two deletion constructs, missing 
either the last 32 C-terminal amino acids (Myc-1bP812) or the entire C-terminal domain (Myc-1bI744). The 
green bar represents the c-myc epitope, black bars the transmembrane domains, grey bars the coiled-coil 
domain. 
(B) Myc-1b, Myc-1bP812 and Myc-1bI744 were co-transfected with soluble RFP into dissociated 
hippocampal neurons. In the upper panel, pictures of the RFP signal (red) and the immunolabelling against 
the c-myc epitope (green) were merged. Both truncated proteins are restricted to the somatodendritic 
compartment, similar to Myc-1b. Scale bar 10 μm.  
(C) A:D ratio of Myc-1b, Myc-1bP812 and Myc-1bI744 expression constructs normalized to RFP (mean ± 
SEM, n = 10-11). The A:D ratio is not significantly different between the three constructs. Statistics: One-
way ANOVA, Scheffe post-hoc test, p ? 0.05. 
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Figure 7. The C-terminal domain of GABAB2 is important for somatodendritic polarization.  
(A) Schematic representation of GABAB2 expression constructs used in this experiment. The distal C-terminal 
domain of Myc-R2 harbours three putative tyrosine-based somatodendritic targeting motifs (Y) and a PDZ-
binding motif (VSGL) (blue bar). A deletion construct was generated missing the entire C-terminal domain 
downstream of the coiled-coil domain (Myc-R2P820). The green bars represent the c-myc epitope, black 
bars the transmembrane domains, grey bars the coiled-coil domain. 
(B) Full-length GABAB2 (Myc-R2) and Myc-R2P820 were co-transfected with soluble RFP into GABAB1a
-/-
 
cultured hippocampal neurons. In the upper panels, the pictures of the RFP signal (red) and the 
immunolabelling against the c-myc epitope (green) were merged. Both proteins are found in dendrites, but in 
contrast to Myc-R2, Myc-R2P820 is additionally present in axons. Scale bar 10 μm.  
(C) A:D ratio of Myc-R2 and Myc-R2P820 expression normalized to RFP (mean ± SEM, n = 5-9). The A:D 
ratio is significantly higher for Myc-R2P820 compared to Myc-R2. Statistics: Student’s t-Test, p* ? 0.05. 
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Discussion 
 
Recently published data provided compelling evidence that GABAB1a conveys non-
redundant synaptic functions, most likely due to its specific localization within neurons 
(Perez-Garci et al., 2006; Shaban et al., 2006; Ulrich et al., 2007; Vigot et al., 2006). 
Imaging analysis demonstrated that GABAB1a but not GABAB1b protein is present in the 
axons of transfected CA3 pyramidal neurons (Vigot et al., 2006). It was speculated that the 
SDs, the only region of sequence divergence between GABAB1a and GABAB1b, dictate 
axonal localization. However, an understanding of the underlying mechanism, as well as 
which SD is involved, remained elusive. Here, we demonstrate that the SDs of GABAB1a 
are the critical determinant for axonal localization. They are sufficient to override dendritic 
signals in the C-terminal region of mGluR1a (Das and Banker, 2006; Francesconi and 
Duvoisin, 2002), and are therefore able to function in the context of a heterologous protein. 
Accordingly, the SDs of GABAB1a can be considered a general axonal targeting motif. 
Moreover, we provide evidence that each SD on its own is capable of mediating axonal 
localization of GABAB1 subunits. 
 
 
Mechanisms of SD-mediated axonal targeting 
An important question is how the SDs mediate axonal localization. Our finding that 
disulfide bond formation is critical for axonal localization of GABAB1a demonstrates that 
proper folding of the SDs into their unique tertiary structure is essential. This suggests that 
the SDs engage in a specific protein interaction that is required for targeting GABAB1a to 
axons. In principle, the SDs may function at any stage in protein targeting. They could 
mediate sorting of GABAB1a into axonal transport vesicles by interaction with proteins in 
the lumen of the TGN. Such a mechanism has been suggested for NgCAM, a member of 
the L1 family of adhesion molecules harboring five fibronectin typeIII-like repeats in its 
ectodomain responsible for axonal localization (Sampo et al., 2003). Not all proteins in a 
transport vesicle have sorting signals that allow them to be selectively targeted. Proteins 
that lack such motifs are transported “piggyback style” through association with proteins 
that have sorting signals (Roos and Kelly, 2000). Thus, the SDs might interact with another 
axonal protein within the lumen of the transport vesicle. This is in line with experiments 
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showing that elements of a mature presynaptic terminal, e.g. calcium channel subunits, 
endocytic proteins and synaptic vesicle proteins are transported along axons as discrete 
“transport packets” (Ahmari et al., 2000). Therefore, the sorting sequences of many axonal 
destined proteins may be actually regions that allow interactions between components of 
the presynaptic terminal within the lumen of the carrier. Interestingly, presynaptic GABAB 
receptors appear to be mostly localized near the active zone (Kulik et al., 2003), which is 
in agreement with their close link with the release machinery (Vigot et al., 2006). 
However, it remains to be elucidated whether there is a direct interaction of GABAB 
receptors with other elements of presynaptic terminals.  
 
Another mechanism proposed to establish polarity in neurons is selective retention (Sampo 
et al., 2003). There, post-Golgi carriers are non-selectively transported to axons and 
dendrites and sorting is achieved directly at the plasma membrane by selective fusion, 
selective interaction with scaffold proteins or selective internalization. In this regard, the 
SDs could convey selective retention through interaction with a membrane bound or 
extracellular matrix protein that anchors GABAB1a at specific sites. As a prerequisite for 
selective retention of GABAB1a versus GABAB1b, both isoforms must be delivered to the 
axonal domain. In line with previous results obtained from organotypic slice cultures 
(Vigot et al., 2006), the experiments presented herein provide evidence that this is not the 
case because endogenous as well as exogenously expressed GABAB1b is excluded from the 
distal axons in dissociated pyramidal hippocampal neurons (Figs. 1 and 2). Furthermore 
the SDs were capable of directing axonal localization of mGluR1a (Fig. 5), which is 
known to be directly targeted to dendrites (Das and Banker, 2006; Stowell and Craig, 
1999). Thus, the available data argue against a role of the SDs in selective retention of 
GABAB1a in the axonal domain. 
 
The two SDs of GABAB1a exhibit strikingly different structural properties (Blein et al., 
2004). This led to the proposal that they participate in protein interactions with multiple 
partners. Our observation that the two SDs are independently capable of directing axonal 
localization suggests that they interact with proteins of similar function or with different 
domains on the same protein(s). Although we did not observe a quantitative difference in 
axonal localization between GABAB1 subunits with one or two SDs it cannot be excluded 
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that the two SDs cooperate in directing axonal localization. A potential binding partner of 
the first SD is the ECM protein fibulin-2, which was identified in a yeast-two-hybrid 
screen (Blein et al., 2004). The fact, however, that cultured hippocampal neurons 
recapitulate the differential localization of GABAB1a and GABAB1b, suggests that receptor 
compartmentalization is cell autonomous and independent of a structured ECM. Thus, the 
putative SD-binding protein mediating axonal localization of GABAB1a in glutamatergic 
neurons remains unknown. 
 
 
Dendritic targeting of GABAB receptors 
Endogenous as well as exogenously expressed GABAB receptors are observed in the soma 
and throughout dendrites of cultured hippocampal neurons (Figs. 1 and 2; (Correa et al., 
2004)). This indicates that they are actively targeted into dendrites. Our experiments using 
deletion constructs reveals that the 120 amino acid C-terminal sequence of GABAB2 
contains essential dendritic targeting information. While full-length GABAB2 was 
restricted to the somatodendritic compartment, a significant amount of the C-terminally 
truncated GABAB2 protein was localized to the axon. The 120 amino acids C-terminal 
sequence of GABAB2 contains two putative tyrosine-based motifs that were shown to 
directly target proteins to dendritic endosomes or plasma membranes in neurons (de Hoop 
et al., 1995; Jareb and Banker, 1998; West et al., 1997), as well as a C-terminal PDZ-
binding motif (VSGL) that was shown to direct interaction with Mupp-1, a PDZ-scaffold 
protein (Balasubramanian et al., 2007). It remains to be elucidated whether any of these 
motifs contribute to the dendritic localization of GABAB receptors. Although the C-
terminally truncated GABAB2 protein was present throughout axons and dendrites, it was 
still polarized to the somatodendritc domain, indicated by an average A:D ratio of 0.42. 
For a completely unpolarized receptor protein one would expect an A:D ratio of 
approximately 1.0 (Das and Banker, 2006; Jareb and Banker, 1998). Therefore, our 
experiments indicate that in addition to the 120 amino acid C-terminal sequence other 
GABAB2 domains mediate dendritic localization. In this regard, our results are in 
agreement with other studies addressing the targeting of GPCRs in cultured hippocampal 
neurons. For example, it was shown that although the C-terminal domain of mGluR1a 
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contains a signal sufficient for dendritic localization, its deletion caused only a modest 
reduction in dendritic polarity (Das and Banker, 2006). 
 
Similarly we investigated the role of the C-terminal domain of GABAB1 in dendritic 
targeting. Deleting the entire C-terminus of GABAB1b resulted neither in axonal 
localization nor did it prevent targeting into distal dendrites. This demonstrates that the C-
terminal domain of GABAB1, which contains a number of “putative” dendritic targeting 
signals (Winckler and Mellman, 1999), is not essential for dendritic targeting. Therefore it 
is likely that GABAB1 subunits are targeted into dendrite in a complex with GABAB2 and 
do not harbour any dendritic targeting information themselves. However, recent evidence 
suggests that GABAB1 subunits may be transported into dendrites prior to assembly into 
heteromeric complexes (Vidal et al., 2007).  In this respect, our finding that deletion of the 
entire C-terminus of GABAB1b did not affect dendritic localization could indicate that other 
regions of the protein are capable of mediating dendritic targeting. 
 
 
A combination of distinct targeting signals regulates differential axonal localization of 
GABAB receptors subtypes 
Our findings are compatible with two possible scenarios for subcellular targeting of 
heteromeric GABAB(1a,2) and GABAB(1b,2) receptors in neurons. In the first model, both 
GABAB(1a,2) and GABAB(1b,2) receptors are transported into dendrites, either in 
somatodendritic post-Golgi carriers or while still residing in the ER (Vidal et al., 2007). 
Additionally, GABAB(1a,2) receptors are selectively packed into axonal transport carriers. 
The C-terminal domain of GABAB2 would thereby mediate dendritic polarization unless 
the SDs in the ectodomain of GABAB1a interact with a protein in the lumen of the TGN 
mediating axonal sorting. The availability of this putative SD-binding protein would 
thereby provide the limiting factor for axonal targeting of GABAB(1a,2). Alternatively, both 
GABAB(1a,2) and GABAB(1b,2) are initially exclusively transported to the somatodendritic 
compartment, where they are inserted into the plasma membrane. Subsequently, some 
GABAB(1a,2) receptors are internalized and redistributed to the axonal compartment, a 
mechanism referred to as transcytosis (Wisco et al., 2003). In this model, the SDs in the 
ectodomain of GABAB1a would mediate internalization through interaction with its 
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putative binding protein, possibly another transcytosed transmembrane protein. Elucidating 
the precise cellular mechanism underlying GABAB receptor compartmentalization needs to 
be further addressed using live cell imaging. The cooperation between 
extracellular/luminal and cytoplasmic targeting signals revealed in this study will be useful 
for studying subcellular targeting of other heteromeric receptors in neurons. 
 
 
Materials and Methods 
 
Mice 
Primary neuronal cultures were prepared from wild-type Balb/c mice or GABAB1
-/-
-,
 
GABAB1a
-/-
- and GABAB1b
-/-
 mice generated in the Balb/c inbred background (Schuler et 
al., 2001; Vigot et al., 2006). All animal experiments were subjected to institutional review 
and conducted in accordance with Swiss guidelines and approved by the veterinary Office 
of Basel-Town. 
 
 
Generation of mutant expression plasmids  
Cloning of myc-tagged expression constructs was based on a strategy described earlier 
(Pagano et al., 2001). Briefly, to allow detection of transiently expressed receptors, the 
endogenous signal peptides were replaced by 36 residues encoding the mGluR5 signal 
peptide MVLLLILSVLLLKEDVRGSAQS,
 
followed by the c-myc epitope, 
TREQKLISEEDLTR (replaced residues: Myc-1a, 1-16 (Kaupmann et al., 1997); Myc-1b, 
1-29 (Kaupmann et al., 1997); Myc-R2, 1-41 (Kaupmann et al., 1998); Myc-mGluR1a, 1-
20 (Masu et al., 1991)). The mGluR5 signal peptide was used because it is known to 
accurately release N-terminal epitope-tags (Ango et al., 1999). To generate Myc-1aCS the 
four cysteine residues at position 29, 95, 99 and 156 (Kaupmann et al., 1997) were mutated 
to serines in Myc-1a by site directed mutagenesis of thymine to adenine. To generate Myc-
1a?SD1 and Myc-1a?SD2 residues G28 to C95 or V96 to Q157 (Kaupmann et al., 1997) were 
deleted in Myc-1a, respectively. To generate Myc-SD-mGluR1a, residues G
17
 to S
134
 of 
GABAB1a (Kaupmann et al., 1997) were introduced behind the myc epitope in Myc-
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mGluR1a. To generate the C-terminal deletion constructs Myc-1bI744, Myc-1bP812 and 
Myc-R2P820 a stop codon was introduced by site directed mutagenesis after the residues 
indicated. Initially all constructs were subcloned into the cytomegalovirus-based 
eukaryotic expression vector pCI (Promega, Madison, WI) to confirm protein expression in 
HEK293 cells. Subsequently all constructs were shuttled into plasmid pMH4-SYN-1 for 
expression in cultured hippocampal neurons under control of the neuron-specific synapsin-
1 promoter (gift from T.G. Oertner and K. Svoboda). All constructs were verified by 
sequencing. 
 
 
Neuronal culture and transfection 
Cultured hippocampal neurons were prepared as described previously (Brewer, 1993; 
Goslin K., 1998). Briefly, embryonic day 16.5 mouse hippocampi were dissected, digested 
with 0.25 % trypsin in Hank`s solution (GIBCO) for 15 min at 37°C, dissociated by 
trituration and plated on glass coverslips coated with 1 mg/ml poly-L-lysine hydrobromide 
(Sigma) in 0.1 M borate buffer (boric acid/sodium tetraborate). Neurons were thereby 
either seeded at low-density (~100-150 cells/mm
2
) for endogenous GABAB1 labeling or at 
high-density (~750 cells/mm
2
) if needed for transfection or electrophysiological recordings 
and incubated at 37°C /0.5% CO2. For low-density cultures, neurons were cultivated in 
HC-MEM medium (1x MEM with Glutamax, 0.3% glucose (w/v), 10% horse serum and 
1% Pen/Strep) for the first 4 hours to allow attachment. Subsequently, the coverslips were 
transferred to a feeder-layer of primary astrocytes in serum-free medium (1x MEM with 
Glutamax, 0.3% glucose (w/v) and 1 % Pen/Strep) supplemented with 1% N2 (Invitrogen). 
Primary astrocytes were obtained from newborn P0-P1 Balb/c mice. To prevent extensive 
proliferation of astrocytes 5 ?M arabinoside (AraC, Sigma) was further added to the 
culture medium after 2 days. In contrast, high-density cultures were grown in 
Neurobasalmedium supplemented with B27 (Invitrogen), 0.5 mM L-glutamine and 50-100 
?g/ml Pen/Strep. In addition, 25 ?M glutamic acid was added to the medium for the first 3 
days. At DIV4, neurons were co-transfected with the appropriate expression constructs and 
soluble RFP (pMH4-SYN-tdimer2-RFP; gift from R. Tsien) using Lipofectamine 2000 
transfection reagent (Invitrogen).  
 
 Chapter III – The sushi domains of GABAB receptors function as a dominant axonal targeting signal 
 
  
75 
 
Electrophysiology 
Hippocampal neurons were cultured for 2-3 weeks. On the day of the experiment, 
coverslips were placed in an interface chamber containing saline (140 mM NaCl, 3 mM 
KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 11.1 mM glucose, 10 mM Hepes, ph 7.2) equilibrated 
with 95% O2/5% CO2 and recordings were performed at 30-32 °C. Whole-cell patch-clamp 
recordings were performed from the somata of neurons to measure holding currents and 
synaptic responses. Neurons were visualized using infrared and differential interference 
contrast optics. Drugs were applied by superfusion into the recording chamber. Na
+
 
currents induced by baclofen (100 ?M) were elicited at –50 mV in the presence of TTX. 
Patch and recording electrode (~5 M?) was filled with a solution containing: 140 mM Cs-
gluconate, 10 mM Hepes, 10 mM Phosphocreatine, 5 mM QX-314, 4 mM Mg-ATP, 0.3 
mM Na-GTP, pH 7.25, 294 mOsm. Miniature EPSCs (mEPSCs) were recorded at -70 mV 
in the presence of 0.5 ?M TTX and 10 ?M bicuculline. Detection and analysis of mEPSCs 
were done using the MiniAnalysis software (Synaptosoft, Decatur, GA, USA). During the 
experiment GABAB receptors were activated using the agonist baclofen and inactivated by 
the selective antagonist CGP54626 (2 ?M). 
 
 
Immunocytochemistry 
Neurons were fixed at 14 days-in-vitro (DIV14) in 4% PFA/120 mM sucrose/phosphate 
buffered saline (137mM NaCl, 8.5mM Na2HPO4, 1.5mM KH2PO4, 3.0mM KCl) for 20 
min at RT, permeabilized with 0.25% Triton-X-100 for 10 min and blocked for 1 h with 
10% normal goat serum (NGS) in phosphate buffered saline (PBS). Primary antibodies 
were diluted in 10% NGS/PBS and incubated overnight at 4°C. After washing with 1xPBS, 
neurons were incubated with secondary antibodies diluted in 1% NGS/PBS for 1 h at RT. 
Primary antibodies: chicken anti-MAP2 (1:10000; Abcam), rabbit anti-GABAB1-C-term 
(1:500; Clone B17; (Kulik et al., 2002); generously provided by Ryuichi Shigemoto), 
mouse anti-myc (1:500; Roche). Secondary antibodies: Alexa goat anti-chicken 647, Alexa 
goat anti-rabbit 568 and Alexa goat anti-mouse 488 (1:500; Molecular probes). 
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Microscopy 
Immunolabeled neurons were viewed on a Leica
 
DM5000B fluorescence microscope. 
Glutamatergic neurons were discriminated from GABAergic neurons by their extensively 
branched spiny dendrites visualized by the RFP filling (Benson et al., 1994; Obermair et 
al., 2003). Pictures were captured with a digital camera (F-View; Soft
 
Imaging System, 
Lakewood, CO, USA) using AnalySIS® software
 
(Soft Imaging System) and processed 
identically in Adope Photoshop®. Three different filters were used to detect secondary 
antibodies: L5-filter to visualize Alexa goat anti-mouse 488 bound to the monoclonal 
antibody against the myc-epitope, Y5-filter to detect Alexa goat anti-chicken 647 binding 
to antibody against MAP2 and a Y3-filter visualizing RFP or Alexa goat anti-rabbit 568 
binding to the polyclonal GABAB1 antibody. Pictures were taken with each filter 
individually and overlaid thereafter. Pictures from the endogenous GABAB1 staining were 
captured using a 63x oil objective with 1.32 numerical aperture (NA) wetted with 
immersion oil without autofluorescence (Leica Microsystems Cat N
o 
11513859, Germany). 
Images to evaluate the axonal versus dendritic distribution of transfected GABAB 
expression constructs were photographed using a 20x 0.7 NA lens.  
 
 
Quantification of polarized distribution  
The axon-to-dendrite (A:D) ratio of epitope-tagged receptor constructs was determined 
essentially as described elsewhere (Gu et al., 2003; Sampo et al., 2003). Briefly, using 
Metamorph Imaging software one-pixel-wide lines were traced along the axons and 
dendrites on the RFP image. Next to each line, a quadrangle was drawn for background 
subtraction. Subsequently, the lines and quadrangles were transferred to the corresponding 
picture of the antibody labeling against the c-myc epitope detecting the different receptor 
constructs. Average pixel intensities were determined along the traced lines and in the 
background quadrangles. After background subtraction, the signal of the antibody labeling 
was normalized to the RFP signal in axons and dendrites and subsequently the A:D ratio 
was determined. The analysis was done for approx. 10 neurons from at least two culture 
preparations for each construct. Neurons that expressed the receptor constructs at very high 
levels or exhibited an irregular RFP filling were excluded from the analysis. SPSS software 
was used to determine the significance of the data (T-Test or one-way ANOVA together 
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with Scheffe post-hoc test. *p ? 0.05; **p ? 0.01; ***p ? 0.001. Error bars: standard error 
of the mean).  
 
 
Reagents 
Tetrodotoxin (TTX) was from Latoxan (Valence, France). Baclofen and CGP54626 were 
from Novartis Pharma AG (Basel, Switzerland). Hepes was from AppliChem (Cat. No. 
A1069.0100). All other reagents were from Fluka/Sigma (Buchs, Switzerland). 
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My contribution to this paper 
 
Data presented in chapter II provided evidence that selectively GABAB1a, but not the 
GABAB1b assembles functional receptors at glutamatergic terminals. The SDs provide the 
only region of sequence divergence between the two GABAB1 subunit isoforms. I thus 
aimed at deciphering the role of the SDs in specifying heteroreceptors by two different 
approaches. First, I studied whether the SDs play a role in the axonal targeting of 
GABAB(1a,2) receptors in glutamatergic neurons  (chapter III). Second, I wanted to clarify 
whether interference with the SDs impairs the function of heteroreceptors.  
 
For this purpose I undertook several experiments: 
 
1) To investigate whether disruption of disulfide bond formation abolishes 
heteroreceptor function I produced two lentiviruses expressing either GABAB1a 
wildtype protein or GABAB1a protein with disrupted SDs. By measuring the 
frequency of mEPSCs after baclofen-application I aimed at investigating to which 
extent the two viral proteins assemble functional heteroreceptors in infected 
GABAB1a
-/-
 cultured hippocampal neurons. For this experiment a nearby 100% 
transfection efficiency is needed since many glutamatergic terminals make 
synapses with the analyzed neuron. The viral particles I produced transfected 
HEK293 cells up to about 80 %, but unfortunately were not sufficiently 
transfecting cultured hippocampal neurons. 
2) In a second experiment I took advantage of a monoclonal SD antibody, which was 
made by a technician in our lab. I applied this antibody directly to the culture 
medium to scaven a putative SD-binding protein at the neuronal surface. However, 
the antibody had no effect on mEPSCs frequencies after baclofen application 
(ACSF was used as control).  
3) In a third experiment I used a soluble recombinant SD protein made by a 
postdoctoral fellow in our laboratory to scavenge the putative SD interacting 
protein. The results are illustrated in figure 4 of this chapter.  
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Abstract 
 
GABAB receptors are the G-protein-coupled receptors for ?-aminobutyric acid (GABA), 
the main inhibitory neurotransmitter in the brain. Receptor subtypes are based on the 
subunit isoforms GABAB1a and GABAB1b. GABAB1a differs from GABAB1b in its 
ectodomain by a pair of conserved protein-binding motifs, the sushi domains (SDs). Here 
we describe GABAB1j, an abundant secreted GABAB1 isoform essentially comprising the 
two SDs. We show that the SDs, when expressed as soluble proteins, impair the activity of 
GABAB heteroreceptors at glutamatergic terminals. In contrast, soluble SD proteins have 
no effect on the activity of GABAB autoreceptors at GABAergic terminals or postsynaptic 
GABAB receptors. Likely, therefore, soluble SD proteins interfere with the binding of 
heteroreceptors to an auxiliary protein at the cell surface. These results show that naturally 
occurring GABAB1j isoforms can regulate the level of presynaptic inhibition at excitatory 
synapses. Of importance for drug discovery, these findings also show that a selective 
therapeutic targeting of GABAB heteroreceptors is possible.  
 
 
Introduction 
 
GABAB receptors mediate pre- and postsynaptic inhibition in the central nervous system 
and are considered promising drug targets for a wide spectrum of psychiatric and 
neurological disorders including anxiety, depression and epilepsy (Bettler et al., 2004). 
GABAB receptors generate slow inhibitory postsynaptic currents (IPSCs) via activation of 
K
+
 channels (Lüscher et al., 1997). Moreover, they prevent neurotransmitter release via 
inhibition of presynaptic Ca
2+
 channels (Dunlap and Fischbach, 1981) and second-
messenger-mediated effects on vesicle priming (Sakaba and Neher, 2003). Presynaptic 
GABAB receptors are commonly divided into auto- and heteroreceptors depending on 
whether they control the release of GABA or other neurotransmitters, respectively. 
Recombinant and native studies showed that functional GABAB receptors are obligate 
heterodimers composed of GABAB1 and GABAB2 subunits (Gassmann et al., 2004; 
Marshall et al., 1999; Prosser et al., 2001; Schuler et al., 2001). At a molecular level, 
diversity in the GABAB receptor system arises from the expression of multiple GABAB1 
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subunit isoforms from a single gene. To date, the best characterized isoforms are GABAB1a 
and GABAB1b, which are generated by alternative promoter usage (Steiger et al., 2004). 
Structurally, the GABAB1a and GABAB1b isoforms differ in their N-terminal ectodomain 
by a tandem pair of SDs that are present in GABAB1a but not GABAB1b (Blein et al., 2004). 
SDs, also known as complement control modules or short consensus repeats, mediate 
protein-interactions in a variety of adhesion molecules (Lehtinen et al., 2004) and 
participate in hormone binding in Family B GPCRs (Perrin et al., 2006). We recently 
generated genetically modified GABAB1a
-/-
(1a
-/-
) and GABAB1b
-/-
(1b
-/-
) mice that 
selectively express either one or the other isoform (Vigot et al., 2006). This facilitated the 
dissociation of individual isoform functions and showed that heteroreceptors almost 
exclusively use the GABAB1a subunit (Shaban et al., 2006; Ulrich and Bettler, 2007; Vigot 
et al., 2006). In contrast, autoreceptors and postsynaptic GABAB receptors can be 
assembled with GABAB1a or GABAB1b subunits. It is therefore expected that the SDs of 
GABAB1a bind to protein(s) that are necessary for the recruitment of heteroreceptors to 
glutamatergic terminals (Ulrich and Bettler, 2007). A known binding partner of the SDs is 
the extracellular matrix (ECM) protein fibulin-2 (Blein et al., 2004), however, it has yet to 
exhibit a function in the context of GABAB receptors. 
GABAB1 subunits, but also several other membrane-linked receptors, produce secreted 
isoforms comprising SDs (Bulanova et al., 2007; Holter et al., 2005; Mosley et al., 1989; 
Schwarz et al., 2000; Wei et al., 2001a). These isoforms were shown to produce dominant-
negative effects in some instances (Bulanova et al., 2007; Mosley et al., 1989), but the 
physiological relevance of secreted GABAB1 isoforms remains unclear. Here we report the 
identification of an additional secreted GABAB1 isoform, GABAB1j, which is abundantly 
expressed in the central nervous system. Conspicuously, all known secreted GABAB1 
isoforms feature SDs. We therefore analyzed whether soluble SDs have the potential to 
regulate GABAB receptor functions in a dominant-negative manner. 
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Results 
 
GABAB1j encodes a secreted glycoprotein.  
We screened a non-amplified rat cortex/cerebellum cDNA library with a SD-specific 
hybridization probe and isolated several GABAB1j clones with an identical insert of ~1.6 
kb. GABAB1j diverges from GABAB1a downstream of exon 4 and encodes a protein of 229 
amino acids (Fig. 1A; supporting information (SI) Fig. 5A). The N-terminal 157 amino 
acids of GABAB1j are identical to GABAB1a and encode the signal peptide and the two 
SDs; the C-terminal 72 residues exhibit no significant homology to known proteins. 
Northern blot analysis revealed a GABAB1j transcript of ~1.6 kb in brain tissue and 
cultured cortical neurons (Fig. 1B). The SD-specific hybridization probe demonstrated that 
GABAB1j transcripts and full-length GABAB1a transcripts are of similar abundance. 
Hydropathicity analysis of the protein sequence revealed that GABAB1j lacks 
transmembrane domains and probably encodes a secreted protein (SI Fig. 5B). Immunoblot 
analysis of transiently transfected HEK293 cells showed that the myc-tagged GABAB1j 
protein has a molecular weight of ~29kD (Fig. 1C). Deglycosylation of GABAB1j with 
peptide N-glycosidase F (PNGase F) decreased the molecular weight to 25kD (data not 
shown), which corresponds to the calculated molecular weight of the mature protein. 
Immunoprecipitation experiments recovered GABAB1j but not GABAB1a from cell-
conditioned culture medium, confirming that GABAB1j is a secreted protein (Fig. 1C). 
 
 
Soluble SD protein selectively impairs the activity of GABAB heteroreceptors. For 
dominant-negative experiments, we produced a recombinant glycosylated SD protein 
(RSDP) in a yeast expression system (SI Fig. 6). It is known that the binding ability of the 
SDs is dependent on the integrity of their conserved disulfide bridges (Hashiguchi et al., 
1993; Perrin et al., 2006; Wei et al., 2001b). For control experiments, therefore, we 
produced mutRSDP, a protein with disrupted disulfide bridges (see supplementary 
information). We first analyzed whether RSDP interferes with presynaptic inhibition 
mediated by GABAB heteroreceptors. Under control conditions in artificial cerebro-spinal 
fluid (ACSF), activation of GABAB heteroreceptors by baclofen (100 μM) resulted in the 
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Figure 1. Characterization of the GABAB1j subunit isoform. 
(A) Schematic representation of the 5’ end of the GABAB1 gene indicating the exons specifying the GABAB1a, 
GABAB1b and GABAB1j isoforms. GABAB1j results from an 870 bp extension of exon 4 at its 3’ end (exon 4’), 
generating an open reading frame of 687 nucleotides. The SDs are indicated. 
(B) Northern blot analysis of GABAB1a and GABAB1j mRNA expression. Total RNA extracted from primary 
cortical neurons in culture (ctx) or mouse brain was hybridized to the 
32
P-labeled probes indicated in A. The 
pan probe encodes part of the extracellular GABA binding domain and detects ~4.5 kb GABAB1a and ~4.1 kb 
GABAB1b transcripts. The 1a probe encodes the two SDs and detects GABAB1a and ~1.6 kb GABAB1j 
transcripts. The 1j specific probe encodes 510 nucleotides of exon 4’. (C) Analysis of transfected HEK293 
cells expressing myc-tagged GABAB1a (myc-1a) and GABAB1j (myc-1j). Conditioned medium (cond. med.) 
was subjected to immunoprecipitation with a rabbit anti-myc antibody and analyzed together with 10 μg of 
total cell lysate (lysate) on Western blots with a mouse anti-myc antibody. GABAB1a protein was only 
detected in the cell lysate while secreted GABAB1j protein was additionally detected in the cell-conditioned 
medium. 
 
expected marked reduction of excitatory postsynaptic currents (EPSCs), which were 
evoked by extracellular stimulation of the Schaffer collaterals and recorded in CA1 
pyramidal neurons (Fig. 2A). Incubation of hippocampal slices with RSDP (1.0 μg/ml) for 
6 hours essentially abolished GABAB heteroreceptor function, as indicated by the failure of 
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baclofen to reduce EPSC amplitudes (Fig. 2A). Incubation of slices with mutRSDP or 
RSDP that was kept in a reduced state (incubation with 20 mM DTT) had no effect on 
heteroreceptor function (Fig. 2A). This shows that the effect of RSDP on heteroreceptor 
function depends on the correct folding of the SDs. Activation of adenosine A1 receptors 
reduced EPSC amplitudes to the same extent in the presence or absence of RSDP, 
demonstrating that presynaptic inhibition by another GPCR remained intact (Fig. 2A). We 
next analyzed whether RSDP interferes with presynaptic inhibition by GABAB 
autoreceptors. Baclofen depressed the amplitude of IPSCs, which were evoked by 
extracellular stimulation of the Schaffer collaterals and recorded from CA1 pyramidal 
neurons, to the same extent in the presence or absence of RSDP (Fig. 2B). This 
demonstrates that RSDP has no measurable effect on GABAB autoreceptors. Likewise, 
baclofen elicited similar K
+
 currents in CA1 neurons in the presence or absence of RSDP, 
demonstrating that RSDP has no effect on postsynaptic GABAB receptors either (Fig. 2C). 
In addition, we tested whether the extracellular matrix protein fibulin-2, which binds to the 
SDs of GABAB1a in vitro (Blein et al., 2004), can interfere with heteroreceptor function. 
Recombinant fibulin-2 (THS-fibulin2) (SI Fig. 7), when applied alone or in equimolar 
combination with RSDP to hippocampal slices, was without effect on heteroreceptors. This 
suggests that fibulin-2 is not an auxiliary signaling component of GABAB heteroreceptors. 
GABAB heteroreceptors not only inhibit evoked but also spontaneous neurotransmitter 
release (Yamada et al., 1999). We therefore investigated whether RSDP can interfere with 
the baclofen-induced reduction of the miniature EPSCs (mEPSCs) frequency. As expected, 
under control conditions (ACSF), baclofen significantly reduced the frequency but not the 
amplitude of mEPSCs recorded in CA1 pyramidal neurons (Fig. 3A). In the presence of 
RSDP, baclofen no longer reduced the mEPSC frequency (Fig. 3A). When applied alone, 
RSDP had no effect on the baseline mEPSC frequency. RSDP had no effect on 
autoreceptor-mediated inhibition of the mIPSC frequency (Fig. 3A), confirming that RSDP 
selectively acts on heteroreceptors.  
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Figure 2. RSDP selectively interferes with GABAB heteroreceptor function. 
(A) Summary histogram of the inhibition of evoked EPSC by baclofen (100 ?M) and adenosine (100 ?M) 
after incubation of hippocampal slices with RSDP (1.0 ?g/ml) or ACSF alone (control) for 6 h. Baclofen 
reduced the EPSC amplitudes recorded from CA1 pyramidal neurons in the presence of ACSF but not of 
RSDP (ACSF: 85 ± 4 % inhibition, n = 6; RSDP: 12.5 ± 3.5 % inhibition, n = 6; ***p < 0.001, Student’s t 
test). Adenosine reduced the EPSC amplitude in the presence of RSDP or ACSF alone to the same extent 
(ACSF: 83 ± 2 % inhibition, n = 6; RSDP: 85 ± 3 % inhibition, n = 6). RSDP treated with reducing agents 
(DTT) or mutated RSDP without disulfide bridges was without effect on heteroreceptor activity.  
(B) Summary histogram of evoked IPSC inhibition by baclofen (100 ?M) and adenosine (100 ?M). Baclofen 
and adenosine depressed the amplitude of evoked IPSCs recorded from CA1 pyramidal neurons under 
control conditions and after incubation with RSDP to the same extent. 
(C) Summary histogram of the amplitude of baclofen- and adenosine-induced K
+
 currents. The amplitude of 
the outward K
+
 current induced by baclofen is similar in the presence of RSDP (n=6) or ACSF alone (n=6). 
Similarly, adenosine-induced currents were unaffected by the presence of RSDP (Vclamp: -50 mV, TTX 1 
?M). Abbreviations: ACSF, artificial cerebrospinal fluid. Values are expressed as mean ± SEM. 
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Figure 3. RSDP interferes with GABAB receptor-mediated inhibition of spontaneous glutamate release 
(A) Summary histogram of mEPSC inhibition by baclofen (100 ?M) and adenosine (100 ?M) under control 
condition (ACSF) and after incubation with RSDP (1.0 ?g/ml) for 6 h. Baclofen depressed the frequency of 
mEPSCs recorded from CA1 pyramidal neurons in control slices but not in slices incubated with RSDP 
(ACSF: 71.0 ± 5.4 % inhibition, n = 5; RSDP: 7.6 ± 2.2 % inhibition, n = 9; ***p < 0.001, Student’s t test). 
As a control, adenosine depressed the frequency of mEPSCs under control conditions and after incubation 
with RSDP (ACSF: 67.0 ± 5.3 % inhibition, n = 5; RSDP: 76.0 ± 3.0 % inhibition, n = 9). Summary 
histogram of IPSC inhibition by baclofen (100 ?M) and adenosine (100 ?M). Baclofen and adenosine 
depressed the frequency of mIPSCs recorded from CA1 pyramidal neurons under control conditions and 
after incubation with RSDP. Effects of RSDP in 1b
-/-
 and 1a
-/-
 hippocampal slices. 
(B) Summary histograms of mEPSC frequency inhibition by baclofen and adenosine. Incubation with RSDP 
(1.0 μg/ml) for 6 h impedes the baclofen-mediated frequency inhibition observed under control condition in 
1b
-/-
 mice (ACSF: 67.0 ± 3.0 % inhibition; SD protein: 6.0 ± 2.0 % inhibition; n = 4; ***p < 0.001, Student’s 
t test). 
(C) In 1a
-/-
 mice, even under control condition, baclofen failed to depress the frequency of mEPSCs 
indicating the lack of functional GABAB heteroreceptors. (B and C) Summary histograms of mIPSC 
frequency inhibition by baclofen and adenosine. Baclofen and adenosine depressed the frequency of mIPSCs 
recorded from 1b
-/-
 as well as 1a
-/-
 CA1 pyramidal neurons under control conditions and after incubation 
with RSDP. (B and C) Summary histograms of the amplitude of baclofen- and adenosine-induced K
+
 
currents. The amplitude of the outward K
+
 current induced by baclofen is not affected by incubation with 
RSDP in slices established from 1b
-/-
 as well as 1a
-/-
 mice. Control adenosine-induced currents are similarly 
unaffected by incubation with RSDP in both genotypes (Vclamp: -50 mV, TTX 1 ?M). Abbreviations: ACSF, 
artificial cerebrospinal fluid; bac, baclofen; adeno, adenosine. Values are expressed as mean ± SEM. 
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RSDP interferes with a subset of GABAB1a-containing receptors.  
The above data show that RSDP selectively interferes with the function of GABAB 
heteroreceptors, which are known to be predominantly assembled with the GABAB1a 
subunit (Vigot et al., 2006). However, the GABAB1a subunit also significantly contributes 
to autoreceptors and postsynaptic GABAB receptors (Vigot et al., 2006). In fact, the 
complete lack of GABAB1b subunits in 1b
-/-
 mice does measurably impair the functions of 
GABAB autoreceptors or postsynaptic GABAB receptors. We therefore studied, in 
hippocampal slices of 1b
-/-
 mice, whether RSDP can interfere with autoreceptors and 
postsynaptic GABAB receptors that are assembled with the GABAB1a subunit. Incubation 
of 1b
-/-
 slices with RSDP neither interfered with autoreceptor responses (Fig. 3B) nor with 
GABAB-mediated K
+
 channel responses (Fig. 3B). However, RSDP strongly impaired 
heteroreceptor responses in 1b
-/-
 slices (Fig. 3B), thus corroborating data obtained with WT 
hippocampal slices (Fig. 3A). RSDP had no effect on pre- and postsynaptic GABAB 
receptors in hippocampal slices of 1a
-/-
 mice, where all receptors are assembled with the 
GABAB1b subunit (Fig. 3C). In all experiments with 1b
-/-
 or 1a
-/-
 mice, RSDP failed to 
interfere with pre- and postsynaptic adenosine A1 receptor responses (Fig. 3B,C). 
Altogether, these results demonstrate that RSDP selectively impairs the activity of 
GABAB1a-containing receptors at glutamatergic terminals. 
We next wanted to determine the time course of heteroreceptor impairment by RSDP. For 
these experiments we used hippocampal neuronal cultures, which enabled rapid access of 
RSDP to its site of action. We measured the inhibitory effect of RSDP on the baclofen-
induced reduction of the mEPSC frequency. At high concentrations, 1.0 μg/ml of RSDP, a 
partial impairment of GABAB heteroreceptor function was observed as early as 10 min 
after RSDP application, while a total impairment was observed after 1 hour (Fig. 4A,B). At 
0.1 μg/ml of RSDP, a maximal impairment of heteroreceptor function was observed 12 
hours after RSDP application. As observed in hippocampal slices (Fig 2, 3), RSDP did not 
interfere with presynaptic inhibition mediated by adenosine A1 receptors (Fig. 4C,D).  
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Figure 4. RSDP acts within minutes and in a dose-dependent manner. 
(A) The inhibition of mEPSC frequency by baclofen was assessed in 2-3 week-old mouse primary 
hippocampal neurons incubated with RSDP for 1 hour, 12 hours or 24 hours. Two different doses of RSDP 
were applied: 0.1 ?g/ml and 1.0 ?g/ml. ACSF was used as a control. mEPSCs were recorded from individual 
neurons and the baclofen-induced percentage inhibition of mEPSC frequency was determined. After 1 h 
incubation with 1.0 ?g/ml RSDP the baclofen-induced mEPSC frequency inhibition is completely abolished.  
(B) Time course of the RSDP-mediated reduction of baclofen-induced mEPSC frequency inhibition 
illustrating that the RSDP exerts its effect within minutes.  
(C and D) Representative trace (C) and summary histogram (D) illustrating that the RSDP selectively 
abolishes baclofen-induced mEPSC frequency inhibition. Primary hippocampal neurons were incubated with 
1.0 μg/ml RSDP for 1 h and the inhibition of mEPSC frequency by adenosine and baclofen was assessed in 
the same cell. ACSF was used as a control. Pre-incubation with RSDP specifically impedes baclofen-
mediated mEPSC frequency inhibition (ACSF: 88.6 ± 2.4 %; SD protein: 15.7 ± 3.2 %, n = 5, ***p < 0.001, 
Student’s t test). Values are expressed in percentage inhibition of mEPSC frequency (mean ± SEM). 
 
 
Discussion 
 
Recent data suggest that excitatory axons can express factors that are necessary for the 
recruitment and functioning of GABAB heteroreceptors (Ulrich and Bettler, 2007). In this 
study we characterized a new GABAB1 isoform, GABAB1j, which joins a growing number 
 Chapter VI – The SDs of secreted 1a isoforms selectively impair heteroreceptors 
 
  
90 
of secreted GABAB1 isoforms that all feature SDs (Holter et al., 2005; Schwarz et al., 
2000; Wei et al., 2001a). We hypothesized that secreted GABAB1 isoforms could act by 
scavenging an auxiliary extracellular binding partner. Indeed we found that RSDP, a 
soluble protein that solely consists of the SDs, can selectively interfere with the activity of 
GABAB heteroreceptors. These results clearly demonstrate that naturally occurring 
secreted GABAB isoforms have the potential to exert dominant-negative effects. It 
therefore appears that the level of presynaptic inhibition at glutamatergic synapses is not 
only dynamically regulated through the control of GABAB1a transcription (Steiger et al., 
2004) and recruitment (Vigot et al., 2006), but also through dominant-negative effects via 
secreted GABAB1 isoforms. Both the recruitment and the dominant-negative effects 
depend on the SDs and may therefore be mechanistically linked.  
It remains unclear how GABAB heteroreceptors are inactivated following RSDP exposure. 
We can exclude that RSDP acts as competitive antagonists of GABAB receptors, because 
RSDP did not prevent the activation of GABAB(1a,2) receptors expressed in HEK293 cells 
(data not shown), nor did it impair the functioning of autoreceptors or postsynaptic 
GABAB receptors assembled with GABAB1a subunits. Likewise, it does not appear that 
receptors rapidly internalize as a consequence of disrupting an extracellular interaction, 
since GABAB autoreceptors or postsynaptic GABAB receptors in 1b
-/-
 animals assembled 
with GABAB1a subunits are stably expressed at the cell surface in the absence of such an 
interaction. As heteroreceptor impairment is seen within minutes of RSDP application in 
cultured neurons, we consider it more likely that RSDP interferes with the signaling rather 
than the axonal delivery of heteroreceptors. Possibly, SD-interacting protein(s) act as 
diffusion traps that keep heteroreceptors and effector Ca
2+
 channels in close proximity; 
RSDP treatment may cause the disassembly of this signaling complex. Alternatively, the 
putative SD-interacting protein could be directly involved in the regulation of synaptic 
vesicle release.  
The extracellular auxiliary factor binding to the SDs of GABAB1a remains enigmatic. The 
ECM protein fibulin-2, which binds to the first SD of GABAB1a (Blein et al., 2004), had no 
measurable effect on GABAB-mediated control of glutamate release. The fact that cultured 
hippocampal neurons reproduce the differential compartmentalization of GABAB receptor 
isoforms also supports that heteroreceptor specification is cell autonomous and 
independent of ubiquitously expressed ECM proteins. We additionally addressed whether 
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the SDs can recruit heteroreceptors through homophilic interactions. We found that RSDP 
does not co-immunoprecipitate with GABAB1a when applied to HEK cells transiently 
expressing surface targeted GABAB1 receptors, rendering this possibility unlikely (data not 
shown). Deciphering the mechanistic aspects of GABAB receptor regulation will largely 
depend on the identification of their extracellular binding partner(s). Extracellular binding 
partners were recently identified for several neurotransmitter receptors and shown to 
regulate their synaptic localization and function (Gally et al., 2004; Saglietti et al., 2007; 
Sia et al., 2007).  
Drug development in the GABAB field has been hampered by the fact that receptor 
subtypes have indistinguishable pharmacological properties. From a drug discovery point 
of view it would be desirable to selectively interfere with pre- and postsynaptic GABAB 
receptors. Our study now provides the first evidence that it is possible to selectively 
manipulate the activity of GABAB heteroreceptors. It is now safe to conclude that small 
molecular weight compounds interfering with SD interactions would have a different 
spectrum of activity than currently available GABAB antagonists, which are in a Phase II 
clinical trial for the treatment of mild cognitive impairment (Froestl et al., 2004). 
 
 
Materials and Methods 
 
Characterization of GABAB1j cDNA and mRNA 
Oligo (dT) primed double-stranded cDNA was synthesized from 5 μg poly(A)+ RNA 
isolated from the cortex/cerebellum of postnatal 7-day-old rats and cloned into pCDNAI 
using BstXI adaptors (Invitrogen, Carlsbad, CA). The cDNA library was screened with a 
32
P-labelled SD-specific cDNA hybridization probe (Kaupmann et al., 1997). For Northern 
blot analysis, total RNA was isolated from mouse brain and primary mouse cortical 
neurons using TRIZOL reagent (Invitrogen, Carlsbad, CA). RNA was blotted to a nylon 
membrane (Gene Screen Hybridization Transfer Membrane, NEN Life Sciences) after 
electrophoretic separation on agarose/formaldehyde gels. The membrane was hybridized 
with random primed 
32
P-labeled cDNA probes using Perfect Hyb hybridization buffer 
(Sigma) at 68°C. After washing in 0.2 x SSC, 0.1% SDS at 65°C the membrane was 
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exposed to Kodak Bio-Max maximum resolution X-ray films (Sigma-Aldrich, St. Louis, 
MO) for 72 hours. 
 
 
GABAB1j expression in HEK293 cells 
A GABAB1j-specific antibody is lacking. We therefore tagged GABAB1a and GABAB1j 
with the c-myc epitope (Pagano et al., 2001) and inserted the resulting cDNAs in the 
expression vector pCI (Promega, Madison, WI). The conditioned medium of transfected 
HEK293 cells (Lipofectamine 2000, Invitrogen) was collected after 48 hours and used to 
immunoprecipitate secreted GABAB1 protein. Briefly, the medium was incubated with 
Protein G-agarose (Roche, Mannheim Germany) for 2 hours, pre-cleared by centrifugation 
at 10000g for 10 minutes and then incubated overnight with a monoclonal anti-myc 
antibody (9E10, Sigma, diluted 1:1000) coupled to Protein G-agarose. After 5 washes in 
RIPA buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate containing 
Complete protease inhibitor cocktail (Roche, Mannheim Germany) immunoprecipitated 
proteins were eluted from the Protein G-agarose using 2 x SDS loading buffer, separated 
on SDS-PAGE and analyzed by Western blotting. To control for GABAB1a and GABAB1j 
expression levels, we lysed transfected HEK cells in RIPA buffer, pre-cleared the lysate at 
10000xg for 10 min before mixing it with 2 x SDS loading buffer. Western blot analysis 
was with a rabbit polyclonal anti-myc (PRB-150C; Covance, Berkley, CA, diluted 1:1000) 
and a peroxidase-coupled secondary antibody (donkey anti-rabbit or anti-mouse HRP-
conjugates, Amersham Biosciences UK Ltd., Little Chalfont, Buckinghamshire, UK; 
diluted 1:2500). Blots were developed using the enhanced chemiluminescence detection 
system (Amersham Biosciences UK, Ltd., Little Chalfont, Buckinghamshire, UK) and 
exposed to Kodak Bio-Max maximum resolution X-ray films (Sigma-Aldrich, St. Louis, 
MO). 
 
 
Production and purification of RSDP 
RSDP containing a polyhistidine tag was expressed in P.pastorsis and purified using Ni
+
-
charged resin (GraviTrap, Amersham, Supplementary information). To prepare RSDP for 
use in electrophysiological recordings, the eluted protein sample was concentrated and 
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dialysed against artificial cerebral spinal fluid (ACSF). The concentration of recombinant 
protein was achieved by ultrafiltering the sample solution though an anisotropic membrane 
YM-10 Centricon (Millipore, Billerica, MA). Following protein concentration, samples 
were immediately dialysed against freshly prepared ACSF according to manufacturer’s 
instructions (Pierce, Rockford, IL) (SI Fig. 8). 
 
 
Electrophysiology in hippocampal slices  
Standard procedures were used to prepare 300 ?M thick horizontal hippocampal slice from 
P22-P28 mice in cooled ACSF (119 mM NaCl, 2.5 mM KCl, 1.3 mM MgCl2, 2.5 mM 
CaCl2, 1.0 mM NaH2PO4, 26.2 mM NaHCO3 and 11 mM glucose, continuously bubbled 
with 95 % O2 and 5 % CO2). After 1 h, slices were incubated for a minimum of 6 h with 
1.0 ?g/ml of SD protein. After 6 h, slice were transferred to the recording chamber and 
superfused (2 ml/min) with ACSF at 30-32°C. Whole-cell patch-clamp recordings were 
performed from the somata of CA1 pyramidal neurons to measure miniature excitatory 
postsynaptic currents (mEPSCs). Neurons were visualized using infrared and differential 
interference contrast optic. Drugs, applied by superfusion into the recording chamber, were 
kept as aliquots and solutions were freshly prepared on the day of the experiment. The 
effect of adenosine (100 ?M) and baclofen (100 ?M) on mEPSCs and mIPSCs were 
elicited at – 60 mV and recorded in the presence of tetrodotoxin (1 ?M) and picrotoxin 
(100 ?M). Patch electrodes (?3 M?) were filled with a solution containing the following: 
140 mM Cs-gluconate, 10 mM HEPES, 10 mM phosphocreatine, 5 mM-314, 4 mM Mg-
ATP, 0.3 mM Na-GTP, at pH 7.2 with Cs-OH and 285 mOsm. During the experiment 
GABAB receptors were activated using the agonist baclofen and inactivated by the 
selective antagonist CGP54626 (1 ?M). MiniAnalysis software (version 6.0.4, 
Synaptosoft, Decatur, GA) was used for detection and analysis of mEPSCs and mIPSCs. 
Significant differences between two distributions of mEPSC and mIPSC amplitudes and 
interevent intervals were determined by using the Kolmogorov-Smirnov test, with P value 
< 0.01 indicating significance. The electrophysiologist was blinded to the treatment of the 
slice.  
EPSCs and IPSCs were elicited by voltage pulses (100 μs, 2-5 V stimuli) delivered through 
a bipolar Pt-Ir electrode (25 μm in diameter) placed in the stratum radiatum at a distance of 
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150-200 μm from the soma of the recorded cell. The recording electrode was filled with a 
solution containing (in mM): 140 Cs-gluconate, 10 HEPES, 10 phosphocreatine, 5 QX-
314, 4 Mg-ATP, 0.3 Na-GTP, at pH 7.25 with CsOH and 285 mOsm. EPSCs were 
measured at –70 mV in the presence of 100 μM picrotoxin.  
 
 
Electrophysiology with cultured neurons 
Primary hippocampal neurons were prepared from 16.5-day mouse embryos as described 
(Goslin K., 1998). Neurons were cultured in Neurobasal medium (Invitrogen, Carlsbad, 
CA) with B27 supplement (Invitrogen, Carlsbad, CA), 0.5 mM L-glutamine and 50-100 
?g/ml Pen/Strep for 2-3 weeks at a density of ~ 750 cells/mm2 on poly-L-lysine-coated 
glass cover slips. For the first three days, the culture medium was supplemented with 25 
?M glutamic acid. On the day of the experiment, cover slips were placed in an interface 
chamber containing saline (140 mM NaCl, 3 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 
11.1 mM glucose, 10 mM Hepes, pH 7.2) equilibrated with 95% O2 / 5% CO2. Whole-cell 
patch clamp recordings were performed at 30-32 °C. 
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Supporting Information 
 
Recombinant protein expression in P. pastoris. 
To express the GABAB1a RSDP, two oligonucleotides (forward: 5’-
TTTGCGGCCGCGAGAACCTGTACGTACAGGGCGGGGCTCAGACCCCC-3’; 
reverse: 5’- AAATCTAGAGTCTGTACGTACAGGTTCTCGTGTGGCGTTCGATT-3’) 
with unique restriction sites inserted were designed against published sequence of the 
mouse GABAB1a gene (accession no. AF114168). In addition, TEV cleavage sites were 
incorporated into the oligonucleotides (SI Fig. 7A). Using PCR, the two oligonucleotides 
will amplify sequence corresponding to residues 17–163 of the mouse GABAB1a gene 
(where residue 17 is Gly and residue 163 is His). The amplification was performed using 
the Expand High Fidelity PCR System (Roche, Mannheim, Germany) according to the 
manufacturer’s instructions and the fidelity of the PCR product confirmed by sequencing. 
For subcloning into the yeast expression plasmid pPICZ? (Invitrogen, Carlsbad, CA), 
plasmid DNA was digested with the restriction enzymes NotI and XbaI and ligation 
reactions performed according to manufacture’s instructions. Ligation reactions were 
tranformed into chemically competent TOP10F’ cells and positive clones were selected on 
low-salt LB/Zeocin plates. For expression of mutRSDP, the same primer sets for PCR 
were used in combination with a rat GABAB1a template with mutated cysteine residue (Gift 
from S. Abdel Aziz). Mutations were designed based on the GABAB1a sequence entry, 
accession no. Y10369; the cysteine residues C29, C95, C99 and C156, were mutated to 
serine residues to prevent the formation of disulfide bridges   ritical for correct SD folding. 
 
For transformation into P. pastoris, strain KM71H (Mut
s
), 20 ?g of linearised GABAB1a 
sushi-domain yeast expression vector was transformed into electrocompetent KM71H 
yeast prepared according to manufacturer’s instructions (Invitrogen). To isolate yeast with 
multiple genomic integration of the expression vector, recombinants were selected on YPD 
media containing 500 ?g/ml of Zeocin. For large-scale protein production, the 
manufacturer’s instructions were followed. Briefly, 10 ml of buffered minimal medium 
with glycerol as the sole carbon source (BMGY) was inoculated with one colony of yeast. 
After overnight growth at 30 
o
C, with vigorous shaking, cells were diluted in 1000 ml of 
BMGY and grown for a further 18 h. To induce protein production, cells were harvested 
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by centrifugation and resuspended in 200 ml of induction medium containing methanol 
(0.5 % (v/v) final concentration) in place of glycerol (BMMY). Protein induction was 
maintained for 4 days with fresh methanol added every 24 h. At the end of the protein 
induction period, the recombinant protein containing supernatant was clarified by 
centrifugation and the recombinant GABAB1a sushi-domain protein purified with Ni
+
-
charged resin (GraviTrap, Amersham Biosciences UK Ltd., Little Chalfont, 
Buckinghamshire, UK). Following protein immobilisation, columns were washed with 
phosphate buffer containing 20 mM imidazole and the purified protein was eluted with 
phosphate buffer containing 500 mM imidazole. The identity of the purified recombinant 
GABAB1a sushi-domain protein was analysed by SDS-PAGE and verified by Coomassie 
blue staining or Western blotting with monoclonal anti-c-myc (Roche, Mannheim, 
Germany)/anti-polyhistidine (Amersham Biosciences UK Ltd., Little Chalfont, 
Buckinghamshire, UK) antibody (SI Fig. 6B) 
 
 
Recombinant protein expression in E. coli. 
To express recombinant fibulin-2 protein, the pET32a(+) expression vector containing the 
fibulin-2 C-terminal residues 1069-1184 (gift from P.N. Barlow) was transformed into 
Escherichia coli strain BL21(DE3) Gold. Cells containing the plasmid were grown in LB 
selective media at 30
o
C.  For protein induction, cells grown to an OD600nm = 0.5 were 
induced by the addition of 0.1 mM isopropyl-?-D-thiogalactopyranoside for 2 h at 30oC. 
Protein purification was performed using Ni
+
-charged resin (GraviTrap, Amersham 
Biosciences UK Ltd., Little Chalfont, Buckinghamshire, UK) following cell lysis with B-
PERII (Pierce, Rockford, IL) supplemented with Complete protease inhibitor cocktail 
(Roche, Mannheim Germany). Following protein immobilisation, columns were washed 
with phosphate buffer containing 50 mM imidazole and the purified protein was eluted 
with phosphate buffer containing 500 mM imidazole. The identity of the purified 
recombinant fibulin2 protein was analysed by SDS-PAGE and verified by Western blotting 
with monoclonal anti-polyhistidine (Amersham Biosciences UK Ltd., Little Chalfont, 
Buckinghamshire, UK) antibody (SI Fig. 7A). For electrophysiological recordings samples 
were dialysed against freshly prepared ACSF according to manufacturer’s instructions 
(Pierce, Rockford, IL). 
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Figure 5.  
(A) Aligned nucleotide and predicted amino acid sequence of GABAB1j isoform compared to the N-terminal 
region of GABAB1a. GABAB1j results from an extension of exon 4 at its 3’ end for 870 bp. This generates an 
open reading frame (ORF) of 687 nucleotides encoding the first 157 amino acids of GABAB1a and 72 
unrelated residues (in italics) without significant homology to known proteins. Note that only the region 
containing the predicted ORF is shown. Arrows delimit the two SDs, the stop codon in GABAB1j is indicated 
by an asterisk.  
(B) Hydropathicity plot of GABAB1j according to Kyte and Doolittle  indicating the lack of putative 
membrane-spanning segments besides the hydrophobic N-terminal signal peptide (grey coloring). Black 
coloring indicates the GABAB1j-specific C-terminal region. 
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Figure 6.  
(A) Schematic representation of the RSDP expressed in P .pastoris. The recombinant protein contains the 
entire GABAB1a sushi-domain that is flanked by two Tobacco Etch Virus cleavage sites (TEVcs) followed by a 
c-myc and polyhistidine (Hisx6) tag at the carboxyl-terminus. The predicted molecular weight of the 
recombinant protein is ~25 kDa.  
(B) Protein analysis of the RSDP. The N-glycosylation of the RSDP (5 ?g) was analysed by treatment with or 
without N-Glycosidase F overnight at 37
o
C according to manufacturer’s instructions (Roche). In addition, 
the RSDP thermalstability was examined by incubating the protein at 37
o
C for 7 days. Individually treated 
protein samples were resolved in 15 % SDS-PAGE and protein visualised by Coomassie blue staining, or 
Western blotting with a mouse anti-myc antibody. The RSDP is N-glycosylated as indicated by the presence 
of a predicted molecular weight protein band in glycosidase treated samples, whilst untreated samples 
resolved at a higher molecular weight (~30 kDa). Degradation of the RSDP was not detected following 
prolonged incubation at 37
o
C (Data not shown).  
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Figure 7. Recombinant fibulin-2 C-terminal (THS-fibulin2) protein does not interfere with GABAB 
heteroreceptor function or RSDP effects.  
(A) Summary histogram of the inhibition of evoked EPSC by baclofen (100 μM) and adenosine (100 μM) 
after incubation of hippocampal slices with RSDP, THS-tag (control) or THS-fibulin2 protein alone (1.0 
μg/ml) for 6 h. Baclofen reduced the EPSC amplitudes recorded from CA1 pyramidal neurons in the 
presence of THS-fibulin2 and control but not of RSDP (THS-tag: 88.8 ± 1.7 % inhibition, n = 4; THS-
fibulin2: 77.6 ± 8.5 % inhibition, n = 5; RSDP: 6.3 ± 0.7 % inhibition, n = 3; ***p < 0.001, Student’s t test). 
Adenosine reduced the EPSC amplitude in the presence of RSDP, THS-fibulin2 or THS-tag to the same 
extent (RSDP: 80.7 ± 2.7 % inhibition, n = 3; THS-tag: 75.8 ± 2.7 % inhibition, n = 4; THS-fibulin2: 81.8 ± 
4.1 % inhibition, n = 5).  
(B) Summary histogram of the inhibition of evoked EPSC by baclofen (100 μM) and adenosine (100 μM) 
after incubation of hippocampal slices with RSDP protein alone or pre-incubated overnight with THS-
fibulin2 / THS-tag (RSDP alone: 10.5 ± 1.7 % inhibition, n = 5; RSDP + THS-tag: 9.2 ± 1.0 % inhibition, n 
= 5; RSDP + THS-fibulin2: 9.5 ± 1.9 % inhibition, n = 6). Adenosine reduced the EPSC amplitude in the 
presence of RSDP alone or  RSDP + THS-tag / THS-fibulin2 to the same extent (RSDP alone: 74.4 ± 6.1 % 
inhibition, n = 5; RSDP + THS-tag: 77.2 ± 2.7 % inhibition, n = 5; RSDP + THS-fibulin2: 79.8 ± 3.4  % 
inhibition, n = 6) (Abbreviations: RSDP, recombinant SD-protein; THS-tag, TrxHisx6S-tag; THS-fibulin-2,  
TrxHisx6S-tag fibulin2 C-terminal.) Values are expressed as mean ± SEM. 
 
 
 
 
 Chapter VI – The SDs of secreted 1a isoforms selectively impair heteroreceptors 
 
  
100 
 
 Chapter V – Discussion and Perspectives 
 
  
101 
 
 
 
 
 
 
‘^09 
^ 
 
 
Chapter V  
 
 
 
 
 
DISCUSSION AND PERSPECTIVES 
 
 
 
 
 Chapter V – Discussion and Perspectives 
 
  
102 
Discussion and Perspectives 
 
       The aim of this doctoral thesis was to unravel the role of the GABAB1a-specific SDs in 
the pre- versus postsynaptic distribution and functional segregation of GABAB receptor 
subtypes. The central findings of this work have been described in chapter 2, 3 and 4 and 
will be discussed in the following section with respect to the current understanding of 
GABAB receptor signaling.  
 
Short summary of the presented data 
Using genetically modified mice with point-mutations in the translation start codons of 
either GABAB1a or GABAB1b we initially demonstrated that the two GABAB1 isoforms 
localize to distinct synaptic sites and convey non-redundant functions (chapter 2). Most 
strikingly it was observed that at CA3-to-CA1 synapses in the hippocampus, GABAB1a 
assembles heteroreceptors controlling glutamate release, while predominantly GABAB1b 
mediates postsynaptic inhibition. This functional segregation of GABAB receptor subtypes 
was confirmed in the thalamus, cortex and lateral amygdala (Perez-Garci et al., 2006; 
Shaban et al., 2006, Ulrich et al., 2007). These results indicated for the first time that 
GABAB1 isoforms differentially compartmentalize in glutamatergic neurons. To further 
unravel the underlying molecular mechanism we aimed at identifying sequence 
determinants accounting for the selective occurrence of GABAB1a at glutamatergic 
terminals. We studied the axonal versus dendritic distribution of transfected GABAB 
expression constructs in cultured hippocampal neurons and demonstrate a role for the 
GABAB1a-specific SDs in axonal targeting of GABAB(1a,2) receptors (chapter 3). In 
addition, we show that the cytoplasmic C-terminal domain of the GABAB2 subunit harbors 
dendritic targeting information. Thus, a combination of distinct signals compartmentalizes 
GABAB receptors to pre- and postsynaptic sites. Last, we show that a recombinant soluble 
protein encoding the SDs (RSDP) is able to selectively abolish heteroreceptor function, 
whilst leaving auto- and postsynaptic receptors unaffected (chapter 4). Likely, RSDPs 
interfere with the binding of the SDs to auxiliary proteins at the cell surface. It thus appears 
that the SDs in GABAB1a exert at least two functions: besides determining axonal targeting 
of GABAB(1a,2) receptors, the SDs are further subject to modulation thereby controlling 
 Chapter V – Discussion and Perspectives 
 
  
103 
heteroreceptor function. Of note, this data provides a first potential tool for a selective 
therapeutic interference within the GABAB receptor system. 
 
How do the SDs mediate axonal targeting? 
In principle, GABAB receptor compartmentalization could involve mechanisms such as 
differential mRNA trafficking, protein targeting or protein retention (Horton & Ehlers, 
2003; Sampo et al., 2003). However, transfected CA3 neurons show an almost elusive 
association of GABAB1a protein with axons (chapter 2, figure 6), which suggest protein 
targeting underlying axonal localization of GABAB(1a,2) receptors. Furthermore, the data 
presented in chapter 3 clearly identified the SDs as the critical axonal determinant. 
Nevertheless, an unsolved question is by which mechanism the SDs determine axonal 
localization.  
 
Our finding that disulfide bond formation is important for the axonal localization of 
GABAB1a (chapter 3, figure 3) demonstrates that proper folding of the SDs into their 
unique tertiary structure is essential. This suggests that the SDs engage in a specific protein 
interaction required for targeting GABAB(1a,2) receptors to axons. The SDs are localized in 
the extracellular domain of GABAB1a. Thus, along the biosynthetic route, the SDs face the 
luminal part of the endoplasmatic reticulum (ER), trans-Golgi network (TGN) and 
transport vesicle and are turned towards the extracellular matrix after insertion into the 
plasma membrane. Three different mechanisms are thus conceivable for explaining the 
mediating of axonal localization of GABAB(1a,2) receptors by the SDs.  
First, the SDs could interact with membrane bound or ECM proteins in the axonal 
compartment, thereby anchoring GABAB(1a,2) receptors at glutamatergic terminals 
(“selective retention”). Second, the SDs could specifically sort GABAB(1a,2) receptors into 
axonally destined carriers through interaction with luminal proteins in the TGN (“selective 
delivery” or “direct targeting”). Third, binding of an unknown protein to the SDs could 
induce internalization of GABAB(1a,2) receptors from the somatodendritic membrane, 
followed by subsequent redistribution to axons, a process referred to as “transcytosis”.   
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Selective retention  
In the case of selective retention, protein-laden post-Golgi carriers are non-selectively 
transported to axons and dendrites, leading to insertion of the delivered cargo into the 
plasma membrane of both compartments. Subsequently, those membrane proteins reaching 
the appropriate compartment bind to specific proteins and are thereby retained at particular 
sites. Without this anchoring, the membrane proteins are internalized and degraded or 
resorted (Sampo et al., 2003; Winckler, 2004). Our finding that exogenous application of 
soluble recombinant SD protein (RSDP) interferes with heteroreceptor function in a 
dominant-negative manner (chapter 4) indicates that the SDs in GABAB1a bind to proteins 
at the cell surface. This result is thus compatible with the SDs acting as retention signal at 
glutamatergic terminals. However, a prerequisite for selective retention is a uniform 
distribution of carriers and an equal insertion of GABAB1a and GABAB1b isoforms into the 
presynaptic membrane. GABAB1b protein was found neither in distal axons of cultured 
pyramidal neurons (chapter 2, figure 1 and 2) nor in axons of pyramidal neurons in 
organotypic slice cultures (chapter 2, figure 6).  It is thus unlikely that selective retention 
accounts for the axonal localization of GABAB(1a,2) receptors.  
 
Selective delivery 
The second possible mechanism, selective delivery, implies that transported membrane 
proteins are sorted into specific axonal or somatodendritic destined carrier vesicles in the 
TGN. Such a mechanism for axonal targeting has been suggested for NgCAM, which uses 
five fibronectin type-III like repeats in its ectodomain as targting signals (Sampo et al., 
2003). Extracellular protein sequences like the SDs cannot directly interact with cytosolic 
molecular motor or adaptor proteins. It was thus suggested that GABAB(1a,2) receptors are 
transported “piggyback style” by interacting with presynaptic proteins in the lumen of the 
transport vesicles, similar to other axonally destined proteins (Roos and Kelly, 2000). The 
elements of a mature presynaptic terminal, e.g. calcium channel subunits, endocytic 
proteins and synaptic vesicle proteins are transported along axons as discrete “transport 
packets” (Ahmari et al., 2000). Since GABAB receptors are localized near the active zone 
(Kulik et al., 2003) and are closely linked to the release machinery (Vigot et al., 2006) it is 
conceivable that GABAB(1a,2) receptors are transported towards glutamatergic terminals in 
such preassembled carriers.  
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Nevertheless, if the SDs mediate axonal targeting how is this compatible with GABAB1a 
isoforms assembling functional postsynaptic receptors (chapter 2)? Possibly, both GABAB 
receptor subtypes are sorted into somatodendritic post-Golgi carriers unless the SDs bind to 
a protein in the lumen of the TGN mediating axonal sorting. The availability of such a 
                           
                                              
              
 
 
Figure 1. Schematic representation of the two possible mechanisms underlying GABAB1a axonal targeting, 
selective delivery and transcytosis.  
Selective delivery: Both GABAB(1a,2) (1a) and GABAB(1b,2) receptors (1b) are transported towards dendrites in 
somatodendritic post-Golgi carriers. Additionally, GABAB(1a,2) receptors are selectively packaged into axonal 
transport carriers probably through a specific interaction of the SDs in the lumen of the TGN.   
Transcytosis: Both GABAB(1a,2)  and GABAB(1b,2) receptors are first eclusively transported to the 
somatodendritic compartment, where they are inserted into the plasma membrane. Subsequently, some 
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GABAB(1a,2) receptors are internalized and redistributed to axons, a scenario which could be induced through 
interaction of the SDs with surface proteins or other transcytosed membrane proteins.  
Direct vesicle targeting to axons or dendrites is indicated by blue arrows, the indirect route by yellow 
arrows. 
 
 
putative SD-binding protein could be limited so that a subset of GABAB(1a,2) receptors is 
sorted into somatodendritic carriers by default.  
 
Transcytosis 
The third possible mechanism for the mediation of axonal localization of GABAB(1a,2) 
receptors by the SDs is transcytosis. There, post-Golgi vesicles transport and insert their 
cargo initially into the somatodendritic membrane. Subsequently, membrane proteins 
destined for the axonal compartment are internalized and redirected to axons. In this 
regard, binding of a ligand or a secreted protein to the SDs in the ectodomain of 
GABAB(1a,2) receptors could modify receptor stability and potentially induce transcytosis. 
Alternatively, the SDs could associate with other transcytosed proteins thereby triggering 
internalization of GABAB(1a,2) receptors.  
In the context of transcytosis, the presence of functional GABAB(1a,2) receptors at 
postsynaptic sites is relatively easy to explain. Individual dendritic segments have distinct 
molecular compositions and functional properties (Horton & Ehlers, 2003). Thus, a SD 
interacting surface or transmembrane protein presumably inducing transcytosis could be 
restricted to some dendritic subdomains. Furthermore, the endocytosis machinery could 
differ between dendritic segments. It is thus interesting to study whether the GABAB1a 
isoform assembles functional receptors all along the dendritic surface or whether the 
expression of GABAB(1a,2) receptors is restricted to some dendritic subdomains.  
 
 
Outlook 
 
Proposed experiments to further decipher the mechanism underlying GABAB(1a,2) 
receptor axonal targeting 
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Our data is compatible with two of the above discussed models, selective delivery and 
transcytosis. Nevertheless, deciphering which of these two scenarios eventually determines 
the localization of GABAB(1a,2) receptors at glutamatergic terminals requires further 
experiments. The identification of proteins binding to the SDs would probably constitute a 
decisive step in this context. Moreover, evidence for a selective internalization of 
GABAB1a, but not GABAB1b protein from the somatodendritic membrane or its co-
localization with endosomal markers would support the transcytosis scenario. 
Alternatively, the movement of eGFP-tagged GABAB1a protein could be analyzed in living 
cultured hippocampal neurons. This would help to distinguish between a direct vesicle 
movement from the TGN to glutamatergic terminals or an indirect, transcytotic pathway 
via the somatodendritic membrane. Of note, both selective delivery and transcytosis were 
shown to underlie the axonal targeting of NgCAM, a neuronal cell adhesion molecule 
(Sampo et al., 2003; Wisco et al., 2003). This suggests that the two scenarios are not 
mutually exclusive. Possibly, the two mechanisms occur in parallel, take place at variant 
time points and/or happen in different subsets of neurons. 
 
Deciphering sequence motifs involved in somatodendritic targeting of GABAB 
receptors 
Our data clearly identify the SDs as the axonal targeting determinant. We further provide 
evidence that the cytoplasmic 120 amino acid C-terminal sequence of the GABAB2 subunit 
is involved in somatodendritic targeting (chapter 2, figure 7). Nevertheless, C-terminal 
truncated GABAB2 protein was still present in dendrites. This indicates that additional 
sequence information must determine dendritic targeting. The identified 120 amino acid 
motif on the GABAB2 subunit harbors a PDZ binding motif (VSGL) that has been shown 
to interact with Mupp-1, a PDZ-scaffold protein (Balasubramanian et al., 2007). It is thus 
possible that a so far unidentified targeting signal mediates dendritic transport of GABAB 
receptors, which are subsequently anchored at postsynaptic sites via the cytoplasmic C-
terminal domain of the GABAB2 subunit.  It is thus important to narrow the amino acids in 
the cytoplasmic C-terminal domain of GABAB2 essential for somatodendritic targeting as 
well as to clarify which additional sequences on the heteromer might further underlie 
dendritic targeting.  
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A putative role for the SDs at postsynaptic sites 
Both GABAB1 isoforms are localized and functional at postsynaptic sites (chapter 2 and 3), 
but it remains to be determined whether they exert different functions in dendrites. A first 
indication for a differential distribution of GABAB1 isoforms in dendrites was given in 
chapter 2: tansfected CA3 pyramidal neurons show a selective occurrence of GABAB1b in 
dendritic spines, whereas both GABAB1a and GABAB1b are present in dendritic shafts. One 
possible explanation is that the SDs bind to a surface protein that anchor GABAB(1a,2) 
receptors in the extrasynaptic membrane, whereas GABAB(1b,2) receptors can freely move 
towards dendritic spines. The diffusion properties of eGFP-tagged GABAB1a and GABAB1b 
protein in the surface membrane between dendritic shafts and spine necks could be 
monitored in living neurons of e.g. organotypic slices cultures using two-photon laser 
scanning microscopy. Our data presented in chapter 3 further indicate that the majority of 
GABAB receptors is localized in intracellular pools. Possibly, GABAB1a and GABAB1b 
isoforms are differentially recruited from intracellular membranes. Thus, to further 
decipher the ratio of surface versus intracellular GABAB1a and GABAB1b protein in a 
quantitative manner the use of pH-sensitive GFP would be beneficial. 
 
The SDs exert multiple functions 
The data presented in this dissertation indicate multiple functions for the SDs. The SDs act 
as an axonal targeting signal, are subject to modulation of heteroreceptor function and 
likely play a role at postsynaptic sites. Of note, the two SDs in GABAB1a exhibit strikingly 
different structural properties (Blein et al., 2004). It is thus conceivable that individual SDs 
bind to different proteins and thereby convey different functions. Further deciphering the 
(distinct) function(s) of the SDs deeply depends on the identification of their extracellular 
and/or intracellular binding partners. The first N-terminal SD in GABAB1a was recently 
shown to interact with the ECM protein fibulin-2. However, a functional correlation with 
GABAB receptors remains elusive. In chapter 3 we have demonstrated that both SDs are 
able to mediate axonal targeting of GABAB(1a,2) receptors in glutamatergic neurons (chapter 
3, figure 4). Nevertheless, it remains to be determined whether individual SDs exert 
distinct functions at postsynaptic sites or differentially modulate heteroreceptor function. 
Of note, different binding properties and diverse functions of the two SDs could account 
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for some of the heterogeneity in the GABAB receptor system that was previously observed 
in native studies. 
 
 
Conclusion 
The data presented in this dissertation provide the first evidence for a functional 
compartmentalization of GABAB receptor subtypes in glutamatergic neurons. This pre- 
versus postssynaptic segregation is mediated by the SDs in the ectodomain of GABAB1a.  
Furthermore, our finding that RSDP selectively abolishes heteroreceptor function via the 
SDs provides a first potential tool for a selective therapeutic interference with individual 
GABAB receptor subtypes. This work thus indicates multiple functions for the SDs and 
provides a first potential tool for a selective therapeutic interference within the GABAB 
field.  
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ABSTRACT
Functional -aminobutyric acid type B (GABAB) receptors are
normally only observed upon coexpression of GABAB1 with
GABAB2 subunits. A C-terminal arginine-based endoplasmic
reticulum (ER) retention/retrieval signal, RSRR, prevents es-
cape of unassembled GABAB1 subunits from the ER and re-
stricts surface expression to correctly assembled heteromeric
receptors. The RSRR signal in GABAB1 is proposed to be
shielded by C-terminal coiled-coil interaction of the GABAB1
with the GABAB2 subunit. Here, we investigated whether the
RSRR motif in GABAB1 remains functional when grafted to
ectopic sites. We found that the RSRR signal in GABAB1 is
inactive in any of the three intracellular loops but remains
functional when moved within the distal zone of the C-terminal
tail. C-terminal deletions that position the RSRR signal closer to
the plasma membrane drastically reduce its effectiveness, sup-
porting that proximity to the membrane restricts access to the
RSRR motif. Functional ectopic RSRR signals in GABAB1 are
efficiently inactivated by the GABAB2 subunit in the absence of
coiled-coil dimerization, supporting that coiled-coil interaction
is not critical for release of the receptor complex from the ER.
The data are consistent with a model in which removal of RSRR
from its active zone rather than its direct shielding by coiled-coil
dimerization triggers forward trafficking. Because arginine-
based intracellular retention signals of the type RXR, where X
represents any amino acid, are used to regulate assembly and
surface transport of several multimeric complexes, such a
mechanism may apply to other proteins as well.
GABAB receptors are the G protein-coupled receptors for
GABA, the predominant inhibitory neurotransmitter in the
mammalian central nervous system. GABAB receptors mod-
ulate synaptic transmission by controlling neurotransmitter
release and by causing postsynaptic hyperpolarization (Bow-
ery et al., 2002; Calver et al., 2002; Bettler et al., 2004). They
are broadly expressed in the nervous system and have been
implicated in a variety of neurological and psychiatric condi-
tions. In heterologous cells, functional GABAB receptors are
usually only observed upon coexpression of GABAB1 with
GABAB2 subunits, which provided compelling evidence for
heteromerization among G protein-coupled receptors (Kaup-
mann et al., 1997, 1998; Jones et al., 1998; White et al., 1998;
Kuner et al., 1999; Marshall et al., 1999; Ng et al., 1999). Two
GABAB1 subunit isoforms, GABAB1a and GABAB1b, arise
from the GABAB1 gene by differential promoter use (Kaup-
mann et al., 1997; Bettler et al., 2004). The data therefore
support the existence of two predominant GABAB receptors
in the nervous system, the heteromeric GABAB(1a,2) and
GABAB(1b,2) receptors. However, knockout studies also sug-
gest that GABAB1a and GABAB1b could be functional in neu-
rons that naturally lack GABAB2 expression (Gassmann et
al., 2004).
In the GABAB heteromer, the GABAB1 subunit binds
GABA and all competitive GABAB ligands (Kaupmann et al.,
1998), whereas the GABAB2 subunit is predominantly re-
sponsible for activating the G protein (Galvez et al., 2001;
Margeta-Mitrovic et al., 2001; Robbins et al., 2001;
Grunewald et al., 2002; Havlickova et al., 2002). Trafficking
This work was supported by Swiss Science Foundation Grant 3100-
067100.01 and the De´sire´e and Niels Yde Foundation (to B.B.).
1 M.G., C.H., and Y.S. contributed equally to this work.
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ABBREVIATIONS: ER, endoplasmic reticulum; HEK, human embryonic kidney; CGP71872, 3-(1-(R)-(3-((4-azido-2-hydroxy-5-iodobenzoylamino)-
pentyl) hydroxyphosphoryl)-2-(S)-hydroxypropylamino)ethyl)benzoic acid; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered
saline; S, surface, H, homogenate; [Ca2]i, change in intracellular calcium concentration; PLC, phospholipase C; PAL, photoaffinity labeling.
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of unassembled GABAB1 subunits to the plasma membrane
is prevented by an arginine-based ER-retention/retrieval sig-
nal, the four amino acids RSRR, in the cytoplasmic tail of
GABAB1 (Couve et al., 1998; Margeta-Mitrovic et al., 2000;
Pagano et al., 2001). This ER-retention/retrieval signal is
proposed to be shielded by C-terminal coiled-coil interaction
of the GABAB1 with the GABAB2 subunit. Within the RSRR
motif the serine residue and the third arginine are not abso-
lutely critical for function, because they can be substituted by
other amino acids (Margeta-Mitrovic et al., 2000; Pagano et
al., 2001). More recently, it was shown that the sequence
context of the RSRR signal in GABAB1 influences its function
(Grunewald et al., 2002). Thus, the full ER-retention/re-
trieval motif in GABAB1 was extended to the sequence
QLQSRQQLRSRR, which includes part of the coiled-coil do-
main. Arginine-based ER-retention/retrieval signals were ob-
served in a number of other multisubunit proteins [e.g., the
KATP channels (Zerangue et al., 1999) andN-methyl-D-aspar-
tate receptors (Scott et al., 2001)], where they control stoi-
chiometry and surface expression of the channel complex.
From the available data, it emerges that the core ER-reten-
tion/retrieval motif is RXR, consisting of two arginines that
are separated by any amino acid (X).
Dilysine ER-retention/retrieval signals require a strict
spacing relative to the C terminus. In contrast to KK-signals,
functional RXR signals are found in a variety of cytosolic
positions, including intracellular loops and the N and C ter-
mini in type II and type I membrane proteins, respectively
(Schutze et al., 1994; Zerangue et al., 1999). This broad
distribution initially suggested that many proteins that har-
bor the consensus sequence RXR are retained in the ER. This
was recently challenged in a study that showed that the
RXR-dependent ER-retention/retrieval machinery is sensi-
tive to the length of the spacer that separates the RXR motif
and the receptor-anchored membrane (Shikano and Li,
2003). Here, we studied whether the RSRR signal in GABAB1
can still function when grafted to ectopic cytoplasmic posi-
tions and whether it can be masked by GABAB2 regardless of
its position. The data let us propose a new mechanism to
explain RSRR inactivation upon GABAB subunit dimeriza-
tion.
Materials and Methods
Generation of Mutant Expression Plasmids. All constructs
were subcloned into the cytomegalovirus-based eukaryotic expres-
sion vector pCI (Promega, Madison, WI). Overlap extension polymer-
ase chain reaction (Horton et al., 1990) was used to introduce ectopic
RSRR and LRSRR motifs into a GABAB1a mutant (R1[ASAA]) where
the endogenous RSRR was inactivated by substitution of arginine
with alanine residues (Pagano et al., 2001). Overlap extension poly-
merase chain reaction was also used to construct GABAB1a deletion
mutants, leaving the wild-type RSRR unchanged.
Cell Surface Labeling. HEK293 cells for transient transfection
of expression constructs were purchased from the American Type
Culture Collection (Manassas, VA) and cultured in Dulbecco’s min-
imum Eagle’s medium (Invitrogen, Basel, Switzerland) supple-
mented with 10% fetal calf serum and 2 mM L-glutamine. The
photoaffinity ligand [125I]CGP71872 specifically binds to the GABA-
binding site of GABAB1 subunits and does not permeate the plasma
membrane (Pagano et al., 2001). [125I]CGP71872 labeling of intact
cells therefore reveals GABAB1 protein at the cell surface, whereas
labeling of lysed cells reveals total GABAB1 protein, independent of
where in the biosynthetic pathway it is present. Six hours after
transfection of expression plasmids using Lipofectamine 2000 trans-
fection reagent (Invitrogen), HEK293 cells were transferred to six-
well plates. After an additional 24-h incubation, cells were washed
twice with ice-cold HEPES, pH 7.6. Half of the cells were then used
for photoaffinity labeling of surface receptors (S in Figs. 2, 6, and 7),
and the other half were used for labeling of total receptors in the cell
homogenates (H in Figs. 2, 6, and 7). For surface labeling, intact cells
were incubated in the dark for 1 h at room temperature with 0.8 nM
[125I]CGP71872. Thereafter, cells were washed twice with ice-cold
Krebs-Tris buffer (118 mM NaCl, 4.7 mM KCl, 1.8 mM CaCl2, 1.2
mM MgSO4, 1.2 mM KH2PO4, 5.6 mM glucose, and 20 mM Tris-Cl,
pH 7.4) to remove unbound ligand. Bound [125I]CGP71872 was cross-
linked to the receptor using UV light (Kaupmann et al., 1997).
Photoaffinity-labeled cells were then harvested, and the radioactiv-
ity was determined in a gamma counter (PerkinElmer Life and
Analytical Sciences, Zurich, Switzerland). For [125I]CGP71872 label-
ing of total GABAB1 protein, cells were harvested and lysed before
incubation with the photoaffinity ligand. Preparation of lysates and
[125I]CGP71872 binding was as described previously (Kaupmann et
al., 1997). For 10% SDS-PAGE, cell pellets and homogenates were
resuspended in Krebs-Tris buffer containing 0.1% SDS. An aliquot
was used for determination of protein concentration (Micro Protein
Assay; Bio-Rad, Munich, Germany). Equal amounts of total protein
were used when comparing S receptors and total receptors in cell Hs.
We normalized the input of radiolabeled protein in the SDS-PAGE
by using equal counts of the H samples for each set of transfections
(expression with and without GABAB2). Photoaffinity-labeled pro-
tein was detected using autoradiography. The S/H ratio of the radio-
activity incorporated into the cell surface and the homogenate frac-
tion was determined from the autoradiograms. Because of the
differences in the radiolabeling procedure for surface and homoge-
nate receptors, the percentage S/H sometimes exceeds the theoreti-
cal value of 100%. Loading was controlled for by Western blot anal-
ysis with the polyclonal GABAB1 antibody Ab174.1 that is directed
against the C-terminal tail of GABAB1 (Malitschek et al., 1998).
Surface labeling with [125I]CGP71872 was compared with surface
biotinylation (Fig. 3). For the biotinylation experiments, we used
membrane-impermeable EZ-link Sulfo-NHS-SS-biotin (Pierce
Chemical, Rockford IL). Forty-eight hours after transfection,
HEK293 cells were washed three times in PBS and then incubated
with 1 mg/ml Sulfo-NHS-SS-biotin for 30 min at 4°C on a rocking
table. To quench the biotinylation reaction, the cells were then
washed in PBS and incubated in 50 mM glycine in PBS for 5 min.
After three washes in PBS, the cells were lysed in radioimmunopre-
cipitation assay buffer (150 mM NaCl, 1% Nonidet-40, 0.5% sodium
deoxycholate, 0.1% SDS, and 50 mM Tris-Cl, pH 7.5). The lysates
were cleared by centrifugation at 10,000g for 10 min. Aliquots were
taken and mixed with 2 SDS loading buffer to detect total GABAB1
protein expressed. The remaining cleared lysates were incubated
with avidin beads (Pierce Chemical) at 4°C overnight. After five
washes in radioimmunoprecipitation assay buffer, biotinylated pro-
teins were eluted from the avidin beads using SDS loading buffer.
Finally, total and eluted GABAB1 proteins were separated on SDS-
PAGE and analyzed on Western blots.
Western Blots. After SDS-PAGE, proteins were blotted onto a
nitrocellulose membrane (Immobilon-P; Millipore Corporation, Bil-
lerica, MA) by standard electrophoretic transfer. After blotting, the
membrane was blocked with 5% nonfat milk powder in PBS for 1 h
at room temperature. Rabbit antiserum Ab174.1 (1:2500; Malitschek
et al., 1998), the monoclonal anti--tubulin antibody MAB3408 (1:
500; Chemicon International, Temecula, CA), and peroxidase-cou-
pled secondary antibodies (donkey anti-rabbit or anti-mouse conju-
gates, 1:2500; Amersham Biosciences UK, Ltd., Little Chalfont,
Buckinghamshire, UK) were incubated in PBS containing 2.5% non-
fat milk powder and 0.1% Tween 20 for 1 h at room temperature.
After antibody incubation, three wash steps with PBS containing
0.1% Tween 20 were carried out for 10 min. The blots were developed
using the enhanced chemiluminescence chemiluminescent detection
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system (Amersham Biosciences UK, Ltd.) and exposed to Kodak
Bio-Max maximum resolution X-ray films (Sigma-Aldrich, St. Louis,
MO).
Fluorimetric Measurement of Changes in the Intracellular
Ca2 Concentration ([Ca2]i). For measurement of [Ca
2]i, all
transfections included GqzIC to artificially couple GABAB receptors
to PLC (Franek et al., 1999). Transfected HEK293 cells were plated
into poly-D-lysine-coated 96-well plates (BD Biosciences, Erembode-
gem, Belgium). After transfection (48–72 h), cells were loaded for 45
min with 2 M fluo-4 acetoxymethyl ester (Molecular Probes, Lei-
den, The Netherlands) in Hanks’ balanced salt solution (Invitrogen)
supplemented with 20 mM HEPES buffer and 50 M probenecid
(Sigma, Buchs, Switzerland). Plates were washed and transferred to
a fluorimetric image plate reader (Molecular Devices, Crawley, UK).
Fluorescence changes F upon addition of GABA (final concentration
of 0.1 mM) were recorded as a function of time, as described previ-
ously (Pagano et al., 2001). No quantitative comparison between
experiments was made, because the signal amplitude depends on the
transfection efficiency.
Results
Generation and Characterization of GABAB1 Mu-
tants with Ectopic RSRR Signals. To study whether ec-
topic RSRR motifs are functional in GABAB1, we introduced
the RSRR motif into a GABAB1 protein where the endoge-
nous RSRR motif is inactivated by substitution of arginine
with alanine residues. This protein, R1[ASAA], is efficiently
transported to the cell surface in the absence of GABAB2
(Pagano et al., 2001). Whenever possible, we inserted the
RSRRmotif at positions that already harbored an arginine or
a serine residue, which is expected to minimize interference
with the wild-type amino acid sequence. A scheme depicting
the insertion sites of ectopic RSRR motifs in R1[ASAA] is
shown in Fig. 1A. The positions of the ectopic RSRR motifs in
the primary sequence of GABAB1a are listed in Fig. 1B. We
confirmed expression of mutant GABAB1 proteins in tran-
siently transfected HEK293 cells by Western blot analysis,
using an antibody directed against a C-terminal epitope (Fig.
1C). In general, the expression levels of mutant GABAB1
proteins are comparable with those of the wild-type GABAB1a
(R1) and R1[ASAA] proteins (Fig. 1C, top). The only excep-
tion is R1[R862SRR], which harbors the ectopic RSRR motif
in the C-terminal tail and for unknown reasons is poorly
expressed. On the other hand, it is also possible that some of
the C-terminal epitopes in R1[R862SRR] are affected by the
mutation and are no longer recognized by the antibody.
Equal loading was controlled for by Western blot analysis
with a -tubulin antibody (Fig. 1C, bottom).
RSRR Remains Functional at the C Terminus but
Not in Any of the Intracellular Loops. To examine the
functionality of ectopic RSRR motifs, we expressed GABAB1
mutants either in isolation or together with GABAB2. We
determined the ratio of surface and total GABAB1 protein
levels by photoaffinity labeling of intact and lysed cells, re-
spectively, with the membrane-impermeable antagonist
[125I]CGP71872. After SDS-PAGE, labeled proteins were vi-
sualized by autoradiography. We consistently observed that
wild-type and mutant GABAB1 proteins bind significantly
more [125I]CGP71872 when coexpressed with GABAB2, sug-
gesting that GABAB2 assists GABAB1 in reaching a binding-
competent conformation. To correct for this as well as vari-
ability in transfection efficiency, the amount of protein
sample subjected to gel electrophoresis was normalized to the
respective amount of radioactivity incorporated into the cell
Hs. Therefore, for the reason mentioned above, substantially
less immunostained GABAB1 protein is seen on all Western
blots of samples where GABAB2 was coexpressed (Fig. 2). For
each transfection, photoaffinity-labeled GABAB1 protein at
the cell S was compared with total GABAB1 protein labeled in
the cell Hs. We investigated whether the binding-incompe-
tent form of GABAB1, which is more abundant in the absence
of GABAB2, is able to reach the cell surface. We used bioti-
nylation of intact cells and precipitation with avidin-Sepha-
rose as an alternative method to [125I]CGP71872 labeling to
detect proteins expressed at the cell surface (Fig. 3). We
failed to detect significant amounts of GABAB1 protein ex-
pressed at the cell surface of HEK293 cells transfected with
GABAB1 alone (R1), indicating that the binding-incompetent
form of GABAB1 fails to reach the cell surface in the absence
of GABAB2. This is also supported by recent studies that
show that ligand binding is a critical requirement for plasma
membrane expression (Mah et al., 2005; Valluru et al., 2005).
In all our experiments, we therefore used photoaffinity label-
ing with [125I]CGP71872 to quantify GABAB1 protein at the
cell surface.
As shown in Fig. 2, wild-type GABAB1 (R1) is retained in the
ER and therefore does not bind the photoaffinity ligand at the
cell surface. However, upon coexpression with GABAB2 (R1 
R2), or inactivation of the RSRR motif (R1[ASAA]), GABAB1 is
released to the cell surface, in agreement with previous reports
(Margeta-Mitrovic et al., 2000; Pagano et al., 2001). Insertion of
RSRR motifs into any of the three intracellular loops (mutant
proteins R1[RS616RR], R1[RS624RR], R1[RV690RSRR],
R1[E699RSRR], and R1[E796RSRR]) failed to confer detectable
intracellular retention in our assay. Likewise, mutants with an
ectopic RSRR motif in the C-terminal tail at positions R862
(R1[R862SRR]), S877 (R1[RS877RR]), or S917 (R1[RS917RR])
were efficiently transported to the cell surface, no matter
whether they were expressed alone or in combination with
GABAB2. In contrast, insertion of an ectopic RSRR motif in the
C-terminal tail at positions S887 (R1[RS887RR]) and R939
(R1[R939SRR]) resulted in partial intracellular retention. In
summary, transposing the RSRR ER-retention/retrieval motif
of GABAB1 to ectopic positions indicates that it can be func-
tional in preventing transport to the cell surface in the cytoplas-
mic tail but not in any of the intracellular loops. Functional
RSRR signals are efficiently masked at ectopic sites by het-
erodimerization with GABAB2, as shown by the release of the
R1[RS887RR] and R1[R939SRR] proteins to the cell surface in
the presence of GABAB2.
Ectopic RSRRMotifs Do Not Interfere with Receptor
Function. The experiments described above show that all
GABAB1 subunits with ectopic RSRR motifs can reach the
cell surface when coexpressed with GABAB2. This suggests
that the mutated GABAB1 proteins fold correctly and assem-
ble into heterodimers. When expressed in heterologous cells,
GABAB1 is not functional by itself, even when artificially
targeted to the cell surface by inactivation of the RSRR signal
or by shielding it with a C-terminal GABAB2 peptide
(Margeta-Mitrovic et al., 2000; Pagano et al., 2001). To con-
firm heteromeric assembly between mutated GABAB1 and
wild-type GABAB2 subunits, we examined whether coexpres-
sion of the subunits yielded functional receptors. Upon tran-
sient coexpression of the subunits with a chimeric G sub-
unit, GqzIC (Franek et al., 1999), in HEK293 cells, we
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measured GABA-induced increases in intracellular Ca2 lev-
els by fluorimetry. As illustrated in Fig. 4, all GABAB1 mu-
tants can be activated with 0.1 mM GABA upon coexpression
with GABAB2, similarly to wild-type GABAB1 (R1  R2).
Hence, insertion of ectopic RSRR motifs does not interfere
with G protein coupling of the mutant proteins.
Appropriate Spacing to the PlasmaMembrane Is Re-
quired for ER-Retention/Retrieval of GABAB1. RXR-
type motifs were proposed to have an operating range and to
be sensitive with regard to their spacing from the plasma
membrane (Shikano and Li, 2003). This could explain why in
GABAB1 ectopic RSRR motifs are only functional when lo-
cated within the distal C-terminal tail (Fig. 2). Conflicting
with this explanation, the ectopic RSRR motif at S917,
in between the functional motifs at S887 and R939, is un-
able to confer intracellular retention (Fig. 2, construct
R1[RS917RR]). Small changes in the local sequence context
can alter the signal strength of arginine-based ER-retention
motifs (Zerangue et al., 2001). For example, the functionality
of RXR signals is described to improve when a hydrophobic
amino acid, in particular leucine, precedes the arginine clus-
ter. We therefore investigated whether insertion of a leucine
preceding the RSRR in R1[RS917RR] rescues intracellular
retention. We additionally tested whether including a leucine
in the R1[RS887RR] and R1[R939SRR] proteins, which are
less well retained than R1[ASAA], improves retention. In-
deed, insertion of a leucine preceding the RSRR at position
S917 renders the otherwise nonfunctional ectopic motif func-
tional (Fig. 5, R1[LRS917RR] versus R1[RS917RR]). In con-
trast, insertion of leucine in R1[RS887RR] or R1[R939SRR]
Fig. 1. Description of GABAB1 mutants with ectopic
RSRR motifs. A, schematic diagram depicting the
insertion sites of the ectopic RSRR motifs in a
GABAB1a mutant protein where the endogenous
RSRR sequence C-terminal to the coiled-coil domain
was mutated to ASAA. The seven transmembrane
helices are shown as black boxes. B, nomenclature of
the GABAB1a constructs used in this study. Residues
that were inserted to generate the ectopic RSRR
motif are underscored. The positions of the ectopic
RSRR motifs are numbered. Residue numbering re-
fers to wild-type GABAB1a protein (GenBank acces-
sion no. Y10369). C, Western blot analysis confirm-
ing expression of the mutant GABAB1a proteins in
HEK293 cells. An antibody specific for the GABAB1
C terminus detects a band of approximately 100 kDa
(top). A second band is sometimes visible, presum-
ably representing incompletely processed intracellu-
lar GABAB1 protein. R1[R862SRR], which harbors
the ectopic RSRR motif in the C terminus proximal
to the coiled-coil domain, is poorly expressed or in-
efficiently recognized by the antibody. Equal loading
of HEK293 cell lysates was controlled for by West-
ern blot analysis with a -tubulin antibody (bottom).
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does not improve intracellular retention of these proteins.
Intracellular retention of the R1[LRS917RR] protein further
supports that the distal cytoplasmic tail has the potential to
harbor functional RSRR signals.
We next tested whether the spacing to the plasma mem-
brane affects the functionality of the ER-retention/retrieval
motif in GABAB1. To that aim, we constructed three deletion
mutants that gradually move the endogenous RSRR motif
closer to the plasma membrane (Fig. 6). Deletion of nine
amino acid residues has no effect on the functionality of the
RSRR motif, whereas deletion of 30 or 52 amino acids in-
creasingly boosts cell surface expression of GABAB1. This
gradual increase in surface expression clearly shows that the
spacing to the plasma membrane is critical for RSRR func-
tion.
Masking of Ectopic RSRR Signals in GABAB1 Does
Not Involve C-Terminal Coiled-Coil Domain Interac-
tion. Two reports indicate that surface trafficking is not
entirely dependent on coiled-coil domain interaction between
the GABAB1 and GABAB2 subunits (Pagano et al., 2001;
Grunewald et al., 2002). For example, GABAB2 mutants lack-
ing the C-terminal coiled-coil domain (R2LZ2) are able to
traffic GABAB1 to the cell surface. We therefore investigated
whether coiled-coil interaction is necessary for masking the
functional ectopic RSRR motifs in R1[RS887RR] and
R1[R939SRR] proteins by cotransfecting them with R2LZ2
(Pagano et al., 2001). As shown in Fig. 7 and in agreement
with previous reports, R2LZ2 is able to traffic wild-type
GABAB1 (R1) to the cell surface, but to a smaller extent than
wild-type GABAB2 (R2). Both wild-type GABAB2 and R2LZ2
are able to traffic the R1[RS887RR] and R1[R939SRR] pro-
teins with functional ectopic RSRR motifs to the cell surface.
In addition R1[LRS917RR], which is efficiently retained in
the absence of GABAB2 (Fig. 5) is translocated to the cell
surface by coexpression with R2LZ2 (S/H ratio 69%; not
shown). This indicates that coiled-coil domain interaction
between the cytoplasmic tails of GABAB1 and GABAB2 is not
crucial for masking the ectopic RSRR motifs in the mutant
GABAB1 subunits. Additional interaction sites between
GABAB1 and GABAB2 obviously mediate heterodimerization
and compensate for the lack of coiled-coil domain interaction,
thereby presumably preventing the ectopic RSRR motifs
from binding to protein(s) that localize it in the ER.
Discussion
The generic membrane trafficking signals RXR and KK are
part of quality control mechanisms that prevent incorrectly
folded and/or assembled membrane proteins from reaching
the cell surface. Signals of the RXR-type are generally used to
control assembly of multimeric protein complexes. It is as-
sumed that the RXR motif is masked upon association with
an appropriate partner subunit and consequently only cor-
rectly assembled complexes are able to exit the ER. In con-
trast to the carboxyl-terminal dilysine signal KK, which ex-
hibits a strict spacing relative to the C terminus, RXR-type
signals are found in a variety of sequence positions. In oc-
tameric KATP channels they are localized in the cytoplasmic
Fig. 2. Surface targeting of wild-type (R1) and mutant GABAB1a proteins
expressed individually and in combination with GABAB2 (R2). Cell Hs
and intact S cells were photoaffinity-labeled with the membrane-imper-
meable GABAB1-specific antagonist [
125I]CGP71872 and subjected to
SDS-PAGE. To correct for the variability in transfection efficiency, the
amount of protein sample subjected to gel electrophoresis was normalized
to the respective amount of radioactivity incorporated into the cell Hs for
each set of transfection (expression with and without GABAB2). Labeled
proteins were then visualized by autoradiography (photoaffinity labeling,
PAL). Loading was controlled for by Western blot (WB) analysis with a
polyclonal antibody raised against GABAB1. It is evident that a larger
fraction of immunolabeled GABAB1 protein binds the photoaffinity ligand
when GABAB2 is coexpressed (lanes 1 and 2 verus 3 and 4). For each
transfection, we compared photoaffinity-labeled GABAB1 protein at the
cell S to total GABAB1 protein labeled in the cell Hs (% S/H). Insertion of
an ectopic RSRR motif at positions S887 (R1[RS887RR]) and R939
(R1[R939SRR]) results in partial intracellular retention (lane 2 versus 1),
which is overcome by coexpression with GABAB2 (lane 4 versus 2). The %
S/H values indicated represent the experiment shown in the figure.
One-way analysis of variance followed by a pairwise comparison via
Tukey’s honestly significant difference test confirmed that the % S/H
values (mean  S.D.) for R1[RS887RR] (17.0  10.1; n  3) as well as
R1[R939SRR] (26,7  11.9; n  3) differ significantly from the one for
R1[ASAA] (57.8  8.7; n  4) (p  0.05 in both cases).
Fig. 3. Surface biotinylation of GABAB1 (R1) and R1[ASAA] in the pres-
ence and absence of GABAB2. The fraction of GABAB1 protein at the cell
surface is similar when measured with surface biotinylation or with the
GABAB1-specific antagonist [
125I]CGP71872 (Fig. 2), supporting that
binding-incompetent GABAB1 protein is not delivered to the cell surface.
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tail of the pore forming  subunit (Kir6.1/2) as well as in a
cytoplasmic loop of the regulatory  subunit SUR1 (Zerangue
et al., 1999). In addition, the related ER-retention/retrieval
motif RR was identified in the cytosolic N terminus of the
myosin heavy chain class II invariant chain isoform lip33, a
type II membrane protein (Schutze et al., 1994). In the ex-
periments presented herein, we transposed the RSRR ER-
retention/retrieval signal of GABAB1 from its normal position
adjacent of the coiled-coil domain to ectopic positions within
the cytoplasmic tail or within the three intracellular loops.
We show that the RSRR motif is not functional in any of the
intracellular loops but that it is partially functional at two
ectopic positions within the cytoplasmic tail (Fig. 2). A pre-
vious study suggested that the functionality of the RSRR
motif of GABAB1 depends on surrounding sequences
(Grunewald et al., 2002). In particular, amino acid residues
that are part of the coiled-coil domain and neighbor the
RSRR motif N-terminally were proposed to be important for
recognition of the RSRR motif. From these previous experi-
ments, it was concluded that the minimal ER retention
sequence in GABAB1 is comprised of the amino acids
QLQXRQQLRSRR, where X can be either S or D (Grunewald
et al., 2002). Our data demonstrate that there is not a strict
requirement for the RSRR motif to be in its normal sequence
context to be functional, because the motif mediates reten-
tion when moved N-terminally of QLQXRQQLRSRR to posi-
tion S887 (R1[RS887RR]) or C-terminally to position R939
(R1[R939SRR]) (Fig. 2). However, the R1[RS917RR] protein,
harboring an RSRR motif positioned in between the motifs in
R1[RS887RR] and R1[R939SRR], is not retained. This sug-
gests that the sequence environment and/or the secondary
structure of the area where the ectopic RSRR motif has been
inserted are nevertheless of some influence. It was proposed
that small changes in the local sequence context can alter the
signal strength of arginine-based ER-retention motifs and
that it is favorable when a hydrophobic amino acid, in par-
ticular leucine, precedes the arginine cluster (Zerangue et al.,
2001). This sequence configuration is also observed for
the ER-retention/retrieval signal in wild-type GABAB1.
R1[RS917RR] and the partly retained R1[RS887RR] and
R1[R939SRR] proteins violate this rule. Insertion of a
leucine preceding the RSRR rescues intracellular reten-
tion of R1[RS917RR] but does not increase retention of
R1[RS887RR] and R1[RS939RR] (Fig. 5). This reinforces
that the local sequence context can influence RSRR func-
tionality and supports that the distal cytoplasmic tail is
accessible for intracellular retention at various sites.
It is emerging that different types of ER-retention/retrieval
motifs have characteristic operating ranges with respect to
the distance to the plasma membrane. Whereas carboxyl-
terminal KK motifs are operational proximal to the mem-
brane, RXR-type motifs are most effective at a certain dis-
tance away from the intracellular plasma membrane
(Shikano and Li, 2003). In our experiments the ectopic RSRR
Fig. 4. Functional analysis in HEK293 cells of GABAB
receptors with ectopic RSRR motifs in the GABAB1 sub-
unit. Artificial coupling of GABAB receptors to PLC upon
coexpression with a chimeric G subunit, GqzIC (Franek
et al., 1999) results in an intracellular Ca2 transient that
is measured by changes in fluo-4 acetoxymethyl ester flu-
orescence intensity. All GABAB1 mutants can be activated
by 0.1 mM GABA upon coexpression with GABAB2, simi-
larly to wild-type GABAB1 (R1  R2). Representative Ca
2
transients of 12 wells are shown. Bars below traces indi-
cate application of GABA.
Fig. 5. Intracellular retention of GABAB1 protein after insertion of a
leucine residue preceding the ectopic RSRR motif at S917. After trans-
fection with the indicated GABAB1 expression constructs, intact HEK293
cells were photoaffinity-labeled with the membrane-impermeable
GABAB1-specific antagonist [
125I]CGP71872 and subjected to SDS-PAGE.
Labeled proteins were then visualized by autoradiography (PAL). Load-
ing was controlled for by Western blot analysis with a polyclonal antibody
raised against GABAB1 (WB). Upon insertion of a leucine preceding the
ectopic RSRR at S917 (R1[LRS917RR]) no labeled protein is detected
indicating that the expressed GABAB1 protein fails to be transported to
the cell surface. No increased retention is observed with R1[LRS887RR]
and R1[LR939SRR] after insertion of a leucine residue.
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motifs in the intracellular loops may therefore be positioned
too close to the plasma membrane to be in the active zone. It
is also conceivable that the binding of a putative RSRR-
interacting protein involved in ER retention depends on ad-
ditional sequence elements within GABAB1. Appropriate
spacing between the RSRR motif and such additional se-
quence elements may be lost in GABAB1 proteins with mu-
tations in the intracellular loops. On the other hand, in
certain ectopic positions the RSRR motif might be inaccessi-
ble because of simple steric hindrance. We show that C-
terminal deletions that progressively move the wild-type
RSRR motif closer to the membrane gradually reduce its
signal strength, favoring that primarily the spacing to the
plasma membrane is important for RSRR function (Fig. 6).
Functional ectopic RSRR signals in GABAB1 are efficiently
masked by the GABAB2 subunit in the absence of coiled-coil
dimerization (Fig. 7). This agrees with previous findings that
coiled-coil interaction is not absolutely necessary for shield-
ing (Pagano et al., 2001). The mechanism by which GABAB2
prevents intracellular retention of GABAB1 therefore re-
mains unclear. The data presented herein suggest a model in
which global conformational changes associated with hetero-
meric assembly remove the RSRR signal from the active
zone, thereby restricting its access and triggering surface
delivery of the complex. COPI and 14-3-3 are prime candi-
dates for regulating aspects of GABAB receptor trafficking.
COPI components can interact with arginine-based motifs
and compete for binding with proteins of the 14-3-3 family
(Yuan et al., 2003). It is thought that 14-3-3 binding over-
comes ER-retention by preventing recycling of correctly as-
sembled proteins from the ER-Golgi intermediate compart-
ment to the ER via COP1 vesicles (O’Kelly et al., 2002; Nufer
and Hauri, 2003). 14-3-3 proteins are known to associate
with the C terminus of GABAB1 through a domain partially
overlapping with the coiled-coil domain (Couve et al., 2001).
It is conceivable that COP1 components bind to RSRR when
GABAB1 in unassembled, which recycles GABAB1 back to the
ER. After heteromeric assembly and removal of the RSRR
motif from its active zone, COP1 could then be replaced by
14-3-3, which avoids recycling and allows for surface traf-
ficking.
In conclusion, our results support that the RSRR ER-re-
tention/retrieval signal of GABAB1 is only functional within
the distal C-terminal tail. Moreover, coiled-coil interaction is
not crucial for inactivation of wild-type (Pagano et al., 2001)
and ectopic RSRR motifs. In the light of these data, we
propose that removal of the RSRR motif from its active zone
rather than direct coiled-coil shielding may trigger surface
delivery of the receptor complex. On a broader scope, the data
Fig. 6. The RSRRmotif is gradually inactivated when positioned closer to
the membrane. A, schematic diagram showing the coding regions of
different GABAB1 expression constructs with deletions of 9 amino acids
(R1R862-Q870), 30 amino acids (R1R862-E891) or 52 amino acids
(R1R862-H913) between transmembrane domain 7 and the extended
ER-retention/retrieval motif QLQSRQQLRSRR. The number of residues
that separate the extended ER-retention/retrieval motif from the trans-
membrane domain is indicated below each construct. B, cell surface
targeting of wild-type (R1), R1[ASAA] and deletion mutants in HEK293
cells in the absence of GABAB2. Cell homogenates (H) and intact cells (S)
were photoaffinity-labeled with the membrane-impermeable GABAB1-
specific antagonist [125I]CGP71872 and subjected to SDS-PAGE. Labeled
proteins were then visualized by autoradiography (PAL). Loading was
controlled for by Western blot (WB) analysis with a polyclonal antibody
raised against GABAB1. For each transfection, photoaffinity-labeled
GABAB1 protein at the cell S was then compared with total GABAB1
protein labeled in the cell Hs (% S/H). A deletion of nine amino acids
(R1R862-Q870) has no effect on the functionality of the endogenous
ER-retention-retrieval motif. However, deletion of 30 amino acids
(R1R862–E891) and 52 amino acids (R1R862–H913) gradually in-
creases cell surface expression of GABAB1.
Fig. 7. Coiled-coil domain interaction is not necessary for masking func-
tional ectopic RSRR motifs. Wild-type GABAB1 (R1) and the GABAB1
mutants with functional ectopic RSRR (constructs R1[RS887RR] and
R1[R939SRR]) were expressed alone (lanes 1 and 2) or in combination
with wild-type GABAB2 (R2) (lanes 3 and 4) or a GABAB2 mutant lacking
the coiled-coil domain (R2LZ2) (lanes 5 and 6). Cell Hs and intact S cells
were photoaffinity-labeled with the membrane-impermeable GABAB1-
specific antagonist [125I]CGP71872 and subjected to SDS-PAGE. Labeled
proteins were then visualized by autoradiography (PAL). Loading was
controlled for by Western blot (WB) analysis with a polyclonal antibody
raised against GABAB1. R2LZ2 is able to traffic wild-type GABAB1 to
the cell surface, but to a smaller extent than wild-type GABAB2 (left, for
each transfection compare photoaffinity-labeled GABAB1 protein at the
cell S to total GABAB1 protein labeled in the cell Hs). Both wild-type
GABAB2 and R2LZ2 are able to traffic the GABAB1 mutants
R1[RS887RR] and R1[R939SRR] to the cell surface to the same extent
(middle and right).
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suggest that many proteins featuring the RXR consensus
sequence in proximity of the membrane escape intracellular
retention because the motif does not reach into its opera-
tional zone.
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